<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Oral misoprostol for induction of labour - Alfirevic, Z - 2014 | Cochrane Library</title> <meta content="Oral misoprostol for induction of labour - Alfirevic, Z - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001338.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Oral misoprostol for induction of labour - Alfirevic, Z - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001338.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001338.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Oral misoprostol for induction of labour" name="citation_title"/> <meta content="Zarko Alfirevic" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Nasreen Aflaifel" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Andrew Weeks" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="aweeks@liv.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD001338.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/06/13" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001338.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001338.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001338.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Intravaginal; Administration, Oral; Cesarean Section [statistics &amp; numerical data]; Dinoprostone [administration &amp; dosage]; Labor, Induced [*methods]; Misoprostol [*administration &amp; dosage]; Oxytocics [*administration &amp; dosage]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001338.pub3&amp;doi=10.1002/14651858.CD001338.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="7a2tKMcJ";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001338\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001338\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","th","de","ms","fa","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001338.pub3",title:"Oral misoprostol for induction of labour",firstPublishedDate:"Jun 13, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7a2tKMcJ&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001338.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001338.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001338.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001338.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001338.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001338.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001338.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001338.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001338.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001338.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>13723 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001338.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-sec-0113"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-sec-0069"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-sec-0103"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/table_n/CD001338StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/table_n/CD001338StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Oral misoprostol for induction of labour</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information#CD001338-cr-0002">Zarko Alfirevic</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information#CD001338-cr-0003">Nasreen Aflaifel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information#CD001338-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Andrew Weeks</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information/en#CD001338-sec-0130">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 13 June 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001338.pub3">https://doi.org/10.1002/14651858.CD001338.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001338-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001338-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001338-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001338-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/th#CD001338-abs-0002">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001338-abs-0001" lang="en"> <section id="CD001338-sec-0001"> <h3 class="title" id="CD001338-sec-0001">Background</h3> <p>Misoprostol is an orally active prostaglandin. In most countries misoprostol is not licensed for labour induction, but its use is common because it is cheap and heat stable. </p> </section> <section id="CD001338-sec-0002"> <h3 class="title" id="CD001338-sec-0002">Objectives</h3> <p>To assess the use of oral misoprostol for labour induction in women with a viable fetus. </p> </section> <section id="CD001338-sec-0003"> <h3 class="title" id="CD001338-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (17 January 2014). </p> </section> <section id="CD001338-sec-0004"> <h3 class="title" id="CD001338-sec-0004">Selection criteria</h3> <p>Randomised trials comparing oral misoprostol versus placebo or other methods, given to women with a viable fetus for labour induction. </p> </section> <section id="CD001338-sec-0005"> <h3 class="title" id="CD001338-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trial data, using centrally‐designed data sheets. </p> </section> <section id="CD001338-sec-0006"> <h3 class="title" id="CD001338-sec-0006">Main results</h3> <p>Overall, there were 75 trials (13,793 women); these were of mixed quality.</p> <p>In nine trials comparing oral misoprostol with placebo (1109 women), women using oral misoprostol were more likely to give birth vaginally within 24 hours (risk ratio (RR) 0.16, 95% confidence interval (CI) 0.05 to 0.49; one trial; 96 women) and less likely to undergo caesarean birth (RR 0.72, 95% CI 0.54 to 0.95; 8 trials; 1029 women). Differences in ‘uterine hyperstimulation with fetal heart rate changes’ were compatible with no effect (RR 2.71, 95% CI 0.84 to 8.68; 7 trials; 669 women). </p> <p>Ten trials compared oral misoprostol with vaginal prostaglandin (dinoprostone) (3,240 women). There was little difference in the frequency of: vaginal birth within 24 hours (RR 1.10, 95% CI 0.99 to 1.22; 5 trials; 2,128 women), uterine hyperstimulation with fetal heart rate changes (RR 0.95, 95% CI 0.59 to 1.53; 7 trials; 2,352 women), and caesarean birth (RR 0.92, 95% CI 0.81 to 1.04; 10 trials; 3240 women). </p> <p>Five trials compared administration of oral misoprostol with intracervical prostaglandin E2 (681 women). Oral misoprostol was associated with fewer instances of failure to achieve vaginal birth within 24 hours (RR 0.78, 95% CI 0.63 to 0.97; 3 trials; 452 women) but more frequent uterine hyperstimulation with fetal heart rate changes (RR 3.57, 95% CI 1.11 to 11.54; 3 trials; 490 women). The available data for this comparison were however limited and the differences in caesarean birth were small (RR 0.85, 95% CI 0.63 to 1.16; 5 trials; 742 women). </p> <p>Nine trials compared oral misoprostol with intravenous oxytocin (1282 women). There were no obvious differences in the frequency of: vaginal birth within 24 hours (RR 0.79, 95% CI 0.59 to 1.05; 6 trials; 789 women), or uterine hyperstimulation with fetal heart rate changes (RR 1.30, 95% CI 0.43 to 3.91; 7 trials; 947 women). There were, however, fewer caesarean births with oral misoprostol (RR 0.77, 95% CI 0.60 to 0.98; 9 trials; 1282 women). </p> <p>Thirty‐seven trials compared oral misoprostol with vaginal misoprostol (6417 women). There was little difference in the frequency of: vaginal birth within 24 hours (RR 1.08, 95% CI 0.86 to 1.36; 14 trials; 2,448 women), uterine hyperstimulation with fetal heart rate changes (RR 0.71, 95% CI 0.47 to 1.08; 29 trials; 5,503 women), and caesarean birth (RR 0.93, 95% CI 0.81 to 1.07; 35 trials; 6,326 women). </p> <p>The incidence of serious neonatal or maternal morbidity or death was rare and no meaningful results were available for any of the comparisons. </p> </section> <section id="CD001338-sec-0007"> <h3 class="title" id="CD001338-sec-0007">Authors' conclusions</h3> <p>Oral misoprostol as an induction agent is effective at achieving vaginal birth. It is more effective than placebo, as effective as vaginal misoprostol and vaginal dinoprostone, and results in fewer caesarean sections than oxytocin alone. </p> <p>Where misoprostol remains unlicensed for the induction of labour, many practitioners will prefer to use a licensed product like dinoprostone. If using oral misoprostol, the evidence suggests that the dose should be 20 to 25 mcg in solution. Given that safety is the primary concern, the evidence supports the use of oral regimens over vaginal regimens. This is especially important in situations where the risk of ascending infection is high and the lack of staff means that women cannot be intensely monitored. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001338-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001338-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001338-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001338-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001338-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001338-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD001338-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD001338-abs-0005">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001338-abs-0004" lang="en"> <h3>Oral misoprostol for induction of labour</h3> <p>Oral misoprostol is effective at inducing (starting) labour. It is more effective than placebo, as effective as vaginal misoprostol and vaginal dinoprostone, and results in fewer caesarean sections than oxytocin. However, there are still not enough data from randomised controlled trials to determine the best dose to ensure safety. </p> <p>Induction of labour in late pregnancy is used to prevent complications when the pregnant woman or her unborn child are at risk. Reasons for induction include being overdue, pre‐labour rupture of membranes and high blood pressure. Prostaglandins are hormones that are naturally present in the uterus (womb); they soften the cervix and stimulate contractions in labour. The artificial prostaglandin E2 dinoprostone can be administered vaginally to induce labour but it is unstable at room temperature and is expensive. Oral misoprostol is a cheap and heat stable prostaglandin E1 synthetic analogue originally developed for the treatment of stomach ulcers. </p> <p>The search for trials took place in January 2014. This review of 75 randomised controlled trials (13,793 women) found that oral misoprostol appears to be at least as effective as current methods of induction. </p> <p>Nine trials (1,282 women) showed that oral misoprostol was equivalent to intravenous infusion of oxytocin. There were no obvious differences in the number of women who had a vaginal birth within 24 hours, or the number of women who experienced uterine hyperstimulation with changes to the baby's heart rate, although there were fewer caesarean sections in the group of women who were given oral misoprostol. </p> <p>For the 37 thirty seven trials (6,417 women) that compared oral and vaginal misoprostol, there was little difference in the number of women who had a vaginal birth within 24 hours, uterine hyperstimulation with changes to the baby's heart rate, or caesarean section. </p> <p>In 10 trials (3,240 women) comparing oral misoprostol with a vaginal prostaglandin (dinoprost), there was little difference in the frequency of vaginal birth within 24 hours, uterine hyperstimulation with changes to the baby's heart rate, or caesarean section. </p> <p>The nine trials that compared oral misoprostol with placebo (1,109 women) and found that oral misoprostol is more effective than placebo for inducing labour. Women in the oral misoprostol group were more likely to have vaginal birth within 24 hours, and less likely to have a caesarean section. There was little difference between groups in terms of the number of women who experienced uterine hyperstimulation with changes to the baby's heart rate. </p> <p>Five trials compared oral misoprostol with intracervical (inserted into the entrance of the womb) prostaglandin E2 (681 women). Oral misoprostol was associated with fewer instances of failure to achieve vaginal birth within 24 hours but more frequent uterine hyperstimulation with changes to the baby's heart rate. The available data for this comparison was limited and the differences in caesarean birth were small. </p> <p>Overall, the incidence of serious illness or death of the mother or her baby was rare and no meaningful results were available for any of the comparisons in this review. </p> <p>Using oral misoprostol to induce labour is effective at achieving vaginal birth. It is more effective than placebo, as effective as vaginal misoprostol and vaginal dinoprostone, and results in fewer caesarean sections than using oxytocin alone. </p> <p>In some countries where misoprostol is not licenced for the purpose of inducing labour, many clinicians may prefer to use some other licensed product such as dinoprostone. Where oral misoprostol is used, evidence suggests that an appropriate dose may be 20 to 25 mcg in solution. Given that safety is the primary concern, the evidence supports the use of oral regimens over vaginal regimens. This is particularly important in settings where the mother is at a higher risk of infection and where there may be insufficient staff to closely monitor the mother and her baby. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001338-sec-0113" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001338-sec-0113"></div> <h3 class="title" id="CD001338-sec-0114">Implications for practice</h3> <section id="CD001338-sec-0114"> <p>Oral misoprostol as an induction agent is effective at achieving vaginal birth. It is more effective than placebo, as effective as vaginal misoprostol and vaginal dinoprostone, and results in fewer caesarean sections than oxytocin alone. Oral misoprostol 20 to 50 mcg is as effective as vaginal misoprostol, and has lower rates of low Apgar scores and postpartum haemorrhage. </p> <p>There had been concerns about high rates of hyperstimulation with oral misoprostol, despite the fact that this had never been shown to cause any increase in adverse fetal outcomes. With low doses of oral misoprostol, this does not appear to be a problem. Rates of hyperstimulation are equivalent to both placebo and the current gold standard, vaginal dinoprostone. Comparisons with vaginal misoprostol are made difficult by the wide variety of doses of both oral and vaginal misoprostol used, which results in significant heterogeneity. </p> <p>Although there were no reported uterine ruptures in the 160 women in this review who were induced with misoprostol having had a previous caesarean sections, observational studies suggest that the uterine rupture rate is high with misoprostol, even when used in low doses. We therefore continue to recommend that it should not be used for women with previous caesarean section scars. </p> <p>In deciding whether to change to oral misoprostol from dinoprostone, practitioners will need to balance the advantages of low‐dose oral misoprostol (reduced caesarean section rate, low cost, heat stability and oral administration) against the problems resulting from the lack of a 25 mcg oral formulation (inaccuracies in dosage and the risks of making up the dosage oneself). If using oral misoprostol, the evidence suggests that the dose 20 to 25 mcg in solution and report serious adverse outcomes. Given that the primary consideration should be safety of induction, the evidence supports the use of oral regimens (using a maximum of 50 mcg) over vaginal regimens. This is especially important in situations where the risk of ascending infection is high and staffing levels mean that women undergoing induction cannot be intensely monitored (i.e. having one‐to‐one care and electronic fetal monitoring). </p> </section> <h3 class="title" id="CD001338-sec-0115">Implications for research</h3> <section id="CD001338-sec-0115"> <p>Methodologically sound clinical trials continue to be a priority, both in developing and industrialised countries. Ideally, these trials should be blinded and be limited to low‐dose oral misoprostol (20 to 50 mcg). A randomised examination comparing different regimens would be helpful to determine whether the labour intensive one‐ to two‐hourly administration is necessary, and the relative benefits of oral solution and the newly available 25 mcg tablets. Unblinded studies are prone to biased reporting of outcomes such as randomisation (induction) to birth interval, uterine hyperstimulation, fetal distress and maternal side effects. Also, in unblinded trials the threshold to perform caesarean section may vary according to the clinician's prior beliefs on the safety of misoprostol. On the other hand, administration of vaginal placebo may increase the number of vaginal examinations, influence clinical decision making and introduce bias in the assessment of women's and clinicians' views. </p> <p>Any proposed dose regimen includes a trade‐off between rapid birth and uterine hyperstimulation. Qualitative studies are required to assess how much emphasis women place on a short labour compared with increased perinatal risks that may be associated with shorter labours. Given that this trade‐off may vary depending on personality and culture, a flexible approach to dosage may be appropriate. </p> <p>Only large, pragmatic trials with adequate sample size or large registries will be able to address the risks of uterine hyperstimulation, uterine rupture, serious neonatal and maternal morbidity, and long‐term safety. The contact author would be happy to collect the information on serious adverse outcomes associated with the use of oral misoprostol (maternal and perinatal deaths, uterine rupture) and report them, with permission, in future updates of this review. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001338-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001338-sec-0029"></div> <p>This review is one of a series of reviews of methods of labour induction using a standardised protocol. For more detailed information on the rationale for this methodological approach, please refer to the currently published 'generic' protocol (<a href="./references#CD001338-bbs2-0124" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074.pub2] ">Hofmeyr 2009</a>). The generic protocol describes how a number of standardised reviews will be combined to compare various methods of preparing the cervix of the uterus and inducing labour. </p> <p>Induction of labour is a common clinical situation. The reasons for an induction are either clinical (post‐term pregnancy, prelabour rupture of membranes, hypertensive disorders) or social (parents' and clinicians' convenience). </p> <p>Prostaglandins have been widely used for labour induction, particularly if the cervix is not 'favourable' (<a href="./references#CD001338-bbs2-0134" title="KeirseMJNC . Prostaglandins in preinduction cervical ripening: meta‐analysis of worldwide clinical experience. Journal of Reproductive Medicine1993;38:89‐98. ">Keirse 1993</a>). Prostaglandin E2 (PGE2 or dinoprostone) appears to be the prostaglandin of choice when used vaginally in the form of gel, tablets or pessaries. Unfortunately, vaginal PGE2 preparations are expensive and unstable at room temperature. </p> <p>Oral administration of prostaglandins is less effective (<a href="./references#CD001338-bbs2-0133" title="KeirseMJNC , ChalmersI . Methods for inducing labour. In: ChalmersI , EnkinM , KeirseMJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:1057‐79. ">Keirse 1989</a>) and has been virtually abandoned, mainly due to gastrointestinal side effects. However, interest in oral prostaglandins has increased with the introduction of a new synthetic prostaglandin E1 analogue ‐ misoprostol. This drug is used mainly for the prevention and treatment of nonsteroidal anti‐inflammatory drug‐induced ulcers of the digestive tract. It is relatively cheap and stable at room temperature. Used for this indication, oral misoprostol is usually given in two to four doses of 200 micrograms (mcg) per day and the time to maximum concentration is 10 to 20 minutes (versus 60 to 80 minutes in the case of vaginal administration, <a href="./references#CD001338-bbs2-0107" title="Abdel‐AleemH , VillarJ , GulmezogluAM , MostafaSA , YoussefAA , ShokryM , et al. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2003;108(1):25‐8. ">Abdel‐Aleem 2003</a>). Side effects are dose dependent and are mainly confined to the digestive tract, such as diarrhoea and nausea (<a href="./references#CD001338-bbs2-0118" title="GarrisRE , KirkwoodCF . Misoprostol: a prostaglandin E1 analogue. Clinical Pharmacology1989;8:627‐44. ">Garris 1989</a>). </p> <p>Uterine contractions induced by misoprostol are often strong enough to expel products of conception in early pregnancy. Widespread use of misoprostol in Brazil for termination of pregnancy (<a href="./references#CD001338-bbs2-0114" title="CostaSH , VesseyMP . Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet1993;341:1258‐61. ">Costa 1993</a>) resulted in the identification of teratogenic effects including abnormalities of extremities (clubfoot, agenesis of the feet and hands, syndactyly, constriction rings) and Mobius sequence (loss of function of the motor cranial nerves, especially VI, VII and XII) (<a href="./references#CD001338-bbs2-0116" title="FonsecaW , AlencarAJC , MotaFSB , CoelhoHLL . Misoprostol and congential malformation. Lancet1991;338:56. ">Fonseca 1991</a>; <a href="./references#CD001338-bbs2-0120" title="GonzalesCH , Marques DiasMJ . Congenital malformation in children exposed to misoprostol in utero. Frontiers in Fetal Health1999;1(1):15. ">Gonzales 1999</a>; <a href="./references#CD001338-bbs2-0144" title="PastuszakAL , SchulerL , Speck‐MartinsCE , CoelhoKFA , CordelloS , VargasF , et al. Use of misoprostol during pregnancy and Mobious' syndrome in infants. New England Journal of Medicine1998;338:1881‐5. ">Pastuszak 1998</a>). These defects affect less than 1% of exposed fetuses (<a href="./references#CD001338-bbs2-0145" title="PhilipNM , ShannonC , WinikoffB . Misoprostol and teratogenicity: reviewing the evidence. Critical Issues in Reproductive Health. New York: Population Council, 2002. ">Philip 2002</a>). Maternal death from uterine rupture at 16 weeks' gestation after self‐medication with misoprostol has been reported (<a href="./references#CD001338-bbs2-0114" title="CostaSH , VesseyMP . Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet1993;341:1258‐61. ">Costa 1993</a>). </p> <p>Randomised trials, which have evaluated the effectiveness of a vaginally administered misoprostol for labour induction with a viable fetus, have been reviewed for <i>The Cochrane Library</i> (<a href="./references#CD001338-bbs2-0125" title="HofmeyrGJ , GülmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941.pub2] ">Hofmeyr 2010</a>). Oral use is particularly attractive because of easy and non‐invasive administration. However, there are inherent risks of such an approach. An overdose, causing uterine hyperstimulation may precipitate labour, and may be life‐threatening for both mother and fetus. It is therefore, important that oral misoprostol is evaluated in a systematic fashion to assess if it can be recommended for routine clinical practice. </p> <p>Despite having been widely studied for several reproductive health indications, misoprostol's licence has never been extended. This is thought to be due to the manufacturer's concerns about potential adverse publicity generated by the powerful US anti‐abortion lobby. Off‐label drug use is common in obstetrics, and includes many drugs, which would be considered mandatory in everyday practice (e.g. corticosteroids to prevent neonatal respiratory distress syndrome after premature labour and oxytocin 10 international units intramuscularly to prevent postpartum haemorrhage). Despite this, many practitioners are concerned about the potential legal consequences of using an off‐label drug should a serious adverse event occur, especially if an effective licensed alternative is available (<a href="./references#CD001338-bbs2-0150" title="WeeksAD , FialaC , SafarP . Misoprostol and the debate over off‐label drug use. BJOG: an international journal of obstetrics and gynaecology2005;112:269‐72. ">Weeks 2005</a>). Now that the patent for misoprostol has expired, generic misoprostol products licensed for reproductive health indications have become available in various parts of the world such as Brazil, France and Egypt. The arrival of licensed products will ease the medico‐legal concerns of those wishing to use misoprostol for induction of labour. </p> <section id="CD001338-sec-0030"> <h3 class="title" id="CD001338-sec-0030">Description of the condition</h3> <p>Induction of labour is used to bring an end to pregnancy when the benefits of giving birth at that time outweigh the risks of the induction process. </p> </section> <section id="CD001338-sec-0031"> <h3 class="title" id="CD001338-sec-0031">Description of the intervention</h3> <p>Oral misoprostol is given as a regular medication to pregnant women either as a tablet or in solution. The dosage and form of the medication varies, but it is generally used only until the woman's cervix is fully ripened. If further uterine stimulation is required after this, an intravenous infusion of oxytocin is generally used until birth, although some studies have continued the use of low‐dose misoprostol. </p> </section> <section id="CD001338-sec-0032"> <h3 class="title" id="CD001338-sec-0032">How the intervention might work</h3> <p>Similar to other prostaglandins, oral misoprostol acts on the uterus to soften (or 'ripen') the cervix and to stimulate contractions. </p> </section> <section id="CD001338-sec-0033"> <h3 class="title" id="CD001338-sec-0033">Why it is important to do this review</h3> <p>Oral misoprostol is a low‐cost and effective method for induction which is in common use in many parts of the world. Until recently, the drug was not licensed for use in pregnancy and so the drug manufacturers had neither formally evaluated it nor packaged the drug for induction of labour. There has been confusion therefore over which misoprostol regimen to use, and the use of excessive doses in late pregnancy has been thought to have been responsible for serious complications including uterine rupture. A formal evaluation of the many published studies is therefore very important to guide national and international recommendations for its appropriate use. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001338-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001338-sec-0034"></div> <p>To determine, from randomised controlled trials, the effectiveness and safety of oral misoprostol for third trimester induction of labour. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001338-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001338-sec-0035"></div> <section id="CD001338-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001338-sec-0037"> <h4 class="title">Types of studies</h4> <p>Clinical trials comparing oral misoprostol for labour induction with placebo/no treatment or other methods for labour induction. Quasi‐randomised trials were not included. This review includes only induction methods listed above oral misoprostol on a predefined list of methods of labour induction (<i>see</i><a href="#CD001338-sec-0045">Data collection and analysis</a>). We have included only trials that have some form of random allocation to the study groups and report at least one of the prestated outcomes. We have also included studies that compare various oral misoprostol regimens. </p> <p>In this review we make no distinction between cervical ripening and induction of labour if the aim was to achieve vaginal birth as safely as possible. However, we excluded the studies if the primary aim of intervention was to 'facilitate' spontaneous onset of labour over a long period of time (for example, oral misoprostol every other day between 40 and 42 weeks' gestation). </p> </section> <section id="CD001338-sec-0038"> <h4 class="title">Types of participants</h4> <p>Pregnant women due for third trimester induction of labour who carry a viable fetus.</p> </section> <section id="CD001338-sec-0039"> <h4 class="title">Types of interventions</h4> <p>Oral misoprostol compared with placebo/no treatment or six other methods for labour induction placed above oral misoprostol on a predefined list (<i>see</i><a href="#CD001338-sec-0045">Data collection and analysis</a>): </p> <p> <ol id="CD001338-list-0001"> <li> <p>placebo/no treatment;</p> </li> <li> <p>vaginal prostaglandin E2;</p> </li> <li> <p>intracervical prostaglandin E2;</p> </li> <li> <p>oxytocin alone;</p> </li> <li> <p>amniotomy alone;</p> </li> <li> <p>amniotomy + oxytocin;</p> </li> <li> <p>vaginal misoprostol.</p> </li> </ol> </p> <p>We will not discuss any of the comparisons listed above without relevant trials in this review. For the details of this selection strategy, please refer to <a href="#CD001338-sec-0045">Data collection and analysis</a>. </p> <p>In previously published versions of this review, we proposed to compare low‐, medium‐ and high‐dose regimens. We defined low‐dose regimens as less than 50 micrograms (mcg), medium‐dose as 50 to 100 mcg inclusive and high‐dose as more than 100 mcg. These arbitrary groups proved impractical because most trials used either 25 mcg, 50 mcg or 100 mcg doses. In order to study dose‐related effects, we decided to group regimens into: (i) 0 to 25 mcg, (ii) 26 to 50 mcg, (iii) 51 to 199 mcg and (iv) 200 mcg or more. We acknowledge that this change has been driven to some extent by the trials' data and is therefore a potential source of bias. Also, the same dose can be given at varying intervals (usually between two and six hours) and these differences could influence the primary outcomes. 'Low‐dose' regimens with two‐hourly administration may result in a higher cumulative dose over 24 hours than 'high‐dose' regimens. However, the plasma half‐life of oral misoprostol is short (20 to 40 minutes) and, therefore, it would appear that dose is more important than frequency. Consequently, at least at this point in time, we have not planned analyses based on frequency of administration. </p> </section> <section id="CD001338-sec-0040"> <h4 class="title">Types of outcome measures</h4> <p>Two authors of labour induction reviews (Justus Hofmeyr and Zarko Alfirevic) prespecified the clinically relevant outcomes for trials of methods of cervical ripening/labour induction. After discussion a consensus has been reached by all registered Cochrane Pregnancy and Childbirth Group review authors with an interest in labour induction. </p> <section id="CD001338-sec-0041"> <h5 class="title">Primary outcomes</h5> <p>We chose five primary outcomes as being most representative of the clinically important measures of ineffectiveness and complications:<br/> (1) vaginal delivery not achieved within 24 hours (includes all caesarean sections);<br/> (2) uterine hyperstimulation with fetal heart rate (FHR) changes;<br/> (3) caesarean section;<br/> (4) serious neonatal morbidity or perinatal death (e.g. seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood);<br/> (5) serious maternal morbidity or death (e.g. uterine rupture, admission to intensive care unit, septicaemia). </p> <p>Perinatal and maternal morbidity and mortality are composite outcomes. This is not an ideal solution because some components are clearly less severe than others. It is possible for one intervention to cause more deaths but fewer babies with severe morbidity. However, in the context of labour induction at term this is unlikely. All these events will be rare, and a modest change in their incidence will be easier to detect if composite outcomes are presented. We will explore the incidence of individual components as secondary outcomes. </p> </section> <section id="CD001338-sec-0042"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes relate to measures of clinical ineffectiveness, complications and satisfaction. </p> <p>Measures of ineffectiveness:<br/> (6) cervix unfavourable/unchanged after 12 to 24 hours;<br/> (7) oxytocin augmentation. </p> <p>Complications:<br/> (8) uterine hyperstimulation without FHR changes;<br/> (9) uterine rupture;<br/> (10) epidural analgesia;<br/> (11) instrumental vaginal delivery;<br/> (12) meconium‐stained liquor;<br/> (13) Apgar score less than seven at five minutes;<br/> (14) neonatal intensive care unit admission;<br/> (15) neonatal encephalopathy;<br/> (16) perinatal death;<br/> (17) disability in childhood;<br/> (18) maternal side effects (all);<br/> (19) maternal nausea;<br/> (20) maternal vomiting;<br/> (21) maternal diarrhoea;<br/> (22) other maternal side effects;<br/> (23) postpartum haemorrhage (as defined by the trial authors);<br/> (24) serious maternal complications (e.g. intensive care unit admission, septicaemia but excluding uterine rupture);<br/> (25) maternal death. </p> <p>Measures of satisfaction:<br/> (26) woman not satisfied;<br/> (27) caregiver not satisfied. </p> <p>'Uterine rupture' includes all clinically significant ruptures of unscarred or scarred uteri. We have excluded asymptomatic scar dehiscence noted incidentally at the time of surgery. </p> <p>While we have sought all of the above outcomes, only those with data appear in the analysis tables. </p> <p>The terminology of uterine hyperstimulation is problematic (<a href="./references#CD001338-bbs2-0115" title="CurtisP , EvansS , ResnickJ . Uterine hyperstimulation. The need for standard terminology. Journal of Reproductive Medicine1987;32:91‐5. ">Curtis 1987</a>). In the reviews we use the term 'uterine hyperstimulation without FHR changes' to include uterine tachysystole (more than five contractions per 10 minutes for at least 20 minutes) and uterine hypersystole/hypertonus (a contraction lasting two minutes or more) and 'uterine hyperstimulation with FHR changes' to denote uterine hyperstimulation syndrome (tachysystole or hypersystole with fetal heart rate changes such as persistent decelerations, tachycardia or decreased short‐term variability). </p> <p>Outcomes are included in the analysis if data were available according to original allocation and reasonable measures were taken to minimise observer bias. </p> <p>Only outcomes with available data appear in the analysis tables. We have, nevertheless, extracted and reported data on outcomes that were not prestated above. However, we have clearly labelled them as such ('not prespecified'). In order to minimise the risk of bias, we have based the conclusions solely on the prestated outcomes. </p> <p>The methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> </section> </section> </section> <section id="CD001338-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001338-sec-0044"> <h4 class="title">Electronic searches</h4> <p>We contacted the Trials Search Co‐ordinator to search the Cochrane Pregnancy and Childbirth Group’s Trials Register (17 January 2014). </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from:  </p> <p> <ol id="CD001338-list-0002"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>.  </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords.  </p> <p>We did not apply any language restrictions, and included data from abstracts so long as there was sufficient information on the study method, population and outcomes. </p> </section> </section> <section id="CD001338-sec-0045"> <h3 class="title" id="CD001338-sec-0045">Data collection and analysis</h3> <p>To avoid duplication of data in a series of reviews on interventions for labour induction as described in the generic protocol for methods for cervical ripening and labour induction in late pregnancy (<a href="./references#CD001338-bbs2-0124" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074.pub2] ">Hofmeyr 2009</a>), the labour induction methods were listed in a specific order, from one to 27. Each review included comparisons between one of the methods (from two to 27) with only those methods above it on the list. Thus, this review of oral misoprostol (8) could include comparisons with any of the following: (1) placebo/no treatment; (2) vaginal prostaglandins; (3) intracervical prostaglandins; (4) intravenous oxytocin; (5) amniotomy; (6) intravenous oxytocin with amniotomy; (7) vaginal misoprostol. The current list is as follows: </p> <p>(1) placebo/no treatment;<br/> (2) vaginal prostaglandins (<a href="./references#CD001338-bbs2-0135" title="KellyAJ , MalikS , SmithL , KavanaghJ , ThomasJ . Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD003101.pub2] ">Kelly 2009</a>);<br/> (3) intracervical prostaglandins (<a href="./references#CD001338-bbs2-0112" title="BoulvainM , KellyAJ , IrionO . Intracervical prostaglandins for induction of labour. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD006971] ">Boulvain 2008</a>);<br/> (4) intravenous oxytocin (<a href="./references#CD001338-bbs2-0108" title="AlfirevicZ , KellyAJ , DowswellT . Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD003246.pub2] ">Alfirevic 2009</a>);<br/> (5) amniotomy (<a href="./references#CD001338-bbs2-0113" title="BrickerL , LuckasM . Amniotomy alone for induction of labour. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD002862] ">Bricker 2000</a>);<br/> (6) intravenous oxytocin with amniotomy (<a href="./references#CD001338-bbs2-0110" title="BimbashiA , DuleyL , NdoniE , DokleA . Amniotomy plus intravenous oxytocin for induction of labour. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2012, issue 4. [DOI: 10.1002/14651858.CD009821; CD009821] ">Bimbashi 2012</a>; <a href="./references#CD001338-bbs2-0126" title="HowarthGR , BothaDJ . Amniotomy plus intravenous oxytocin for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 3. [DOI: 10.1002/14651858.CD003250] ">Howarth 2001</a>);<br/> (7) vaginal misoprostol (<a href="./references#CD001338-bbs2-0125" title="HofmeyrGJ , GülmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941.pub2] ">Hofmeyr 2010</a>);<br/> (8) oral misoprostol (this review);<br/> (9) mechanical methods including extra‐amniotic Foley catheter (<a href="./references#CD001338-bbs2-0128" title="JozwiakM , BloemenkampKWM , KellyAJ , MolBWJ , IrionO , BoulvainM . Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD001233.pub2] ">Jozwiak 2012</a>);<br/> (10) membrane sweeping (<a href="./references#CD001338-bbs2-0111" title="BoulvainM , StanC , IrionO . Membrane sweeping for induction of labour. Cochrane Database of Systematic Reviews2005, Issue 1. [DOI: 10.1002/14651858.CD000451.pub2] ">Boulvain 2005</a>);<br/> (11) extra‐amniotic prostaglandins (<a href="./references#CD001338-bbs2-0127" title="HuttonE , MozurkewichE . Extra‐amniotic prostaglandin for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003092] ">Hutton 2001</a>);<br/> (12) intravenous prostaglandins (<a href="./references#CD001338-bbs2-0140" title="LuckasM , BrickerL . Intravenous prostaglandin for induction of labour. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD002864] ">Luckas 2000</a>);<br/> (13) oral prostaglandins (<a href="./references#CD001338-bbs2-0117" title="FrenchL . Oral prostaglandin E2 for induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003098] ">French 2001</a>);<br/> (14) mifepristone (<a href="./references#CD001338-bbs2-0121" title="HapangamaD , NeilsonJP . Mifepristone for induction of labour. Cochrane Database of Systematic Reviews2009, issue 3. [DOI: 10.1002/14651858.CD002865.pub2] ">Hapangama 2009</a>);<br/> (15) oestrogens with or without amniotomy (<a href="./references#CD001338-bbs2-0149" title="ThomasJ , KellyAJ , KavanaghJ . Oestrogens alone or with amniotomy for cervical ripening or induction of labour. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD003393] ">Thomas 2001</a>);<br/> (16) corticosteroids (<a href="./references#CD001338-bbs2-0131" title="KavanaghJ , KellyAJ , ThomasJ . Corticosteroids for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003100.pub2] ">Kavanagh 2006a</a>);<br/> (17) relaxin (<a href="./references#CD001338-bbs2-0137" title="KellyAJ , KavanaghJ , ThomasJ . Relaxin for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003103] ">Kelly 2013</a>);<br/> (18) hyaluronidase (<a href="./references#CD001338-bbs2-0132" title="KavanaghJ , KellyAJ , ThomasJ . Hyaluronidase for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003097.pub2] ">Kavanagh 2006b</a>);<br/> (19) castor oil, bath, and/or enema (<a href="./references#CD001338-bbs2-0138" title="KellyAJ , KavanaghJ , ThomasJ . Castor oil, bath and/or enema for cervical priming and induction of labour. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD003099.pub2] ">Kelly 2013a</a>);<br/> (20) acupuncture (<a href="./references#CD001338-bbs2-0148" title="SmithCA , CrowtherCA , GrantSJ . Acupuncture for induction of labour. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD002962.pub3] ">Smith 2013</a>);<br/> (21) breast stimulation (<a href="./references#CD001338-bbs2-0130" title="KavanaghJ , KellyAJ , ThomasJ . Breast stimulation for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD003392.pub2] ">Kavanagh 2005</a>);<br/> (22) sexual intercourse (<a href="./references#CD001338-bbs2-0129" title="KavanaghJ , KellyAJ , ThomasJ . Sexual intercourse for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD003093] ">Kavanagh 2001</a>);<br/> (23) homoeopathic methods (<a href="./references#CD001338-bbs2-0147" title="SmithCA . Homoeopathy for induction of labour. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD003399] ">Smith 2003</a>);<br/> (24) nitric oxide donors (<a href="./references#CD001338-bbs2-0136" title="KellyAJ , MunsonC , MindenL . Nitric oxide donors for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2011, Issue 6. [DOI: 10.1002/14651858.CD006901.pub2] ">Kelly 2011</a>);<br/> (25) buccal or sublingual misoprostol (<a href="./references#CD001338-bbs2-0142" title="MuzonziniG , HofmeyrGJ . Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD004221.pub2] ">Muzonzini 2004</a>);<br/> (26) hypnosis (<a href="./references#CD001338-bbs2-0143" title="NishiD , ShirakawaMN , OtaE , HanadaN , MoriR . Hypnosis for induction of labour. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD010852] ">Nishi 2013</a>);<br/> (27) other methods for induction of labour. </p> <p>The reviews were analysed by the following clinical categories of participants:</p> <p> <ol id="CD001338-list-0003"> <li> <p>previous caesarean section or not;</p> </li> <li> <p>nulliparity or multiparity;</p> </li> <li> <p>membranes intact or ruptured;</p> </li> <li> <p>cervix favourable, unfavourable or undefined.</p> </li> </ol> </p> <p>For most reviews, the initial data extraction process was conducted centrally. This was co‐ordinated from the Clinical Effectiveness Support Unit (CESU) at the Royal College of Obstetricians and Gynaecologists, UK, in co‐operation with the Pregnancy and Childbirth Group of The Cochrane Collaboration. This process allowed the data extraction process to be standardised across all the reviews. From 2001, the data extraction was no longer conducted centrally. </p> <p>The trials were initially reviewed on eligibility criteria, using a standardised form and the basic selection criteria specified above. Following this, a standardised data extraction form was developed and then piloted for consistency and completeness. This pilot process involved the researchers at the CESU and previous review authors in the area of induction of labour. For a description of the methods used to carry out the initial reviews, <i>see</i><a href="./references#CD001338-bbs2-0124" title="HofmeyrGJ , AlfirevicZ , KellyAJ , KavanaghJ , ThomasJ , NeilsonJP , et al. Methods for cervical ripening and labour induction in late pregnancy: generic protocol. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD002074.pub2] ">Hofmeyr 2009</a>. </p> <p>For this update we used the following methods when assessing the reports identified by the updated search. </p> <section id="CD001338-sec-0046"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion with the third author. </p> </section> <section id="CD001338-sec-0047"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, at least two review authors extracted the data using the agreed form. We resolved discrepancies through discussion with the third author. We entered data into Review Manager software (<a href="./references#CD001338-bbs2-0146" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and checked it for accuracy. </p> <p>When information regarding any of the above is unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD001338-sec-0048"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001338-bbs2-0122" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved any disagreement by discussion or by involving the third author. </p> <section id="CD001338-sec-0049"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD001338-list-0004"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD001338-sec-0050"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD001338-list-0005"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD001338-sec-0051"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD001338-list-0006"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD001338-sec-0052"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods used to blind outcome assessment as:</p> <p> <ul id="CD001338-list-0007"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD001338-sec-0053"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re‐included missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD001338-list-0008"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD001338-sec-0054"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD001338-list-0009"> <li> <p>low risk of bias (where it is clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s prespecified outcomes have been reported; one or more reported primary outcomes were not prespecified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD001338-sec-0055"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we have about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD001338-list-0010"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD001338-sec-0056"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD001338-bbs2-0122" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD001338-sec-0068">Sensitivity analysis</a>. </p> </section> </section> <section id="CD001338-sec-0057"> <h4 class="title">Measures of treatment effect</h4> <section id="CD001338-sec-0058"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD001338-sec-0059"> <h5 class="title">Continuous data</h5> <p>We did not analyse any continuous data in this update. In future updates, if we include continuous data, we will use the mean difference if outcomes are measured in the same way between trials. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods. </p> </section> </section> <section id="CD001338-sec-0060"> <h4 class="title">Unit of analysis issues</h4> <section id="CD001338-sec-0061"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not include any cluster‐randomised trials in this update. If included in future updates, we will include cluster‐randomised trials in the analyses along with individually‐randomised trials. We will adjust their sample sizes using the methods described in the <i>Handbook [Section 16.3.4 or 16.3.6]</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity or subgroup analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD001338-sec-0062"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials are not eligible for inclusion in this review.</p> </section> </section> <section id="CD001338-sec-0063"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD001338-sec-0064"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD001338-sec-0065"> <h4 class="title">Assessment of reporting biases</h4> <p>Funnel plots were not used to assess reporting bias.</p> </section> <section id="CD001338-sec-0066"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD001338-bbs2-0146" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful we did not provide a summary statistic. </p> <p>If random‐effects analyses were used, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> <p>Where the data allowed, the results were analysed by the following clinical categories of participants: </p> <p> <ol id="CD001338-list-0011"> <li> <p>previous caesarean section or not;</p> </li> <li> <p>nulliparity or multiparity;</p> </li> <li> <p>membranes intact or ruptured;</p> </li> <li> <p>cervix favourable, unfavourable or undefined.</p> </li> </ol> </p> </section> <section id="CD001338-sec-0067"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we investigated it using subgroup and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, we used random‐effects analysis to produce it (see details in <a href="#CD001338-sec-0066">Data synthesis</a>). </p> <p>In the main analysis ("all women") for each comparison (i.e. not on the clinical categories) we carried out the following subgroup analyses: </p> <p> <ol id="CD001338-list-0012"> <li> <p>dose‐related effects of oral misoprostol, regimens: 0 to 25 mcg versus 26 to 50 mcg versus 51 to 199 mcg versus 200 mcg or more. </p> </li> </ol> </p> <p>The subgroup analysis was conducted for all outcomes within the main analysis.</p> <p>We assessed subgroup differences by interaction tests available within RevMan (<a href="./references#CD001338-bbs2-0146" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD001338-sec-0068"> <h4 class="title">Sensitivity analysis</h4> <p>In the event of significant heterogeneity, we carried out sensitivity analyses to explore the effect of trial quality (judged according to the method and reporting of allocation concealment), with poor‐quality studies (allocation concealment inadequate or not reported) being excluded from the analyses in order to assess whether this explained the heterogeneity. No other sensitivity analysis was conducted. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001338-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001338-sec-0069"></div> <section id="CD001338-sec-0070"> <h3 class="title">Description of studies</h3> <section id="CD001338-sec-0071"> <h4 class="title">Results of the search</h4> <p>We have included 76 studies in the current review, containing a total of 14,412 women. Only 160 women in three studies had undergone previous caesarean section (<a href="./references#CD001338-bbs2-0009" title="CarlanSJ , BouldinS , BlustD , O'BrienWF . Safety and efficacy of misoprostol orally and vaginally: a randomized trial. Obstetrics &amp; Gynecology2001;98:107‐12. ">Carlan 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0027" title="HowH , LeaseburgeL , KhouryJ , SiddiqiT , SibaiB . Is there an ideal route of misoprostol administration for cervical ripening and labor induction [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S118. HowH , LeaseburgeL , KhouryJ , SiddiqiT , SpinnatoJ , SibaiB . A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. American Journal of Obstetrics and Gynecology2001;185:911‐5. ">How 2001 (V25)</a>; <a href="./references#CD001338-bbs2-0048" title="PatilPK , SwamyMK , Rao RadhikaK . Oral misoprostol vs intra‐cervical dinoprostone for cervical ripening and labour induction. Journal of Obstetrics and Gynaecology of India2005;55(2):128‐31. ">Patil 2005</a>). </p> </section> <section id="CD001338-sec-0072"> <h4 class="title">Included studies</h4> <section id="CD001338-sec-0073"> <h5 class="title">Placebo/no treatment as comparator</h5> <p>Nine studies were categorised under this comparison. Only two studies compared oral misoprostol with no treatment (expectant management) (<a href="./references#CD001338-bbs2-0028" title="JavaidMK , HassanS , TahiraT . Management pre labour rupture of the membranes at term; induction of labor compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD001338-bbs2-0055" title="RathDM , ManasK . Induction of labor with oral misoprostol in women with prelabor rupture of membranes at term. Journal of Obstetrics and Gynecology of India2007;57(6):505‐8. ">Rath 2007</a>). In both studies only women with ruptured membranes were included and those randomised to the expectant group had no treatment for 20 to 24 hours. Seven studies compared oral misoprostol with placebo. Two of these studies used initial 50 mcg doses (<a href="./references#CD001338-bbs2-0011" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD001338-bbs2-0035" title="LevyR , VaisbuchE , FurmanB , BrownD , VolachV , HagayZJ . Induction of labor with oral misoprostol for premature rupture of membranes at term in women with unfavorable cervix: a randomized, double‐blind, placebo‐controlled trial. Journal of Perinatal Medicine2007;35:126‐9. LevyR , VaisbuchE , FurmanB , DoitchH , OronS , HagayZ . Prospective randomized clinical trial of immediate induction of labor with oral misoprostol for prelabor rupture of the membranes in women with unfavorable cervix at term. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S44. ">Levy 2007</a>); three studies used initial 100 mcg doses (<a href="./references#CD001338-bbs2-0025" title="HoffmanR , AnthonyJ , FawcusJ . Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2001;72:215‐21. HoffmanRAM , FawcusS , AnthonyJ . Oral misoprostol versus placebo in the management of prelabour rupture of membranes at term. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3‐6; Cape Town South Africa. 1999:65. ">Hoffman 2001</a>; <a href="./references#CD001338-bbs2-0036" title="LoJ , AlexanderJ , McIntireD , LevenoK . Efficacy of oral misoprostol in nulliparous women with premature rupture of membranes. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. LoJ , AlexanderJ , McIntireD , LevenoK . Randomized trial of oral misoprostol in nulliparous women with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. LoJY , AlexanderJM , McIntireDD , LevenoKJ . Ruptured membranes at term: randomized, double‐blind trial of oral misoprostol for labor induction. Obstetrics &amp; Gynecology2003;101(4):685‐9. ">Lo 2003</a>; <a href="./references#CD001338-bbs2-0037" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>); and two used 200 mcg doses (<a href="./references#CD001338-bbs2-0006" title="BeigiA , KabiriM , ZarrinkoubF . Cervical ripening with oral misoprostol at term. International Journal of Gynecology &amp; Obstetrics2003;83:251‐5. ">Beigi 2003</a>; <a href="./references#CD001338-bbs2-0043" title="NgaiCSW , ToWWK , LaoT , HoPC . Cervical priming with oral misoprostol in prelabour rupture of membranes at term. 27th British Congress of Obstetrics and Gynaecology;1995 July 4‐7, Dublin, Ireland. 1995:A479. NgaiSW , ToWK , LaoT , HoPC . Cervical priming with oral misoprostol in pre‐labor rupture of membranes at term. Obstetrics &amp; Gynecology1996;87:923‐6. ">Ngai 1996</a>). In <a href="./references#CD001338-bbs2-0011" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>, women were randomised three ways: to placebo, 50 mcg or 100 mcg misoprostol. As 50 mcg is the most commonly recommended dose for oral misoprostol, we chose to include only the outcomes for the placebo versus 50 mcg dose. We have also included the outcomes for the 50 mcg versus 100 mcg doses in that section of the review. In <a href="./references#CD001338-bbs2-0025" title="HoffmanR , AnthonyJ , FawcusJ . Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2001;72:215‐21. HoffmanRAM , FawcusS , AnthonyJ . Oral misoprostol versus placebo in the management of prelabour rupture of membranes at term. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3‐6; Cape Town South Africa. 1999:65. ">Hoffman 2001</a> women in both arms received dinoprostone after 12 hours if not in active labour. The participants all had ruptured membranes at term except in <a href="./references#CD001338-bbs2-0006" title="BeigiA , KabiriM , ZarrinkoubF . Cervical ripening with oral misoprostol at term. International Journal of Gynecology &amp; Obstetrics2003;83:251‐5. ">Beigi 2003</a>, where women with intact membranes were also included. </p> </section> <section id="CD001338-sec-0074"> <h5 class="title">Dinoprostone as comparator</h5> <p>In 10 studies, the comparison was with the prostaglandin dinoprostone administered vaginally (<a href="./references#CD001338-bbs2-0014" title="DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial. American Journal of Obstetrics and Gynecology2003;188(1):162‐7. DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction? A randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S108. ">Dallenbach 2003 (T)</a>; <a href="./references#CD001338-bbs2-0017" title="DoddJ , CrowtherC , RonbinsonJ . Misoprostol for the induction of labour at term: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2005;45:347‐8. DoddJM , CrowtherCA , RobinsonJS . Factors associated with adverse maternal health outcomes following induction of labour at term: analyses from a randomised trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:86. DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol for induction of labour at term: randomised controlled trial. BMJ2006;332(7540):509‐13. DoddJM , CrowtherCA , RobinsonJS . Time of commencing induction of labour: a nested randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:85. ">Dodd 2006</a>; <a href="./references#CD001338-bbs2-0119" title="GhermanRB , HeathT . Trial of labor after cesarean delivery: a pilot study of oral misoprostol for preinduction cervical ripening. Obstetrics &amp; Gynecology2001;97(Suppl 1):S68. ">Gherman 2001a</a>; <a href="./references#CD001338-bbs2-0024" title="HenrichW , DudenhausenJW , HanelC , ChenFC . Oral misoprostol against vaginal dinoprostone for labor induction at term: a randomized comparison [Prospektiv randomisierte Studie zum Vergleich von Misoprostol oral mit Dinoproston vaginal bei der Geburtseinleitung am Termin]. Zeitschrift fur Geburtshilfe und Neonatologie2008;212(5):183‐8. ">Henrich 2008 (T)</a>; <a href="./references#CD001338-bbs2-0026" title="HofmyerGJ , AlfirevicZ , MatonhodzeB , BrocklehurstP , CampbellE , NikodemC . Titrated oral misoprostol solution for labour induction: a multi‐centre, randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:952‐9. MatonhodzeB , AlfirevicZ , HofmeyrJ , BrocklehurstP . Titrated oral misoprostol for labour induction: a randomised trial [abstract]. Prenatal and Neonatal Medicine2000;5(Suppl 2):148. MatonhodzeB , AlfirevicZ , HofmeyrJ , CampbellL , BrocklehurstP . Titrated oral misoprostol for labour induction: a random allocation trial. Journal of Obstetrics and Gynaecology2000;20(Suppl 1):S19. MatonhodzeBB , HofmeyrGJ , LevinJ . Labour induction at term‐‐a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. South African Medical Journal2003;93(5):375‐9. ">Hofmeyr 2001(T)</a>; <a href="./references#CD001338-bbs2-0034" title="leRouxP , OlarogunJ , PennyJ , AnthonyJ . Oral and vaginal misoprostol compared with dinoprostone for induction of labor: a randomized controlled trial. Obstetrics &amp; Gynecology2002;99(2):201‐5. ">le Roux 2002 (V50)</a>; <a href="./references#CD001338-bbs2-0038" title="MajokoF , ZwizwaiM , NystromL , LindmarkG . Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin f2 alpha gel and prostaglandin e2 pessary. Central African Journal of Medicine2002;48(11‐12):123‐8. ">Majoko 2002 (V50)</a>; <a href="./references#CD001338-bbs2-0040" title="MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term ‐ a comparative study. South African Journal of Obstetrics and Gynaecology2003;9(2):34‐7. MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term‐‐a comparative study. South African Medical Journal2003;93:371‐4. ">Moodley 2003</a>; <a href="./references#CD001338-bbs2-0065" title="ShettyA , LivingstoneI , AcharyaS , DanielianP , RiceP , TempletonA . A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term. BJOG: an international journal of obstetrics and gynaecology2003;110:963. ShettyA , LivingstoneI , AcharyaS , DanielianP , TempletonA , RiceP . A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term. BJOG: an international journal of obstetrics and gynaecology2004;111:436‐40. ">Shetty 2004</a>; <a href="./references#CD001338-bbs2-0069" title="* Tessier F , DanserauJ . Oral misoprostol versus vaginal dinoprostone for labor induction: a double‐blind randomized controlled trial. Personal communication1997. TessierF , DansereauJ . A double‐blind randomized controlled trial comparing oral misoprostol to vaginal prostaglandin E2 gel for the induction of labour at or near term. American Journal of Obstetrics and Gynecology1997;176(1):S111. ">Tessier 1997</a>). The studies included only women with intact membranes, except for <a href="./references#CD001338-bbs2-0026" title="HofmyerGJ , AlfirevicZ , MatonhodzeB , BrocklehurstP , CampbellE , NikodemC . Titrated oral misoprostol solution for labour induction: a multi‐centre, randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:952‐9. MatonhodzeB , AlfirevicZ , HofmeyrJ , BrocklehurstP . Titrated oral misoprostol for labour induction: a randomised trial [abstract]. Prenatal and Neonatal Medicine2000;5(Suppl 2):148. MatonhodzeB , AlfirevicZ , HofmeyrJ , CampbellL , BrocklehurstP . Titrated oral misoprostol for labour induction: a random allocation trial. Journal of Obstetrics and Gynaecology2000;20(Suppl 1):S19. MatonhodzeBB , HofmeyrGJ , LevinJ . Labour induction at term‐‐a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. South African Medical Journal2003;93(5):375‐9. ">Hofmeyr 2001(T)</a>, which also included women with ruptured membranes and <a href="./references#CD001338-bbs2-0024" title="HenrichW , DudenhausenJW , HanelC , ChenFC . Oral misoprostol against vaginal dinoprostone for labor induction at term: a randomized comparison [Prospektiv randomisierte Studie zum Vergleich von Misoprostol oral mit Dinoproston vaginal bei der Geburtseinleitung am Termin]. Zeitschrift fur Geburtshilfe und Neonatologie2008;212(5):183‐8. ">Henrich 2008 (T)</a> and <a href="./references#CD001338-bbs2-0069" title="* Tessier F , DanserauJ . Oral misoprostol versus vaginal dinoprostone for labor induction: a double‐blind randomized controlled trial. Personal communication1997. TessierF , DansereauJ . A double‐blind randomized controlled trial comparing oral misoprostol to vaginal prostaglandin E2 gel for the induction of labour at or near term. American Journal of Obstetrics and Gynecology1997;176(1):S111. ">Tessier 1997</a> did not specify the membrane status for the included women. The initial dosage of misoprostol was 50 mcg or less in all studies except for <a href="./references#CD001338-bbs2-0065" title="ShettyA , LivingstoneI , AcharyaS , DanielianP , RiceP , TempletonA . A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term. BJOG: an international journal of obstetrics and gynaecology2003;110:963. ShettyA , LivingstoneI , AcharyaS , DanielianP , TempletonA , RiceP . A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term. BJOG: an international journal of obstetrics and gynaecology2004;111:436‐40. ">Shetty 2004</a>, where 100 mcg was used. In <a href="./references#CD001338-bbs2-0038" title="MajokoF , ZwizwaiM , NystromL , LindmarkG . Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin f2 alpha gel and prostaglandin e2 pessary. Central African Journal of Medicine2002;48(11‐12):123‐8. ">Majoko 2002 (V50)</a>, the initial dose was 10 mcg and each successive four‐hourly dose was doubled to a maximum of 400 mcg. In the studies by <a href="./references#CD001338-bbs2-0014" title="DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial. American Journal of Obstetrics and Gynecology2003;188(1):162‐7. DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction? A randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S108. ">Dallenbach 2003 (T)</a> and <a href="./references#CD001338-bbs2-0026" title="HofmyerGJ , AlfirevicZ , MatonhodzeB , BrocklehurstP , CampbellE , NikodemC . Titrated oral misoprostol solution for labour induction: a multi‐centre, randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:952‐9. MatonhodzeB , AlfirevicZ , HofmeyrJ , BrocklehurstP . Titrated oral misoprostol for labour induction: a randomised trial [abstract]. Prenatal and Neonatal Medicine2000;5(Suppl 2):148. MatonhodzeB , AlfirevicZ , HofmeyrJ , CampbellL , BrocklehurstP . Titrated oral misoprostol for labour induction: a random allocation trial. Journal of Obstetrics and Gynaecology2000;20(Suppl 1):S19. MatonhodzeBB , HofmeyrGJ , LevinJ . Labour induction at term‐‐a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. South African Medical Journal2003;93(5):375‐9. ">Hofmeyr 2001(T)</a>, women received 20 mcg oral misoprostol (dissolved in water) two‐hourly for two doses and then 40 mcg two‐hourly. Doses could also be given in labour if contractions slowed. In the studies by <a href="./references#CD001338-bbs2-0040" title="MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term ‐ a comparative study. South African Journal of Obstetrics and Gynaecology2003;9(2):34‐7. MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term‐‐a comparative study. South African Medical Journal2003;93:371‐4. ">Moodley 2003</a> and <a href="./references#CD001338-bbs2-0017" title="DoddJ , CrowtherC , RonbinsonJ . Misoprostol for the induction of labour at term: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2005;45:347‐8. DoddJM , CrowtherCA , RobinsonJS . Factors associated with adverse maternal health outcomes following induction of labour at term: analyses from a randomised trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:86. DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol for induction of labour at term: randomised controlled trial. BMJ2006;332(7540):509‐13. DoddJM , CrowtherCA , RobinsonJS . Time of commencing induction of labour: a nested randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:85. ">Dodd 2006</a>, women received 20 mcg of oral solution two‐hourly. A third arm of the <a href="./references#CD001338-bbs2-0040" title="MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term ‐ a comparative study. South African Journal of Obstetrics and Gynaecology2003;9(2):34‐7. MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term‐‐a comparative study. South African Medical Journal2003;93:371‐4. ">Moodley 2003</a> study, where women received an initial 25 mcg of vaginal misoprostol followed by 20 mcg oral misoprostol, is not included in this review. </p> <p>Oral misoprostol was compared with intracervical dinoprostone in the studies by <a href="./references#CD001338-bbs2-0005" title="BarthaJL , Comino‐DelgadoR , Garcia‐BenasachF , Martinez‐Del‐FresnoP , Moreno‐CorralLJ . Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: a randomized comparison. Obstetrics &amp; Gynecology2000;96:465‐9. ">Bartha 2000</a> and <a href="./references#CD001338-bbs2-0048" title="PatilPK , SwamyMK , Rao RadhikaK . Oral misoprostol vs intra‐cervical dinoprostone for cervical ripening and labour induction. Journal of Obstetrics and Gynaecology of India2005;55(2):128‐31. ">Patil 2005</a> (both 200 mcg dose), as well as <a href="./references#CD001338-bbs2-0033" title="LangeneggerEJ , OdendaalHJ , GroveD . Oral misoprostol versus intracervical dinoprostone for induction of labour. International Journal of Gynecology &amp; Obstetrics2005;88:242‐8. ">Langenegger 2005</a>, <a href="./references#CD001338-bbs2-0059" title="SheelaCN , MhaskarA , GeorgeS . Comparison of vaginal misoprostol and oral misoprostol with intracervical dinoprostone gel for labor induction at term. Journal of Obstetrics and Gynaecology of India2007;57(4):327‐30. ">Sheela 2007 (V25)</a> and <a href="./references#CD001338-bbs2-0042" title="NagpalMB , RaghunandanC , SailiA . Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2009;106(1):23‐6. ">Nagpal 2009</a> (50 mcg dose). All studies included only women with intact membranes except for <a href="./references#CD001338-bbs2-0042" title="NagpalMB , RaghunandanC , SailiA . Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2009;106(1):23‐6. ">Nagpal 2009</a> which included only women with ruptured membranes. </p> <p>In the <a href="./references#CD001338-bbs2-0069" title="* Tessier F , DanserauJ . Oral misoprostol versus vaginal dinoprostone for labor induction: a double‐blind randomized controlled trial. Personal communication1997. TessierF , DansereauJ . A double‐blind randomized controlled trial comparing oral misoprostol to vaginal prostaglandin E2 gel for the induction of labour at or near term. American Journal of Obstetrics and Gynecology1997;176(1):S111. ">Tessier 1997</a> study, 23 of the 267 women had undergone a caesarean section in a previous pregnancy. </p> </section> <section id="CD001338-sec-0075"> <h5 class="title">Oxytocin as comparator</h5> <p>Nine studies compared oral misoprostol with oxytocin. In six, the women had ruptured membranes at term (<a href="./references#CD001338-bbs2-0004" title="Al‐HussainiTK , Abdel‐AalSA , YoussefMA . Oral misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2003;82(1):73‐5. ">Al‐Hussaini 2003</a>; <a href="./references#CD001338-bbs2-0008" title="ButtKD , BennettKA , CraneJM , HutchensD , YoungDC . Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstetrics &amp; Gynecology1999;94(6):994‐9. ">Butt 1999</a>; <a href="./references#CD001338-bbs2-0013" title="CraneJ , DelaneyT , HutchensD . Oral misoprostol labor induction in term prelabor membrane rupture. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. CraneJMG , DelaneyT , HutchensD . Oral misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:720‐4. ">Crane 2003</a>; <a href="./references#CD001338-bbs2-0018" title="DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol versus intravenous oxytocin for induction of labour following artificial or spontaneous rupture of membranes: a randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:258. ">Dodd 2006a (T)</a>; <a href="./references#CD001338-bbs2-0041" title="MozurkewichE , HorrocksJ , DaleyS , VonOeyenP , SarvisA , HalvorsonM , et al. The misoprostol study: a randomized controlled trial of misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. MozurkewichE , HorrocksJ , DaleyS , vonOeyenP , HalvorsonM , JohnsonM , et al. The MisoPROM study: a multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:1026‐30. ">Mozurkewich 2003</a>; <a href="./references#CD001338-bbs2-0044" title="JacksonN , Paterson‐BrownS . Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes [letter]. BJOG: an international journal of obstetrics and gynaecology2000;107(9):1181‐2. NgaiSW , ChanYM , LamSW , LaoT . Prospective randomised study to compare misoprostol and oxytocin for labour induction in prelabour rupture of membranes in term pregnancy. British Journal of Obstetrics and Gynaecology1998;105 Suppl 17:82. NgaiSW , ChanYM , LamSW , LaoTT . Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of membranes. British Journal of Obstetrics and Gynecology2000;107(2):222‐7. ">Ngai 2000</a>), whilst in two other trials women with intact membranes were also included (<a href="./references#CD001338-bbs2-0045" title="NigamA , SinghVK , DubayP , PandeyK , BhagioliwalA , PrakashA . Misoprostol vs. oxytocin for induction of labor at term. International Journal of Gynecology &amp; Obstetrics2004;86:398‐400. ">Nigam 2004</a>; <a href="./references#CD001338-bbs2-0075" title="WingDA , FassettMJ , GubermanC , TranS , ParrishA , GuinnD . A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervix examinations. American Journal of Obstetrics and Gynecology2004;190:1689‐96. ">Wing 2004</a>), and one study included a mix of women with ruptured and intact membranes (<a href="./references#CD001338-bbs2-0001" title="Aalami‐HarandiR , KaramaliM , MoeiniA . Induction of labor with titrated oral misoprostol solution versus oxytocin in term pregnancy: randomized controlled trial. Revista Brasileira de Ginecologia e Obstetricia2013;35(2):60‐5. ">Aalami‐Harandi 2013 (T)</a>). In most trials the dose was 100 mcg. However, in <a href="./references#CD001338-bbs2-0018" title="DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol versus intravenous oxytocin for induction of labour following artificial or spontaneous rupture of membranes: a randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:258. ">Dodd 2006a (T)</a> (abstract form only), an hourly dose of titrated oral solution starting with 5 mcg was used; in <a href="./references#CD001338-bbs2-0008" title="ButtKD , BennettKA , CraneJM , HutchensD , YoungDC . Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstetrics &amp; Gynecology1999;94(6):994‐9. ">Butt 1999</a> and <a href="./references#CD001338-bbs2-0045" title="NigamA , SinghVK , DubayP , PandeyK , BhagioliwalA , PrakashA . Misoprostol vs. oxytocin for induction of labor at term. International Journal of Gynecology &amp; Obstetrics2004;86:398‐400. ">Nigam 2004</a>, 50 mcg was used; and in <a href="./references#CD001338-bbs2-0013" title="CraneJ , DelaneyT , HutchensD . Oral misoprostol labor induction in term prelabor membrane rupture. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. CraneJMG , DelaneyT , HutchensD . Oral misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:720‐4. ">Crane 2003</a>, 75 mcg was used. <a href="./references#CD001338-bbs2-0001" title="Aalami‐HarandiR , KaramaliM , MoeiniA . Induction of labor with titrated oral misoprostol solution versus oxytocin in term pregnancy: randomized controlled trial. Revista Brasileira de Ginecologia e Obstetricia2013;35(2):60‐5. ">Aalami‐Harandi 2013 (T)</a> used a 200 mcg tablet of misoprostol dissolved in 200 mL water, and administered 25 mL (25 mcg) every two hours. </p> </section> <section id="CD001338-sec-0076"> <h5 class="title">Vaginal misoprostol as comparator</h5> <p>The most common comparison in this review is with vaginal misoprostol (37 studies). The figure in brackets after the study reference indicates the initial dosage of vaginal misoprostol used in the comparison. In 16 studies the participants had intact membranes (<a href="./references#CD001338-bbs2-0002" title="AdairCD , WeeksJW , BarrilleauxPS , PhilibertL , EdwardsMS , LewisDF . Labor induction with oral versus vaginal misoprostol: a randomized, double‐blind trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S93. AdairCD , WeeksJW , BarrilleauxS , EdwardsM , BurlisonK , LewisDF . Oral or vaginal misoprostol administration for induction of labor: a randomised, double‐blind trial. Obstetrics &amp; Gynecology1998;92(5):810‐3. ">Adair 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0007" title="BennettK , ButtK , CraneJ , HutchensD , YoungD . Misoprostol for labour induction at term. Society of Obstetricians and Gynaecologists of Canada 54th Annual Meeting; 1998 June; Victoria, Canada. 1998:11. BennettKA , ButtK , CraneJMG , HutchensD , YoungDC . A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction. Obstetrics &amp; Gynecology1998;92(4 Suppl 1):481‐6. ">Bennett 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0009" title="CarlanSJ , BouldinS , BlustD , O'BrienWF . Safety and efficacy of misoprostol orally and vaginally: a randomized trial. Obstetrics &amp; Gynecology2001;98:107‐12. ">Carlan 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0021" title="FisherS , DaviesG , MackenzieP . Oral versus vaginal misoprostol for induction of labour: a double‐blind, placebo‐controlled randomised trial. American Journal of Obstetrics and Gynecology2001;184(1):S117. FisherS , MackenzieV , DaviesG . Oral versus vaginal misoprostol for induction of labor: a double‐blind randomized controlled trial. American Journal of Obstetrics and Gynecology2001;185:906‐10. ">Fisher 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0030" title="KhazardoostS , HakimiP , NoorzadehM , ShafaatM . Misoprostol for cervical ripening: a clinical trial in 60 pregnant women. Tehran University Medical Journal2011;68(10):595‐9. ">Khazardoost 2011 (V25)</a>; <a href="./references#CD001338-bbs2-0032" title="KwonJ , DaviesG , MacKenzieV . A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:23‐6. KwonJS , MackenzieVP , DaviesGAL . A comparison of oral and vaginal misoprostol for induction of labour. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S128. ">Kwon 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0034" title="leRouxP , OlarogunJ , PennyJ , AnthonyJ . Oral and vaginal misoprostol compared with dinoprostone for induction of labor: a randomized controlled trial. Obstetrics &amp; Gynecology2002;99(2):201‐5. ">le Roux 2002 (V50)</a>; <a href="./references#CD001338-bbs2-0038" title="MajokoF , ZwizwaiM , NystromL , LindmarkG . Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin f2 alpha gel and prostaglandin e2 pessary. Central African Journal of Medicine2002;48(11‐12):123‐8. ">Majoko 2002 (V50)</a>; <a href="./references#CD001338-bbs2-0039" title="MehrotraS , SinghU , GuptaHP . A prospective double blind study using oral versus vaginal misoprostol for labour induction. Journal of Obstetrics &amp; Gynaecology2010;30(5):461‐4. ">Mehrotra 2010 (V50)</a>; <a href="./references#CD001338-bbs2-0046" title="NopdonrattakoonL . A comparison between intravaginal and oral misoprostol for labor induction: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2003;29(2):87‐91. ">Nopdonrattkaoon 2003 (V50)</a>; <a href="./references#CD001338-bbs2-0049" title="PaungmoraN , HerabutayaY , O‐PrasertsawatP . A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised controlled trial. Thai Journal of Obstetrics and Gynaecology2003;15(4):272. PaungmoraN , HerabutyaY , O‐PrasertsawatP , PunyavachiraP . Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial. Journal of Obstetrics &amp; Gynaecology Research2004;30(5):358‐62. ">Paungmora 2004 (V50)</a>; <a href="./references#CD001338-bbs2-0052" title="PongsathaS , VijittrawiwatA , TongsongT . A comparison of labor induction by oral and vaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;88:140‐1. ">Pongsatha 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0059" title="SheelaCN , MhaskarA , GeorgeS . Comparison of vaginal misoprostol and oral misoprostol with intracervical dinoprostone gel for labor induction at term. Journal of Obstetrics and Gynaecology of India2007;57(4):327‐30. ">Sheela 2007 (V25)</a>; <a href="./references#CD001338-bbs2-0061" title="ShettyA , DanielianP , TempletonA . A comparison of oral and vaginal misoprostol in the induction of labour at term: a random allocation trial. Journal of Obstetrics and Gynaecology2000;20(Suppl 1):S19. ShettyA , DanielianP , TempletonA . A comparison of oral and vaginal misoprostol tablets in induction of labour at term. BJOG: an international journal of obstetrics and gynaecology2001;108:238‐43. ShettyA , DanielianP , TempletonA . A comparison of oral and vaginal tablets in the induction of labor at term. XVI FIGO World Congress of Obstetrics &amp; Gynecology. Book 4; 2000 Sept 3‐8; Washington DC, USA. 2000:28‐9. ShettyA , DanielianP , TempletonA . Oral versus vaginal misoprostol in the induction of labour at term: a randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2000;107:813. ">Shetty 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0064" title="LivingstoneI , AcharyaS , ShettyA , RiceP , DanielianP , TempletonA . 100ug of oral misoprostol versus 25ug of vaginal misoprostol in term labour induction ‐ a randomised comparison. Journal of Obstetrics and Gynaecology2004;24(1):106. ShettyA , LivingstoneI , AcharyaS , RiceP , DanielianP , TempletonA . Oral misoprostol (100ug) versus vaginal misoprostol (25ug) in term labor induction: a randomized comparison. Acta Obstetricia et Gynecologica Scandinavica2003;82(12):1103‐6. ">Shetty 2003 (V25)</a>; <a href="./references#CD001338-bbs2-0073" title="WingD , HamD , PaulRH . A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(5):1155‐60. WingDA , HamD , PaulRH . A comparison of orally administered misoprostol to vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S127. ">Wing 1999 (V25)</a>) and in three studies they had ruptured membranes (<a href="./references#CD001338-bbs2-0029" title="JindalP , AvasthiK , KaurM . A comparison of vaginal vs. oral misoprostol for induction of labor‐double blind randomized trial. Journal of Obstetrics and Gynecology of India2011;61(5):538‐42. ">Jindal 2011 (V50)</a>; <a href="./references#CD001338-bbs2-0053" title="PugaO , NienJ , GomezR , MedinaL , CarstensM , GonzalezR , et al. Premature rupture of membranes after 35 weeks: a randomized clinical trial of induction of labor with oral versus vaginal administration of misoprostol. American Journal of Obstetrics and Gynecology2001;184(1):S85. ">Puga 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0056" title="RizviS , UmberF , YusufAW . Labour induction at term; oral versus intravaginal misoprostol. Annals of King Edward Medical College2007;13(1):119‐21. ">Rizvi 2007 (V25)</a>). Eleven studies included women with both intact and ruptured membranes (<a href="./references#CD001338-bbs2-0010" title="ChengSY , MingH , LeeJC . Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstetrics &amp; Gynecology2008;111(1):119‐25. ">Cheng 2008 (T) (V25)</a>; <a href="./references#CD001338-bbs2-0012" title="ColonI , ClawsonK , HunterK , DruzinML , TaslimiMM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. American Journal of Obstetrics and Gynecology2005;192:747‐52. ColonI , ClawsonK , TaslimiM , DruzinM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S15. ">Colon 2005 (V25)</a>; <a href="./references#CD001338-bbs2-0016" title="DeshmukhVL , YelikarKA , WasoV . Comparative study of efficacy and safety of oral versus vaginal misoprostol for induction or labour. Journal of Obstetrics and Gynaecology of India2013;63(5):321‐4. ">Deshmukh 2013 (V50)</a>; <a href="./references#CD001338-bbs2-0019" title="DyarTR , GreigP , CummingsR , NicholsK . The efficacy and safety of oral versus vaginal misoprostol for the induction of term labor. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S135. ">Dyar 2000 (V50)</a>; <a href="./references#CD001338-bbs2-0023" title="HallR , Duarte‐GardeaM , HarlassF . Oral versus vaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2002;99(6):1044‐8. ">Hall 2002 (V25)</a>; <a href="./references#CD001338-bbs2-0047" title="PaisarntantiwongR , GetganM . A comparison between single dose of 50 microg oral misoprostol and 25 microg vaginal misoprostol for labor induction. Journal of the Medical Association of Thailand2005;88(Suppl 2):S56‐S62. ">Pais'wong 2008 (V25)</a>; <a href="./references#CD001338-bbs2-0054" title="RahmanH . Comparative evaluation of 50ug oral misoprostol and 25ug intra‐vaginal misoprostol for induction of labour at term. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5‐9; Hyderabad, Andhra Pradesh, India. 2011:316. RahmanH , PradhanA , KharkaL , RenjhenP , KarS , DuttaS . Comparative evaluation of 50 microgram oral misoprostol and 25 microgram intravaginal misoprostol for induction of labour at term: a randomized trial. Journal of Obstetrics and Gynaecology Canada : JOGC2013;35(5):408‐16. ">Rahman 2013 (V25)</a>; <a href="./references#CD001338-bbs2-0067" title="Rolland SouzaA . [Titrated oral suspension compared with vaginal misoprostol for labor induction: a randomized controlled trial] [Misoprostol em solução oral titulada escalonada versus via vaginal para indução do trabalho de parto: ensaio clínico randomizado]. Revista Brazileira de Ginecologia e Obstetricia2011;33(9):270. Rolland de SouzaA . Oral misoprostol titrated solution versus vaginal misoprostol for induction of labour: randomized controlled trial. http://clinicaltrials.gov/ct2/show/record/NCT00992524 (accessed 22 January 2013)2011. SouzaAS , FeitosaFE , CostaAA , PereiraAP , CarvalhoAS , PaixaoRM , et al. Titrated oral misoprostol solution versus vaginal misoprostol for labor induction. International Journal of Gynecology and Obstetrics2013;123(3):207‐12. ">Souza 2013(V25)(T)</a>; <a href="./references#CD001338-bbs2-0071" title="ToppozadaMK , AnwarMYM , HassanHA , El‐GazaerlyWS . Oral or vaginal misoprostol for induction of labour. International Journal of Gynecology &amp; Obstetrics1997;56:135‐9. ">Toppozada 1997 (V100</a>); <a href="./references#CD001338-bbs2-0072" title="UludagS , SaricaliFS , MadazliR , CepniI . A comparison of oral and vaginal misoprostol for induction of labour. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2005;122:57‐60. ">Uludag 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0074" title="WingDA , ParkMR , PaulRH . A randomised comparison of oral and intravaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2000;95(6 Pt 1):905‐8. ">Wing 2000 (V25)</a>), whilst in six studies the membrane status was not clarified (<a href="./references#CD001338-bbs2-0003" title="AdamI , HassanOA , ElhassanEM . Oral misoprostol vs. vaginal misoprostol for cervical ripening and labour induction. International Journal of Gynecology &amp; Obstetrics2005;89:142‐3. ">Adam 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0020" title="ElhassanEM , NasrAM , AdamI . Sublingual compared with oral and vaginal misoprostol for labor induction. International Journal of Gynecology &amp; Obstetrics2007;97(2):153‐4. ">Elhassan 2007 (V50)</a>; <a href="./references#CD001338-bbs2-0058" title="SchneiderM , RamseyR , KaoL , BennettKA . Misoprostol is effective for induction of labor in high risk pregnant women: a randomized controlled trial. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S73. ">Schneider 2004 (V25)</a>; <a href="./references#CD001338-bbs2-0060" title="SheikherC , SuriN , KholiU . Comparative evaluation of oral misoprostol, vaginal misoprostol and intracervical Foley's catheter for induction of labour at term. JK Science2009;11(2):75‐7. ">Sheikher 2009 (V25)</a>; <a href="./references#CD001338-bbs2-0066" title="SitthiwattanawongW . A comparison between oral and intravaginal administration of 50 microgram misoprostol for cervical ripening and induction of labor. Thai Journal of Obstetrics and Gynaecology2000;12(4):352. SitthiwattanawongW , PongsathaS . Oral misoprostol for cervical ripening and labour induction: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology1999;11(2):87‐92. ">Sitthiwattanawong 1999</a>; <a href="./references#CD001338-bbs2-0068" title="SultanaN , RoufS , RashidM . Oral versus vaginal misoprostol for induction of labour. Journal of Bangladesh College of Physicians and Surgeons2006;24(2):44‐9. ">Sultana 2006 (V100)</a>). Most trials used a 50 mcg dose of oral misoprostol (16 studies), but three used 20 to 25 mcg (<a href="./references#CD001338-bbs2-0010" title="ChengSY , MingH , LeeJC . Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstetrics &amp; Gynecology2008;111(1):119‐25. ">Cheng 2008 (T) (V25)</a>; <a href="./references#CD001338-bbs2-0027" title="HowH , LeaseburgeL , KhouryJ , SiddiqiT , SibaiB . Is there an ideal route of misoprostol administration for cervical ripening and labor induction [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S118. HowH , LeaseburgeL , KhouryJ , SiddiqiT , SpinnatoJ , SibaiB . A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. American Journal of Obstetrics and Gynecology2001;185:911‐5. ">How 2001 (V25)</a>; <a href="./references#CD001338-bbs2-0067" title="Rolland SouzaA . [Titrated oral suspension compared with vaginal misoprostol for labor induction: a randomized controlled trial] [Misoprostol em solução oral titulada escalonada versus via vaginal para indução do trabalho de parto: ensaio clínico randomizado]. Revista Brazileira de Ginecologia e Obstetricia2011;33(9):270. Rolland de SouzaA . Oral misoprostol titrated solution versus vaginal misoprostol for induction of labour: randomized controlled trial. http://clinicaltrials.gov/ct2/show/record/NCT00992524 (accessed 22 January 2013)2011. SouzaAS , FeitosaFE , CostaAA , PereiraAP , CarvalhoAS , PaixaoRM , et al. Titrated oral misoprostol solution versus vaginal misoprostol for labor induction. International Journal of Gynecology and Obstetrics2013;123(3):207‐12. ">Souza 2013(V25)(T)</a>), 11 used 100 mcg (<a href="./references#CD001338-bbs2-0023" title="HallR , Duarte‐GardeaM , HarlassF . Oral versus vaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2002;99(6):1044‐8. ">Hall 2002 (V25)</a>; <a href="./references#CD001338-bbs2-0030" title="KhazardoostS , HakimiP , NoorzadehM , ShafaatM . Misoprostol for cervical ripening: a clinical trial in 60 pregnant women. Tehran University Medical Journal2011;68(10):595‐9. ">Khazardoost 2011 (V25)</a>; <a href="./references#CD001338-bbs2-0049" title="PaungmoraN , HerabutayaY , O‐PrasertsawatP . A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised controlled trial. Thai Journal of Obstetrics and Gynaecology2003;15(4):272. PaungmoraN , HerabutyaY , O‐PrasertsawatP , PunyavachiraP . Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial. Journal of Obstetrics &amp; Gynaecology Research2004;30(5):358‐62. ">Paungmora 2004 (V50)</a>; <a href="./references#CD001338-bbs2-0052" title="PongsathaS , VijittrawiwatA , TongsongT . A comparison of labor induction by oral and vaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;88:140‐1. ">Pongsatha 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0053" title="PugaO , NienJ , GomezR , MedinaL , CarstensM , GonzalezR , et al. Premature rupture of membranes after 35 weeks: a randomized clinical trial of induction of labor with oral versus vaginal administration of misoprostol. American Journal of Obstetrics and Gynecology2001;184(1):S85. ">Puga 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0056" title="RizviS , UmberF , YusufAW . Labour induction at term; oral versus intravaginal misoprostol. Annals of King Edward Medical College2007;13(1):119‐21. ">Rizvi 2007 (V25)</a>; <a href="./references#CD001338-bbs2-0064" title="LivingstoneI , AcharyaS , ShettyA , RiceP , DanielianP , TempletonA . 100ug of oral misoprostol versus 25ug of vaginal misoprostol in term labour induction ‐ a randomised comparison. Journal of Obstetrics and Gynaecology2004;24(1):106. ShettyA , LivingstoneI , AcharyaS , RiceP , DanielianP , TempletonA . Oral misoprostol (100ug) versus vaginal misoprostol (25ug) in term labor induction: a randomized comparison. Acta Obstetricia et Gynecologica Scandinavica2003;82(12):1103‐6. ">Shetty 2003 (V25)</a>; <a href="./references#CD001338-bbs2-0068" title="SultanaN , RoufS , RashidM . Oral versus vaginal misoprostol for induction of labour. Journal of Bangladesh College of Physicians and Surgeons2006;24(2):44‐9. ">Sultana 2006 (V100)</a>; <a href="./references#CD001338-bbs2-0071" title="ToppozadaMK , AnwarMYM , HassanHA , El‐GazaerlyWS . Oral or vaginal misoprostol for induction of labour. International Journal of Gynecology &amp; Obstetrics1997;56:135‐9. ">Toppozada 1997 (V100</a>; <a href="./references#CD001338-bbs2-0072" title="UludagS , SaricaliFS , MadazliR , CepniI . A comparison of oral and vaginal misoprostol for induction of labour. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2005;122:57‐60. ">Uludag 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0074" title="WingDA , ParkMR , PaulRH . A randomised comparison of oral and intravaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2000;95(6 Pt 1):905‐8. ">Wing 2000 (V25)</a>) and two used 200 mcg (<a href="./references#CD001338-bbs2-0002" title="AdairCD , WeeksJW , BarrilleauxPS , PhilibertL , EdwardsMS , LewisDF . Labor induction with oral versus vaginal misoprostol: a randomized, double‐blind trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S93. AdairCD , WeeksJW , BarrilleauxS , EdwardsM , BurlisonK , LewisDF . Oral or vaginal misoprostol administration for induction of labor: a randomised, double‐blind trial. Obstetrics &amp; Gynecology1998;92(5):810‐3. ">Adair 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0009" title="CarlanSJ , BouldinS , BlustD , O'BrienWF . Safety and efficacy of misoprostol orally and vaginally: a randomized trial. Obstetrics &amp; Gynecology2001;98:107‐12. ">Carlan 2001 (V50)</a>). In <a href="./references#CD001338-bbs2-0038" title="MajokoF , ZwizwaiM , NystromL , LindmarkG . Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin f2 alpha gel and prostaglandin e2 pessary. Central African Journal of Medicine2002;48(11‐12):123‐8. ">Majoko 2002 (V50)</a>, the initial dose was 10 mcg and each successive four‐hourly dose was doubled, to a maximum of 400 mcg. In <a href="./references#CD001338-bbs2-0012" title="ColonI , ClawsonK , HunterK , DruzinML , TaslimiMM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. American Journal of Obstetrics and Gynecology2005;192:747‐52. ColonI , ClawsonK , TaslimiM , DruzinM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S15. ">Colon 2005 (V25)</a>, the initial dose was 50 mcg, but increased to 100 mcg for subsequent doses. The dosage of vaginal misoprostol varied from 25 mcg to 100 mcg. The initial dose of vaginal misoprostol is stated in mcg after the year of article publication. </p> <p>Two studies (<a href="./references#CD001338-bbs2-0009" title="CarlanSJ , BouldinS , BlustD , O'BrienWF . Safety and efficacy of misoprostol orally and vaginally: a randomized trial. Obstetrics &amp; Gynecology2001;98:107‐12. ">Carlan 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0027" title="HowH , LeaseburgeL , KhouryJ , SiddiqiT , SibaiB . Is there an ideal route of misoprostol administration for cervical ripening and labor induction [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S118. HowH , LeaseburgeL , KhouryJ , SiddiqiT , SpinnatoJ , SibaiB . A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. American Journal of Obstetrics and Gynecology2001;185:911‐5. ">How 2001 (V25)</a>) included women who had previous caesarean sections (131 and 27 respectively). </p> </section> <section id="CD001338-sec-0077"> <h5 class="title">Sublingual misoprostol as comparator</h5> <p>There was just one study (<a href="./references#CD001338-bbs2-0020" title="ElhassanEM , NasrAM , AdamI . Sublingual compared with oral and vaginal misoprostol for labor induction. International Journal of Gynecology &amp; Obstetrics2007;97(2):153‐4. ">Elhassan 2007 (V50)</a>) which compared 50 mcg of oral, vaginal and sublingual misoprostol (50 women in each group). </p> </section> <section id="CD001338-sec-0078"> <h5 class="title">Vaginal dinoprostone insert as comparator</h5> <p>One study (<a href="./references#CD001338-bbs2-0057" title="RouziAA . Randomized clinical trial between titrated oral dose of misoprostol and Propess for induction of labor. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000420943 (accessed 22 January 2013)2011. RouziAA , AlsibianiS , MansouriN , AlsinaniN , DarhouseK . Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor. American Journal of Obstetrics and Gynecology2014;210(1):56.e1‐6. ">Rouzi 2014</a>) compared titrated oral misoprostol solution at 20 mcg with a 10 mcg dinoprostone vaginal, inserted for a maximum of 24 hours. </p> </section> <section id="CD001338-sec-0079"> <h5 class="title">Other comparisons</h5> <p>There were several other randomised trials comparing different oral misoprostol protocols. In one study <a href="./references#CD001338-bbs2-0031" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynecology &amp; Obstetrics2005;88:108‐11. ">Kipikasa 2005</a> compared 25 mcg and 50 mcg doses every three days for nine days. This study was conducted on an outpatient basis. Two studies compared 50 mcg and 100 mcg doses (<a href="./references#CD001338-bbs2-0011" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD001338-bbs2-0062" title="ShettyA , MartinR , DanielianP , TempletonA . A comparison of two dosage regimens of oral misoprostol for labor induction at term. Acta Obstetricia et Gynecologica Scandinavica2002;81:337‐42. ShettyA , MartinR , DanielianP , TempletonA . A comparison of two dose regimens of oral misoprostol in the induction of labour at term: a random allocation controlled trial [abstract]. Journal of Obstetrics &amp; Gynaecology2001;21(1):91. ">Shetty 2002</a>) and two studies by the same team examined frequency of dosaging. They initially compared 50 mcg given four‐hourly or six‐hourly (<a href="./references#CD001338-bbs2-0050" title="PongsathaS , TongsongT , SomsakT . A comparison between 50 mcg oral misoprostol every 4 hours and 6 hours for labor induction: a prospective randomized controlled trial. Journal of the Medical Association of Thailand2001;84(7):989‐94. SomsakT , PongsathaS . A comparison between oral misoprostol 50 micrograms every 4 hours and every 6 hours for labor induction. Thai Journal of Obstetrics and Gynaecology2000;12(4):334. ">Pongsatha 2001</a>) and then conducted a similar study comparing 100 mcg three‐hourly and six‐hourly (<a href="./references#CD001338-bbs2-0051" title="PongsathaS , SirisukkasemS , TongsongT . A comparison of 100ug oral misoprostol every 3 hours and 6 hours for labor induction: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2002;28(6):308‐12. ">Pongsatha 2002</a>). In this review, we have grouped together the dosage frequency studies with dosage subgroups. </p> <p>One study compared a regimen of oral misoprostol 25 mcg given three‐hourly until in labour (with oxytocin only if contractions settled) with a regimen of two oral misoprostol tablets followed by routine oxytocin (<a href="./references#CD001338-bbs2-0015" title="DeA , BaggaR , GopalanS . The routine use of oxytocin after oral misoprostol for labour induction in women with an unfavourable cervix is not of benefit. Australian and New Zealand Journal of Obstetrics and Gynaecology2006;46(4):323‐9. ">De 2006</a>). Another examined two management policies for women with ruptured membranes at term (<a href="./references#CD001338-bbs2-0063" title="ShettyA , StewartK , StewartG , RiceP , DanielianP , TempletonA . Active management of term prelabour rupture of membranes with oral misoprostol. BJOG: an international journal of obstetrics and gynaecology2002;109:1354‐8. ">Shetty 2002a</a>). One group received oral misoprostol 50 mcg four‐hourly at recruitment and the other had conservative management for 24 hours followed by PGE2 1 to 2 mg six‐hourly. The study by <a href="./references#CD001338-bbs2-0070" title="ThaisomboonA , RussameecharoenK , WanitpongpanP , PhattanachindakunB , ChangnoiA . Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. International Journal of Gynecology and Obstetrics2012;116(1):13‐6. ">Thaisomboon 2012 (T)</a> included only women with intact membranes. In this study, one group received hourly misoprostol solution 20 mcg (200 mcg tablet dissolved in 200 mL of tap water). If no uterine contractions were achieved after the first four doses the dose was doubled to 40 mcg up to a maximum of eight doses. The other group received misoprostol solution orally 50 mcg every four hours (20 mL of 200 mcg misoprostol in 80 mL water). The study was double blinded by the use of 20 mL of placebo solution between doses. </p> </section> </section> <section id="CD001338-sec-0080"> <h4 class="title">Excluded studies</h4> <p>Four exclusions are potentially controversial. We have excluded the study by <a href="./references#CD001338-bbs2-0089" title="WindrimR , BennettK , MundleW , YoungDC . Oral administration of misoprostol for labor induction: a randomized controlled trial. Obstetrics &amp; Gynecology1997;89:392‐7. ">Windrim 1997</a> because 138 women in the comparator group were induced with four different methods (intracervical dinoprostone, vaginal dinoprostone, oxytocin, vaginal misoprostol). We felt that these methods are too different to be compared to oral misoprostol as one intervention. <a href="./references#CD001338-bbs2-0077" title="Ascher‐WalshC , BurkeB , BaxiL . Outpatient management of prolonged pregnancy with misoprostol: a randomised, double‐blind, placebo‐controlled study, prelim.data. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S520. ">Ascher‐Walsh 2000</a> used oral misoprostol to achieve spontaneous onset of labour, i.e. oral misoprostol or placebo were given in three‐day intervals between 40 and 42 weeks of pregnancy. This review with its clinical outcomes concentrates on methods to achieve vaginal birth as quickly as possible, so we decided to exclude this trial.The study by <a href="./references#CD001338-bbs2-0090" title="ZvandasaraP , SaungwemeG , MlamboJ , ChidemboW , MadzivanziraN , MwanjiraC . Induction of labour with titrated oral misoprostol suspension. A comparative study with vaginal misoprostol. Central African Journal of Medicine2008;54(9‐12):43‐9. ">Zvandasara 2008</a> was excluded as it included women with intrauterine fetal death (four women). Finally,the study by <a href="./references#CD001338-bbs2-0086" title="RasheedR , AlamAA , YounusS , RazaF . Oral versus vaginal misoprostol for labour induction. JPMA ‐ Journal of the Pakistan Medical Association2007;57(8):404‐7. ">Rasheed 2007 (V50)</a> included data on 25 women who were not randomised.These women were undergoing induction of labour with oral misoprostol (their normal unit induction method) just before the trial started. We therefore included their data with the oral misoprostol arm within the data set from the 285 women who were in the randomised group. The additional data has resulted in an uneven balance between the groups (165 versus 145), and the data derived from those randomised alone are not retrievable from the manuscript. </p> <p>A number of studies were excluded as they used a combination of techniques. We excluded the studies by <a href="./references#CD001338-bbs2-0084" title="KadanaliS , KucukozkanT , ZorN , KumptepeY . Comparison of labor induction with misoprostol versus oxytocin/prostaglandin E2 in term pregnancy. International Journal of Gynecology &amp; Obstetrics1996;55:99‐104. ">Kadanali 1996</a> and <a href="./references#CD001338-bbs2-0080" title="BrickerL , PedenH , AlfirevicZ . The PROMMIS trial: a multicentre randomised trial to evaluate a low dose misoprostol regimen for induction of labour in the presence of prelabour rupture of the amniotic membranes [abstract]. Journal of Obstetrics and Gynaecology2007;27(Suppl 1):S22‐3. BrickerL , PedenH , TomlinsonAJ , Al‐HussainiTK , IdamaT , CandelierC , et al. Titrated low‐dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial. BJOG: an international journal of obstetrics and gynaecology2008;115(12):1503‐11. ">Bricker 2008</a> because they used vaginal misoprostol followed by oral administration. These studies are therefore included in the Cochrane review of vaginal misoprostol by <a href="./references#CD001338-bbs2-0123" title="HofmeyrGJ , GülmezogluAM . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2003, Issue 1. [DOI: 10.1002/14651858.CD000941] ">Hofmeyr 2003</a>. The study by <a href="./references#CD001338-bbs2-0085" title="NetoCM , DelbinAL , Do Val JuniorR . Tocographic pattern caused by misoprostol [Padrao tocografico desencadeado pelo misoprostol]. Revista Paulista de Medicina1988;106(4):205‐8. ">Neto 1988</a> concentrated on the uterine effects of oral and vaginal misoprostol. Five women received oral misoprostol in the dose of 200 mcg four‐hourly, five women received 400 mcg four‐hourly and five women received a single 200 mcg tablet vaginally. The reported outcomes included initiation, dynamics and duration of uterine contractions. Clinical outcomes were not reported and we have therefore excluded the study. We excluded <a href="./references#CD001338-bbs2-0079" title="BozhinovaS . Is it already time to legalize the usage of cytotec (misoprostol) in the obstetrics' practice?. Akusherstvo i Ginekologiia2007;46(9):56‐61. ">Bozhinova 2007</a> as the comparison of oral misoprostol was with combined vaginal and sublingual misoprostol. <a href="./references#CD001338-bbs2-0081" title="DelaneyT , CraneJ , HutchensD , FanningC , YoungD . Oral misoprostol labor induction in patients with a favorable cervix. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S202. ">Delaney 2001</a> was excluded as women had an artificial rupture of membranes performed at study entry and the oxytocin or oral misoprostol was only used for those who were not in labour one hour later. </p> <p>We excluded <a href="./references#CD001338-bbs2-0083" title="HoM , ChengSY , LiTC . Titrated oral misoprostol solution compared with intravenous oxytocin for labor augmentation: a randomized controlled trial. Obstetrics &amp; Gynecology2010;116(3):612‐8. ">Ho 2010</a> as it is a study of labour augmentation in women with 'failure to progress in labour' rather than labour induction. </p> <p>As reported above, the study by <a href="./references#CD001338-bbs2-0040" title="MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term ‐ a comparative study. South African Journal of Obstetrics and Gynaecology2003;9(2):34‐7. MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term‐‐a comparative study. South African Medical Journal2003;93:371‐4. ">Moodley 2003</a> had three arms. We have included outcomes from the groups treated with oral misoprostol and vaginal dinoprostone in this review, but not from the third group, where women received a mixture of oral and vaginal misoprostol. </p> <p>Several studies are still ongoing (<a href="./references#CD001338-bbs2-0104" title="DebBarmaAM . A comparative study of misoprostol oral versus vaginal route for induction of labour. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4251 (accessed 22 January 2013). ">DebBarma 2013</a>; <a href="./references#CD001338-bbs2-0105" title="GhermanR . A randomized double‐blind comparison of oral misoprostol dosing regimens for cervical ripening. Obstetrics &amp; Gynecology2002;99(4 Suppl):47S. ">Gherman 2002</a>; <a href="./references#CD001338-bbs2-0106" title="PranuthiR , PadmajaA , PadmajaP . Comparison of oral misoprostol with vaginal misoprostol for induction of labour. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5‐9; Hyderabad, Andhra Pradesh, India. 2011:118. ">Pranuthi 2011</a>), awaiting translation or have not been not been reported fully yet (<a href="./references#CD001338-bbs2-0091" title="AtkinsonMW , VanKessel , BenedettiT . The use of low dose oral misoprostol to induce labour in the third trimester. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S129. ">Atkinson 2000</a>; <a href="./references#CD001338-bbs2-0092" title="BonebrakeR , HaagT , FlemingA , TempM , HaynatzkiG . Vaginal misoprostol is more effective with fewer side effects than oral misoprostol for cervical ripening and induction of labor [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. ">Bonebrake 2001</a>; <a href="./references#CD001338-bbs2-0093" title="ButlerB , CraneJ , DelaneyT . Induction of labour with misoprostol in women at term with an unfavorable cervix: a randomized comparison of oral and vaginal administration. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S190. ">Butler 2004</a>; <a href="./references#CD001338-bbs2-0094" title="GetganM , PaisarntantiwongR , SripramoteM . A randomized comparison between 50 micrograms orally and misoprostol 25 micrograms vaginally for cervical ripening and induction of labor. Thai Journal of Obstetrics and Gynaecology2003;15(4):276. ">Getgan 2003</a>; <a href="./references#CD001338-bbs2-0095" title="GoedkenJ , PoehlmannS , PaulM . A blinded randomized controlled trial of misoprostol, dinoprostone, and oxytocin for labor induction. Obstetrics &amp; Gynecology2000;95(4 Suppl):73S. ">Goedken 2000</a>; <a href="./references#CD001338-bbs2-0096" title="MadhaviN , JahanA . Prospective randomised comparative study of labour with misoprostol vs oxytocin in pre labour rupture of membranes. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5‐9; Hyderabad, Andhra Pradesh, India. 2011:106. ">Madhavi 2011</a>; <a href="./references#CD001338-bbs2-0097" title="NiroomaneshS , DadashalihaM , AkramiM . Titrated oral misoprostol solution compared with oxytocin for induction of labor in women with unfavorable cervix. Tehran University Medical Journal2011;69(7):413‐9. ">Niroomanesh 2011</a>; <a href="./references#CD001338-bbs2-0098" title="PearsonM , HollierL , ShahA , YeomansE . A randomized comparison of oral misoprostol versus intravenous oxytocin for induction of labor with term premature rupture of membranes. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S174. ">Pearson 2002</a>; <a href="./references#CD001338-bbs2-0099" title="SaldivarD , TrianaH , SoriaA , GuzmanA , CaberoL , FarranI , et al. Oral misoprostol versus intracervical dinoprostone for induction of labour in women with an unfavourable cervix [Misoprostol oral vs dinoprostona intracervical en la induccion del trabajo en pacientes con cervix desfavorable]. Journal of Perinatal Medicine2001;29 Suppl 1(Pt 1):293. ">Saldivar 2001</a>; <a href="./references#CD001338-bbs2-0100" title="TuipaeS , KhooarmornpattanaS . Effectiveness of oral misoprostol for cervical priming in term pre‐labor rupture of membranes (PROM). Thai Journal of Obstetrics and Gynaecology1999;11(4):276. ">Tuipae 1999</a>; <a href="./references#CD001338-bbs2-0101" title="VijitrawiwatA , PongsathaS . A comparison between oral misoprostol 100 micrograms every 3 hours and vaginal misoprostol 50 micrograms every 4 hours for labor induction. Thai Journal of Obstetrics and Gynaecology2003;15(4):285. ">Vijitrawiwat 2003</a>; <a href="./references#CD001338-bbs2-0102" title="YazdaniSH , BouzariZ , FarahiS , TabaryAM . Oral misoprostol with oxytocin versus oxytocin alone for labor induction in pre‐labor rupture of membranes (PROM) at term pregnancy. Journal of Babol University of Medical Sciences2012;14(3):7‐12. ">Yazdani 2012</a>; <a href="./references#CD001338-bbs2-0103" title="YoungD , DelaneyT , ArmsonT , FanningC . Lower dose vaginal and oral misoprostol in labor induction ‐ rct. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S203. ">Young 2001</a>). </p> </section> </section> <section id="CD001338-sec-0081"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD001338-fig-0001">Figure 1</a>; <a href="#CD001338-fig-0002">Figure 2</a> for a summary of 'Risk of bias' assessments. </p> <div class="figure" id="CD001338-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001338-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001338-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001338-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD001338-sec-0082"> <h4 class="title">Allocation</h4> <section id="CD001338-sec-0083"> <h5 class="title">Sequence generation</h5> <p>Thirty‐three trials were assessed as being low risk of bias (<a href="./references#CD001338-bbs2-0001" title="Aalami‐HarandiR , KaramaliM , MoeiniA . Induction of labor with titrated oral misoprostol solution versus oxytocin in term pregnancy: randomized controlled trial. Revista Brasileira de Ginecologia e Obstetricia2013;35(2):60‐5. ">Aalami‐Harandi 2013 (T)</a>; <a href="./references#CD001338-bbs2-0006" title="BeigiA , KabiriM , ZarrinkoubF . Cervical ripening with oral misoprostol at term. International Journal of Gynecology &amp; Obstetrics2003;83:251‐5. ">Beigi 2003</a>; <a href="./references#CD001338-bbs2-0007" title="BennettK , ButtK , CraneJ , HutchensD , YoungD . Misoprostol for labour induction at term. Society of Obstetricians and Gynaecologists of Canada 54th Annual Meeting; 1998 June; Victoria, Canada. 1998:11. BennettKA , ButtK , CraneJMG , HutchensD , YoungDC . A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction. Obstetrics &amp; Gynecology1998;92(4 Suppl 1):481‐6. ">Bennett 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0008" title="ButtKD , BennettKA , CraneJM , HutchensD , YoungDC . Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstetrics &amp; Gynecology1999;94(6):994‐9. ">Butt 1999</a>; <a href="./references#CD001338-bbs2-0009" title="CarlanSJ , BouldinS , BlustD , O'BrienWF . Safety and efficacy of misoprostol orally and vaginally: a randomized trial. Obstetrics &amp; Gynecology2001;98:107‐12. ">Carlan 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0010" title="ChengSY , MingH , LeeJC . Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstetrics &amp; Gynecology2008;111(1):119‐25. ">Cheng 2008 (T) (V25)</a>; <a href="./references#CD001338-bbs2-0011" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD001338-bbs2-0012" title="ColonI , ClawsonK , HunterK , DruzinML , TaslimiMM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. American Journal of Obstetrics and Gynecology2005;192:747‐52. ColonI , ClawsonK , TaslimiM , DruzinM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S15. ">Colon 2005 (V25)</a>; <a href="./references#CD001338-bbs2-0013" title="CraneJ , DelaneyT , HutchensD . Oral misoprostol labor induction in term prelabor membrane rupture. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. CraneJMG , DelaneyT , HutchensD . Oral misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:720‐4. ">Crane 2003</a>; <a href="./references#CD001338-bbs2-0014" title="DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial. American Journal of Obstetrics and Gynecology2003;188(1):162‐7. DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction? A randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S108. ">Dallenbach 2003 (T)</a>; <a href="./references#CD001338-bbs2-0015" title="DeA , BaggaR , GopalanS . The routine use of oxytocin after oral misoprostol for labour induction in women with an unfavourable cervix is not of benefit. Australian and New Zealand Journal of Obstetrics and Gynaecology2006;46(4):323‐9. ">De 2006</a>; <a href="./references#CD001338-bbs2-0021" title="FisherS , DaviesG , MackenzieP . Oral versus vaginal misoprostol for induction of labour: a double‐blind, placebo‐controlled randomised trial. American Journal of Obstetrics and Gynecology2001;184(1):S117. FisherS , MackenzieV , DaviesG . Oral versus vaginal misoprostol for induction of labor: a double‐blind randomized controlled trial. American Journal of Obstetrics and Gynecology2001;185:906‐10. ">Fisher 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0022" title="BrowningJ , GhermanRB . Oral misoprostol versus intravaginal prostaglandin E2 for preinduction cervical ripening: a randomized trial. Obstetrics &amp; Gynecology2000;95(4 Suppl):76S. GhermanR , BrowningJ , O'BoyleA , Murphy GoodwinT . Oral misoprostol vs. intravaginal prostaglandin e2 for preinduction cervical ripening. Journal of Reproductive Medicine2001;46(7):641‐6. ">Gherman 2001</a>; <a href="./references#CD001338-bbs2-0023" title="HallR , Duarte‐GardeaM , HarlassF . Oral versus vaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2002;99(6):1044‐8. ">Hall 2002 (V25)</a>; <a href="./references#CD001338-bbs2-0025" title="HoffmanR , AnthonyJ , FawcusJ . Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2001;72:215‐21. HoffmanRAM , FawcusS , AnthonyJ . Oral misoprostol versus placebo in the management of prelabour rupture of membranes at term. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3‐6; Cape Town South Africa. 1999:65. ">Hoffman 2001</a>; <a href="./references#CD001338-bbs2-0026" title="HofmyerGJ , AlfirevicZ , MatonhodzeB , BrocklehurstP , CampbellE , NikodemC . Titrated oral misoprostol solution for labour induction: a multi‐centre, randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:952‐9. MatonhodzeB , AlfirevicZ , HofmeyrJ , BrocklehurstP . Titrated oral misoprostol for labour induction: a randomised trial [abstract]. Prenatal and Neonatal Medicine2000;5(Suppl 2):148. MatonhodzeB , AlfirevicZ , HofmeyrJ , CampbellL , BrocklehurstP . Titrated oral misoprostol for labour induction: a random allocation trial. Journal of Obstetrics and Gynaecology2000;20(Suppl 1):S19. MatonhodzeBB , HofmeyrGJ , LevinJ . Labour induction at term‐‐a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. South African Medical Journal2003;93(5):375‐9. ">Hofmeyr 2001(T)</a>; <a href="./references#CD001338-bbs2-0027" title="HowH , LeaseburgeL , KhouryJ , SiddiqiT , SibaiB . Is there an ideal route of misoprostol administration for cervical ripening and labor induction [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S118. HowH , LeaseburgeL , KhouryJ , SiddiqiT , SpinnatoJ , SibaiB . A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. American Journal of Obstetrics and Gynecology2001;185:911‐5. ">How 2001 (V25)</a>; <a href="./references#CD001338-bbs2-0031" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynecology &amp; Obstetrics2005;88:108‐11. ">Kipikasa 2005</a>; <a href="./references#CD001338-bbs2-0041" title="MozurkewichE , HorrocksJ , DaleyS , VonOeyenP , SarvisA , HalvorsonM , et al. The misoprostol study: a randomized controlled trial of misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. MozurkewichE , HorrocksJ , DaleyS , vonOeyenP , HalvorsonM , JohnsonM , et al. The MisoPROM study: a multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:1026‐30. ">Mozurkewich 2003</a>; <a href="./references#CD001338-bbs2-0042" title="NagpalMB , RaghunandanC , SailiA . Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2009;106(1):23‐6. ">Nagpal 2009</a>; <a href="./references#CD001338-bbs2-0043" title="NgaiCSW , ToWWK , LaoT , HoPC . Cervical priming with oral misoprostol in prelabour rupture of membranes at term. 27th British Congress of Obstetrics and Gynaecology;1995 July 4‐7, Dublin, Ireland. 1995:A479. NgaiSW , ToWK , LaoT , HoPC . Cervical priming with oral misoprostol in pre‐labor rupture of membranes at term. Obstetrics &amp; Gynecology1996;87:923‐6. ">Ngai 1996</a>; <a href="./references#CD001338-bbs2-0047" title="PaisarntantiwongR , GetganM . A comparison between single dose of 50 microg oral misoprostol and 25 microg vaginal misoprostol for labor induction. Journal of the Medical Association of Thailand2005;88(Suppl 2):S56‐S62. ">Pais'wong 2008 (V25)</a>; <a href="./references#CD001338-bbs2-0049" title="PaungmoraN , HerabutayaY , O‐PrasertsawatP . A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised controlled trial. Thai Journal of Obstetrics and Gynaecology2003;15(4):272. PaungmoraN , HerabutyaY , O‐PrasertsawatP , PunyavachiraP . Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial. Journal of Obstetrics &amp; Gynaecology Research2004;30(5):358‐62. ">Paungmora 2004 (V50)</a>; <a href="./references#CD001338-bbs2-0054" title="RahmanH . Comparative evaluation of 50ug oral misoprostol and 25ug intra‐vaginal misoprostol for induction of labour at term. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5‐9; Hyderabad, Andhra Pradesh, India. 2011:316. RahmanH , PradhanA , KharkaL , RenjhenP , KarS , DuttaS . Comparative evaluation of 50 microgram oral misoprostol and 25 microgram intravaginal misoprostol for induction of labour at term: a randomized trial. Journal of Obstetrics and Gynaecology Canada : JOGC2013;35(5):408‐16. ">Rahman 2013 (V25)</a>; <a href="./references#CD001338-bbs2-0057" title="RouziAA . Randomized clinical trial between titrated oral dose of misoprostol and Propess for induction of labor. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000420943 (accessed 22 January 2013)2011. RouziAA , AlsibianiS , MansouriN , AlsinaniN , DarhouseK . Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor. American Journal of Obstetrics and Gynecology2014;210(1):56.e1‐6. ">Rouzi 2014</a>; <a href="./references#CD001338-bbs2-0062" title="ShettyA , MartinR , DanielianP , TempletonA . A comparison of two dosage regimens of oral misoprostol for labor induction at term. Acta Obstetricia et Gynecologica Scandinavica2002;81:337‐42. ShettyA , MartinR , DanielianP , TempletonA . A comparison of two dose regimens of oral misoprostol in the induction of labour at term: a random allocation controlled trial [abstract]. Journal of Obstetrics &amp; Gynaecology2001;21(1):91. ">Shetty 2002</a>; <a href="./references#CD001338-bbs2-0066" title="SitthiwattanawongW . A comparison between oral and intravaginal administration of 50 microgram misoprostol for cervical ripening and induction of labor. Thai Journal of Obstetrics and Gynaecology2000;12(4):352. SitthiwattanawongW , PongsathaS . Oral misoprostol for cervical ripening and labour induction: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology1999;11(2):87‐92. ">Sitthiwattanawong 1999</a>; <a href="./references#CD001338-bbs2-0067" title="Rolland SouzaA . [Titrated oral suspension compared with vaginal misoprostol for labor induction: a randomized controlled trial] [Misoprostol em solução oral titulada escalonada versus via vaginal para indução do trabalho de parto: ensaio clínico randomizado]. Revista Brazileira de Ginecologia e Obstetricia2011;33(9):270. Rolland de SouzaA . Oral misoprostol titrated solution versus vaginal misoprostol for induction of labour: randomized controlled trial. http://clinicaltrials.gov/ct2/show/record/NCT00992524 (accessed 22 January 2013)2011. SouzaAS , FeitosaFE , CostaAA , PereiraAP , CarvalhoAS , PaixaoRM , et al. Titrated oral misoprostol solution versus vaginal misoprostol for labor induction. International Journal of Gynecology and Obstetrics2013;123(3):207‐12. ">Souza 2013(V25)(T)</a>; <a href="./references#CD001338-bbs2-0069" title="* Tessier F , DanserauJ . Oral misoprostol versus vaginal dinoprostone for labor induction: a double‐blind randomized controlled trial. Personal communication1997. TessierF , DansereauJ . A double‐blind randomized controlled trial comparing oral misoprostol to vaginal prostaglandin E2 gel for the induction of labour at or near term. American Journal of Obstetrics and Gynecology1997;176(1):S111. ">Tessier 1997</a>; <a href="./references#CD001338-bbs2-0070" title="ThaisomboonA , RussameecharoenK , WanitpongpanP , PhattanachindakunB , ChangnoiA . Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. International Journal of Gynecology and Obstetrics2012;116(1):13‐6. ">Thaisomboon 2012 (T)</a>; <a href="./references#CD001338-bbs2-0071" title="ToppozadaMK , AnwarMYM , HassanHA , El‐GazaerlyWS . Oral or vaginal misoprostol for induction of labour. International Journal of Gynecology &amp; Obstetrics1997;56:135‐9. ">Toppozada 1997 (V100</a>; <a href="./references#CD001338-bbs2-0073" title="WingD , HamD , PaulRH . A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(5):1155‐60. WingDA , HamD , PaulRH . A comparison of orally administered misoprostol to vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S127. ">Wing 1999 (V25)</a>; <a href="./references#CD001338-bbs2-0075" title="WingDA , FassettMJ , GubermanC , TranS , ParrishA , GuinnD . A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervix examinations. American Journal of Obstetrics and Gynecology2004;190:1689‐96. ">Wing 2004</a>) for sequence generation. The method of randomisation was unclear in 21 trials (<a href="./references#CD001338-bbs2-0002" title="AdairCD , WeeksJW , BarrilleauxPS , PhilibertL , EdwardsMS , LewisDF . Labor induction with oral versus vaginal misoprostol: a randomized, double‐blind trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S93. AdairCD , WeeksJW , BarrilleauxS , EdwardsM , BurlisonK , LewisDF . Oral or vaginal misoprostol administration for induction of labor: a randomised, double‐blind trial. Obstetrics &amp; Gynecology1998;92(5):810‐3. ">Adair 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0003" title="AdamI , HassanOA , ElhassanEM . Oral misoprostol vs. vaginal misoprostol for cervical ripening and labour induction. International Journal of Gynecology &amp; Obstetrics2005;89:142‐3. ">Adam 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0004" title="Al‐HussainiTK , Abdel‐AalSA , YoussefMA . Oral misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2003;82(1):73‐5. ">Al‐Hussaini 2003</a>; <a href="./references#CD001338-bbs2-0005" title="BarthaJL , Comino‐DelgadoR , Garcia‐BenasachF , Martinez‐Del‐FresnoP , Moreno‐CorralLJ . Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: a randomized comparison. Obstetrics &amp; Gynecology2000;96:465‐9. ">Bartha 2000</a>; <a href="./references#CD001338-bbs2-0016" title="DeshmukhVL , YelikarKA , WasoV . Comparative study of efficacy and safety of oral versus vaginal misoprostol for induction or labour. Journal of Obstetrics and Gynaecology of India2013;63(5):321‐4. ">Deshmukh 2013 (V50)</a>; <a href="./references#CD001338-bbs2-0017" title="DoddJ , CrowtherC , RonbinsonJ . Misoprostol for the induction of labour at term: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2005;45:347‐8. DoddJM , CrowtherCA , RobinsonJS . Factors associated with adverse maternal health outcomes following induction of labour at term: analyses from a randomised trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:86. DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol for induction of labour at term: randomised controlled trial. BMJ2006;332(7540):509‐13. DoddJM , CrowtherCA , RobinsonJS . Time of commencing induction of labour: a nested randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:85. ">Dodd 2006</a>; <a href="./references#CD001338-bbs2-0018" title="DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol versus intravenous oxytocin for induction of labour following artificial or spontaneous rupture of membranes: a randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:258. ">Dodd 2006a (T)</a>; <a href="./references#CD001338-bbs2-0019" title="DyarTR , GreigP , CummingsR , NicholsK . The efficacy and safety of oral versus vaginal misoprostol for the induction of term labor. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S135. ">Dyar 2000 (V50)</a>; <a href="./references#CD001338-bbs2-0020" title="ElhassanEM , NasrAM , AdamI . Sublingual compared with oral and vaginal misoprostol for labor induction. International Journal of Gynecology &amp; Obstetrics2007;97(2):153‐4. ">Elhassan 2007 (V50)</a>; <a href="./references#CD001338-bbs2-0024" title="HenrichW , DudenhausenJW , HanelC , ChenFC . Oral misoprostol against vaginal dinoprostone for labor induction at term: a randomized comparison [Prospektiv randomisierte Studie zum Vergleich von Misoprostol oral mit Dinoproston vaginal bei der Geburtseinleitung am Termin]. Zeitschrift fur Geburtshilfe und Neonatologie2008;212(5):183‐8. ">Henrich 2008 (T)</a>; <a href="./references#CD001338-bbs2-0028" title="JavaidMK , HassanS , TahiraT . Management pre labour rupture of the membranes at term; induction of labor compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD001338-bbs2-0029" title="JindalP , AvasthiK , KaurM . A comparison of vaginal vs. oral misoprostol for induction of labor‐double blind randomized trial. Journal of Obstetrics and Gynecology of India2011;61(5):538‐42. ">Jindal 2011 (V50)</a>; <a href="./references#CD001338-bbs2-0030" title="KhazardoostS , HakimiP , NoorzadehM , ShafaatM . Misoprostol for cervical ripening: a clinical trial in 60 pregnant women. Tehran University Medical Journal2011;68(10):595‐9. ">Khazardoost 2011 (V25)</a>; <a href="./references#CD001338-bbs2-0032" title="KwonJ , DaviesG , MacKenzieV . A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:23‐6. KwonJS , MackenzieVP , DaviesGAL . A comparison of oral and vaginal misoprostol for induction of labour. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S128. ">Kwon 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0039" title="MehrotraS , SinghU , GuptaHP . A prospective double blind study using oral versus vaginal misoprostol for labour induction. Journal of Obstetrics &amp; Gynaecology2010;30(5):461‐4. ">Mehrotra 2010 (V50)</a>; <a href="./references#CD001338-bbs2-0055" title="RathDM , ManasK . Induction of labor with oral misoprostol in women with prelabor rupture of membranes at term. Journal of Obstetrics and Gynecology of India2007;57(6):505‐8. ">Rath 2007</a>; <a href="./references#CD001338-bbs2-0056" title="RizviS , UmberF , YusufAW . Labour induction at term; oral versus intravaginal misoprostol. Annals of King Edward Medical College2007;13(1):119‐21. ">Rizvi 2007 (V25)</a>; <a href="./references#CD001338-bbs2-0060" title="SheikherC , SuriN , KholiU . Comparative evaluation of oral misoprostol, vaginal misoprostol and intracervical Foley's catheter for induction of labour at term. JK Science2009;11(2):75‐7. ">Sheikher 2009 (V25)</a>; <a href="./references#CD001338-bbs2-0068" title="SultanaN , RoufS , RashidM . Oral versus vaginal misoprostol for induction of labour. Journal of Bangladesh College of Physicians and Surgeons2006;24(2):44‐9. ">Sultana 2006 (V100)</a>; <a href="./references#CD001338-bbs2-0072" title="UludagS , SaricaliFS , MadazliR , CepniI . A comparison of oral and vaginal misoprostol for induction of labour. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2005;122:57‐60. ">Uludag 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0074" title="WingDA , ParkMR , PaulRH . A randomised comparison of oral and intravaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2000;95(6 Pt 1):905‐8. ">Wing 2000 (V25)</a>) </p> </section> <section id="CD001338-sec-0084"> <h5 class="title">Allocation concealment</h5> <p>Forty‐six trials were low risk of bias for allocation concealment (<a href="./references#CD001338-bbs2-0002" title="AdairCD , WeeksJW , BarrilleauxPS , PhilibertL , EdwardsMS , LewisDF . Labor induction with oral versus vaginal misoprostol: a randomized, double‐blind trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S93. AdairCD , WeeksJW , BarrilleauxS , EdwardsM , BurlisonK , LewisDF . Oral or vaginal misoprostol administration for induction of labor: a randomised, double‐blind trial. Obstetrics &amp; Gynecology1998;92(5):810‐3. ">Adair 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0005" title="BarthaJL , Comino‐DelgadoR , Garcia‐BenasachF , Martinez‐Del‐FresnoP , Moreno‐CorralLJ . Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: a randomized comparison. Obstetrics &amp; Gynecology2000;96:465‐9. ">Bartha 2000</a>; <a href="./references#CD001338-bbs2-0007" title="BennettK , ButtK , CraneJ , HutchensD , YoungD . Misoprostol for labour induction at term. Society of Obstetricians and Gynaecologists of Canada 54th Annual Meeting; 1998 June; Victoria, Canada. 1998:11. BennettKA , ButtK , CraneJMG , HutchensD , YoungDC . A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction. Obstetrics &amp; Gynecology1998;92(4 Suppl 1):481‐6. ">Bennett 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0008" title="ButtKD , BennettKA , CraneJM , HutchensD , YoungDC . Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstetrics &amp; Gynecology1999;94(6):994‐9. ">Butt 1999</a>; <a href="./references#CD001338-bbs2-0009" title="CarlanSJ , BouldinS , BlustD , O'BrienWF . Safety and efficacy of misoprostol orally and vaginally: a randomized trial. Obstetrics &amp; Gynecology2001;98:107‐12. ">Carlan 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0010" title="ChengSY , MingH , LeeJC . Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstetrics &amp; Gynecology2008;111(1):119‐25. ">Cheng 2008 (T) (V25)</a>; <a href="./references#CD001338-bbs2-0011" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD001338-bbs2-0012" title="ColonI , ClawsonK , HunterK , DruzinML , TaslimiMM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. American Journal of Obstetrics and Gynecology2005;192:747‐52. ColonI , ClawsonK , TaslimiM , DruzinM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S15. ">Colon 2005 (V25)</a>; <a href="./references#CD001338-bbs2-0013" title="CraneJ , DelaneyT , HutchensD . Oral misoprostol labor induction in term prelabor membrane rupture. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. CraneJMG , DelaneyT , HutchensD . Oral misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:720‐4. ">Crane 2003</a>; <a href="./references#CD001338-bbs2-0014" title="DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial. American Journal of Obstetrics and Gynecology2003;188(1):162‐7. DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction? A randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S108. ">Dallenbach 2003 (T)</a>; <a href="./references#CD001338-bbs2-0017" title="DoddJ , CrowtherC , RonbinsonJ . Misoprostol for the induction of labour at term: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2005;45:347‐8. DoddJM , CrowtherCA , RobinsonJS . Factors associated with adverse maternal health outcomes following induction of labour at term: analyses from a randomised trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:86. DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol for induction of labour at term: randomised controlled trial. BMJ2006;332(7540):509‐13. DoddJM , CrowtherCA , RobinsonJS . Time of commencing induction of labour: a nested randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:85. ">Dodd 2006</a>; <a href="./references#CD001338-bbs2-0018" title="DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol versus intravenous oxytocin for induction of labour following artificial or spontaneous rupture of membranes: a randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:258. ">Dodd 2006a (T)</a>; <a href="./references#CD001338-bbs2-0021" title="FisherS , DaviesG , MackenzieP . Oral versus vaginal misoprostol for induction of labour: a double‐blind, placebo‐controlled randomised trial. American Journal of Obstetrics and Gynecology2001;184(1):S117. FisherS , MackenzieV , DaviesG . Oral versus vaginal misoprostol for induction of labor: a double‐blind randomized controlled trial. American Journal of Obstetrics and Gynecology2001;185:906‐10. ">Fisher 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0119" title="GhermanRB , HeathT . Trial of labor after cesarean delivery: a pilot study of oral misoprostol for preinduction cervical ripening. Obstetrics &amp; Gynecology2001;97(Suppl 1):S68. ">Gherman 2001a</a>; <a href="./references#CD001338-bbs2-0023" title="HallR , Duarte‐GardeaM , HarlassF . Oral versus vaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2002;99(6):1044‐8. ">Hall 2002 (V25)</a>; <a href="./references#CD001338-bbs2-0024" title="HenrichW , DudenhausenJW , HanelC , ChenFC . Oral misoprostol against vaginal dinoprostone for labor induction at term: a randomized comparison [Prospektiv randomisierte Studie zum Vergleich von Misoprostol oral mit Dinoproston vaginal bei der Geburtseinleitung am Termin]. Zeitschrift fur Geburtshilfe und Neonatologie2008;212(5):183‐8. ">Henrich 2008 (T)</a>; <a href="./references#CD001338-bbs2-0025" title="HoffmanR , AnthonyJ , FawcusJ . Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2001;72:215‐21. HoffmanRAM , FawcusS , AnthonyJ . Oral misoprostol versus placebo in the management of prelabour rupture of membranes at term. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3‐6; Cape Town South Africa. 1999:65. ">Hoffman 2001</a>; <a href="./references#CD001338-bbs2-0026" title="HofmyerGJ , AlfirevicZ , MatonhodzeB , BrocklehurstP , CampbellE , NikodemC . Titrated oral misoprostol solution for labour induction: a multi‐centre, randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:952‐9. MatonhodzeB , AlfirevicZ , HofmeyrJ , BrocklehurstP . Titrated oral misoprostol for labour induction: a randomised trial [abstract]. Prenatal and Neonatal Medicine2000;5(Suppl 2):148. MatonhodzeB , AlfirevicZ , HofmeyrJ , CampbellL , BrocklehurstP . Titrated oral misoprostol for labour induction: a random allocation trial. Journal of Obstetrics and Gynaecology2000;20(Suppl 1):S19. MatonhodzeBB , HofmeyrGJ , LevinJ . Labour induction at term‐‐a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. South African Medical Journal2003;93(5):375‐9. ">Hofmeyr 2001(T)</a>; <a href="./references#CD001338-bbs2-0027" title="HowH , LeaseburgeL , KhouryJ , SiddiqiT , SibaiB . Is there an ideal route of misoprostol administration for cervical ripening and labor induction [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S118. HowH , LeaseburgeL , KhouryJ , SiddiqiT , SpinnatoJ , SibaiB . A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. American Journal of Obstetrics and Gynecology2001;185:911‐5. ">How 2001 (V25)</a>; <a href="./references#CD001338-bbs2-0032" title="KwonJ , DaviesG , MacKenzieV . A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:23‐6. KwonJS , MackenzieVP , DaviesGAL . A comparison of oral and vaginal misoprostol for induction of labour. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S128. ">Kwon 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0033" title="LangeneggerEJ , OdendaalHJ , GroveD . Oral misoprostol versus intracervical dinoprostone for induction of labour. International Journal of Gynecology &amp; Obstetrics2005;88:242‐8. ">Langenegger 2005</a>; <a href="./references#CD001338-bbs2-0034" title="leRouxP , OlarogunJ , PennyJ , AnthonyJ . Oral and vaginal misoprostol compared with dinoprostone for induction of labor: a randomized controlled trial. Obstetrics &amp; Gynecology2002;99(2):201‐5. ">le Roux 2002 (V50)</a>; <a href="./references#CD001338-bbs2-0035" title="LevyR , VaisbuchE , FurmanB , BrownD , VolachV , HagayZJ . Induction of labor with oral misoprostol for premature rupture of membranes at term in women with unfavorable cervix: a randomized, double‐blind, placebo‐controlled trial. Journal of Perinatal Medicine2007;35:126‐9. LevyR , VaisbuchE , FurmanB , DoitchH , OronS , HagayZ . Prospective randomized clinical trial of immediate induction of labor with oral misoprostol for prelabor rupture of the membranes in women with unfavorable cervix at term. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S44. ">Levy 2007</a>; <a href="./references#CD001338-bbs2-0038" title="MajokoF , ZwizwaiM , NystromL , LindmarkG . Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin f2 alpha gel and prostaglandin e2 pessary. Central African Journal of Medicine2002;48(11‐12):123‐8. ">Majoko 2002 (V50)</a>; <a href="./references#CD001338-bbs2-0039" title="MehrotraS , SinghU , GuptaHP . A prospective double blind study using oral versus vaginal misoprostol for labour induction. Journal of Obstetrics &amp; Gynaecology2010;30(5):461‐4. ">Mehrotra 2010 (V50)</a>; <a href="./references#CD001338-bbs2-0040" title="MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term ‐ a comparative study. South African Journal of Obstetrics and Gynaecology2003;9(2):34‐7. MoodleyJ , VenkatachalamS , SongcaP . Misoprostol for cervical ripening at and near term‐‐a comparative study. South African Medical Journal2003;93:371‐4. ">Moodley 2003</a>; <a href="./references#CD001338-bbs2-0041" title="MozurkewichE , HorrocksJ , DaleyS , VonOeyenP , SarvisA , HalvorsonM , et al. The misoprostol study: a randomized controlled trial of misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. MozurkewichE , HorrocksJ , DaleyS , vonOeyenP , HalvorsonM , JohnsonM , et al. The MisoPROM study: a multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:1026‐30. ">Mozurkewich 2003</a>; <a href="./references#CD001338-bbs2-0042" title="NagpalMB , RaghunandanC , SailiA . Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2009;106(1):23‐6. ">Nagpal 2009</a>; <a href="./references#CD001338-bbs2-0043" title="NgaiCSW , ToWWK , LaoT , HoPC . Cervical priming with oral misoprostol in prelabour rupture of membranes at term. 27th British Congress of Obstetrics and Gynaecology;1995 July 4‐7, Dublin, Ireland. 1995:A479. NgaiSW , ToWK , LaoT , HoPC . Cervical priming with oral misoprostol in pre‐labor rupture of membranes at term. Obstetrics &amp; Gynecology1996;87:923‐6. ">Ngai 1996</a>; <a href="./references#CD001338-bbs2-0044" title="JacksonN , Paterson‐BrownS . Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes [letter]. BJOG: an international journal of obstetrics and gynaecology2000;107(9):1181‐2. NgaiSW , ChanYM , LamSW , LaoT . Prospective randomised study to compare misoprostol and oxytocin for labour induction in prelabour rupture of membranes in term pregnancy. British Journal of Obstetrics and Gynaecology1998;105 Suppl 17:82. NgaiSW , ChanYM , LamSW , LaoTT . Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of membranes. British Journal of Obstetrics and Gynecology2000;107(2):222‐7. ">Ngai 2000</a>; <a href="./references#CD001338-bbs2-0046" title="NopdonrattakoonL . A comparison between intravaginal and oral misoprostol for labor induction: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2003;29(2):87‐91. ">Nopdonrattkaoon 2003 (V50)</a>; <a href="./references#CD001338-bbs2-0047" title="PaisarntantiwongR , GetganM . A comparison between single dose of 50 microg oral misoprostol and 25 microg vaginal misoprostol for labor induction. Journal of the Medical Association of Thailand2005;88(Suppl 2):S56‐S62. ">Pais'wong 2008 (V25)</a>; <a href="./references#CD001338-bbs2-0048" title="PatilPK , SwamyMK , Rao RadhikaK . Oral misoprostol vs intra‐cervical dinoprostone for cervical ripening and labour induction. Journal of Obstetrics and Gynaecology of India2005;55(2):128‐31. ">Patil 2005</a>; <a href="./references#CD001338-bbs2-0054" title="RahmanH . Comparative evaluation of 50ug oral misoprostol and 25ug intra‐vaginal misoprostol for induction of labour at term. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5‐9; Hyderabad, Andhra Pradesh, India. 2011:316. RahmanH , PradhanA , KharkaL , RenjhenP , KarS , DuttaS . Comparative evaluation of 50 microgram oral misoprostol and 25 microgram intravaginal misoprostol for induction of labour at term: a randomized trial. Journal of Obstetrics and Gynaecology Canada : JOGC2013;35(5):408‐16. ">Rahman 2013 (V25)</a>; <a href="./references#CD001338-bbs2-0057" title="RouziAA . Randomized clinical trial between titrated oral dose of misoprostol and Propess for induction of labor. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000420943 (accessed 22 January 2013)2011. RouziAA , AlsibianiS , MansouriN , AlsinaniN , DarhouseK . Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor. American Journal of Obstetrics and Gynecology2014;210(1):56.e1‐6. ">Rouzi 2014</a>; <a href="./references#CD001338-bbs2-0061" title="ShettyA , DanielianP , TempletonA . A comparison of oral and vaginal misoprostol in the induction of labour at term: a random allocation trial. Journal of Obstetrics and Gynaecology2000;20(Suppl 1):S19. ShettyA , DanielianP , TempletonA . A comparison of oral and vaginal misoprostol tablets in induction of labour at term. BJOG: an international journal of obstetrics and gynaecology2001;108:238‐43. ShettyA , DanielianP , TempletonA . A comparison of oral and vaginal tablets in the induction of labor at term. XVI FIGO World Congress of Obstetrics &amp; Gynecology. Book 4; 2000 Sept 3‐8; Washington DC, USA. 2000:28‐9. ShettyA , DanielianP , TempletonA . Oral versus vaginal misoprostol in the induction of labour at term: a randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2000;107:813. ">Shetty 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0062" title="ShettyA , MartinR , DanielianP , TempletonA . A comparison of two dosage regimens of oral misoprostol for labor induction at term. Acta Obstetricia et Gynecologica Scandinavica2002;81:337‐42. ShettyA , MartinR , DanielianP , TempletonA . A comparison of two dose regimens of oral misoprostol in the induction of labour at term: a random allocation controlled trial [abstract]. Journal of Obstetrics &amp; Gynaecology2001;21(1):91. ">Shetty 2002</a>; <a href="./references#CD001338-bbs2-0063" title="ShettyA , StewartK , StewartG , RiceP , DanielianP , TempletonA . Active management of term prelabour rupture of membranes with oral misoprostol. BJOG: an international journal of obstetrics and gynaecology2002;109:1354‐8. ">Shetty 2002a</a>; <a href="./references#CD001338-bbs2-0064" title="LivingstoneI , AcharyaS , ShettyA , RiceP , DanielianP , TempletonA . 100ug of oral misoprostol versus 25ug of vaginal misoprostol in term labour induction ‐ a randomised comparison. Journal of Obstetrics and Gynaecology2004;24(1):106. ShettyA , LivingstoneI , AcharyaS , RiceP , DanielianP , TempletonA . Oral misoprostol (100ug) versus vaginal misoprostol (25ug) in term labor induction: a randomized comparison. Acta Obstetricia et Gynecologica Scandinavica2003;82(12):1103‐6. ">Shetty 2003 (V25)</a>; <a href="./references#CD001338-bbs2-0065" title="ShettyA , LivingstoneI , AcharyaS , DanielianP , RiceP , TempletonA . A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term. BJOG: an international journal of obstetrics and gynaecology2003;110:963. ShettyA , LivingstoneI , AcharyaS , DanielianP , TempletonA , RiceP . A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term. BJOG: an international journal of obstetrics and gynaecology2004;111:436‐40. ">Shetty 2004</a>; <a href="./references#CD001338-bbs2-0070" title="ThaisomboonA , RussameecharoenK , WanitpongpanP , PhattanachindakunB , ChangnoiA . Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. International Journal of Gynecology and Obstetrics2012;116(1):13‐6. ">Thaisomboon 2012 (T)</a>; <a href="./references#CD001338-bbs2-0069" title="* Tessier F , DanserauJ . Oral misoprostol versus vaginal dinoprostone for labor induction: a double‐blind randomized controlled trial. Personal communication1997. TessierF , DansereauJ . A double‐blind randomized controlled trial comparing oral misoprostol to vaginal prostaglandin E2 gel for the induction of labour at or near term. American Journal of Obstetrics and Gynecology1997;176(1):S111. ">Tessier 1997</a>; <a href="./references#CD001338-bbs2-0072" title="UludagS , SaricaliFS , MadazliR , CepniI . A comparison of oral and vaginal misoprostol for induction of labour. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2005;122:57‐60. ">Uludag 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0073" title="WingD , HamD , PaulRH . A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(5):1155‐60. WingDA , HamD , PaulRH . A comparison of orally administered misoprostol to vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S127. ">Wing 1999 (V25)</a>; <a href="./references#CD001338-bbs2-0074" title="WingDA , ParkMR , PaulRH . A randomised comparison of oral and intravaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2000;95(6 Pt 1):905‐8. ">Wing 2000 (V25)</a>; <a href="./references#CD001338-bbs2-0075" title="WingDA , FassettMJ , GubermanC , TranS , ParrishA , GuinnD . A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervix examinations. American Journal of Obstetrics and Gynecology2004;190:1689‐96. ">Wing 2004</a>). The following trials were assessed as unclear risk of bias for this domain (<a href="./references#CD001338-bbs2-0001" title="Aalami‐HarandiR , KaramaliM , MoeiniA . Induction of labor with titrated oral misoprostol solution versus oxytocin in term pregnancy: randomized controlled trial. Revista Brasileira de Ginecologia e Obstetricia2013;35(2):60‐5. ">Aalami‐Harandi 2013 (T)</a>; <a href="./references#CD001338-bbs2-0003" title="AdamI , HassanOA , ElhassanEM . Oral misoprostol vs. vaginal misoprostol for cervical ripening and labour induction. International Journal of Gynecology &amp; Obstetrics2005;89:142‐3. ">Adam 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0004" title="Al‐HussainiTK , Abdel‐AalSA , YoussefMA . Oral misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2003;82(1):73‐5. ">Al‐Hussaini 2003</a>; <a href="./references#CD001338-bbs2-0006" title="BeigiA , KabiriM , ZarrinkoubF . Cervical ripening with oral misoprostol at term. International Journal of Gynecology &amp; Obstetrics2003;83:251‐5. ">Beigi 2003</a>; <a href="./references#CD001338-bbs2-0015" title="DeA , BaggaR , GopalanS . The routine use of oxytocin after oral misoprostol for labour induction in women with an unfavourable cervix is not of benefit. Australian and New Zealand Journal of Obstetrics and Gynaecology2006;46(4):323‐9. ">De 2006</a>; <a href="./references#CD001338-bbs2-0016" title="DeshmukhVL , YelikarKA , WasoV . Comparative study of efficacy and safety of oral versus vaginal misoprostol for induction or labour. Journal of Obstetrics and Gynaecology of India2013;63(5):321‐4. ">Deshmukh 2013 (V50)</a>; <a href="./references#CD001338-bbs2-0019" title="DyarTR , GreigP , CummingsR , NicholsK . The efficacy and safety of oral versus vaginal misoprostol for the induction of term labor. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S135. ">Dyar 2000 (V50)</a>; <a href="./references#CD001338-bbs2-0020" title="ElhassanEM , NasrAM , AdamI . Sublingual compared with oral and vaginal misoprostol for labor induction. International Journal of Gynecology &amp; Obstetrics2007;97(2):153‐4. ">Elhassan 2007 (V50)</a>; <a href="./references#CD001338-bbs2-0028" title="JavaidMK , HassanS , TahiraT . Management pre labour rupture of the membranes at term; induction of labor compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD001338-bbs2-0029" title="JindalP , AvasthiK , KaurM . A comparison of vaginal vs. oral misoprostol for induction of labor‐double blind randomized trial. Journal of Obstetrics and Gynecology of India2011;61(5):538‐42. ">Jindal 2011 (V50)</a>; <a href="./references#CD001338-bbs2-0030" title="KhazardoostS , HakimiP , NoorzadehM , ShafaatM . Misoprostol for cervical ripening: a clinical trial in 60 pregnant women. Tehran University Medical Journal2011;68(10):595‐9. ">Khazardoost 2011 (V25)</a>; <a href="./references#CD001338-bbs2-0031" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynecology &amp; Obstetrics2005;88:108‐11. ">Kipikasa 2005</a>; <a href="./references#CD001338-bbs2-0036" title="LoJ , AlexanderJ , McIntireD , LevenoK . Efficacy of oral misoprostol in nulliparous women with premature rupture of membranes. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. LoJ , AlexanderJ , McIntireD , LevenoK . Randomized trial of oral misoprostol in nulliparous women with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. LoJY , AlexanderJM , McIntireDD , LevenoKJ . Ruptured membranes at term: randomized, double‐blind trial of oral misoprostol for labor induction. Obstetrics &amp; Gynecology2003;101(4):685‐9. ">Lo 2003</a>; <a href="./references#CD001338-bbs2-0037" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>; <a href="./references#CD001338-bbs2-0045" title="NigamA , SinghVK , DubayP , PandeyK , BhagioliwalA , PrakashA . Misoprostol vs. oxytocin for induction of labor at term. International Journal of Gynecology &amp; Obstetrics2004;86:398‐400. ">Nigam 2004</a>; <a href="./references#CD001338-bbs2-0049" title="PaungmoraN , HerabutayaY , O‐PrasertsawatP . A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised controlled trial. Thai Journal of Obstetrics and Gynaecology2003;15(4):272. PaungmoraN , HerabutyaY , O‐PrasertsawatP , PunyavachiraP . Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial. Journal of Obstetrics &amp; Gynaecology Research2004;30(5):358‐62. ">Paungmora 2004 (V50)</a>; <a href="./references#CD001338-bbs2-0050" title="PongsathaS , TongsongT , SomsakT . A comparison between 50 mcg oral misoprostol every 4 hours and 6 hours for labor induction: a prospective randomized controlled trial. Journal of the Medical Association of Thailand2001;84(7):989‐94. SomsakT , PongsathaS . A comparison between oral misoprostol 50 micrograms every 4 hours and every 6 hours for labor induction. Thai Journal of Obstetrics and Gynaecology2000;12(4):334. ">Pongsatha 2001</a>; <a href="./references#CD001338-bbs2-0051" title="PongsathaS , SirisukkasemS , TongsongT . A comparison of 100ug oral misoprostol every 3 hours and 6 hours for labor induction: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2002;28(6):308‐12. ">Pongsatha 2002</a>; <a href="./references#CD001338-bbs2-0053" title="PugaO , NienJ , GomezR , MedinaL , CarstensM , GonzalezR , et al. Premature rupture of membranes after 35 weeks: a randomized clinical trial of induction of labor with oral versus vaginal administration of misoprostol. American Journal of Obstetrics and Gynecology2001;184(1):S85. ">Puga 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0055" title="RathDM , ManasK . Induction of labor with oral misoprostol in women with prelabor rupture of membranes at term. Journal of Obstetrics and Gynecology of India2007;57(6):505‐8. ">Rath 2007</a>; <a href="./references#CD001338-bbs2-0056" title="RizviS , UmberF , YusufAW . Labour induction at term; oral versus intravaginal misoprostol. Annals of King Edward Medical College2007;13(1):119‐21. ">Rizvi 2007 (V25)</a>; <a href="./references#CD001338-bbs2-0058" title="SchneiderM , RamseyR , KaoL , BennettKA . Misoprostol is effective for induction of labor in high risk pregnant women: a randomized controlled trial. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S73. ">Schneider 2004 (V25)</a>; <a href="./references#CD001338-bbs2-0059" title="SheelaCN , MhaskarA , GeorgeS . Comparison of vaginal misoprostol and oral misoprostol with intracervical dinoprostone gel for labor induction at term. Journal of Obstetrics and Gynaecology of India2007;57(4):327‐30. ">Sheela 2007 (V25)</a>; <a href="./references#CD001338-bbs2-0060" title="SheikherC , SuriN , KholiU . Comparative evaluation of oral misoprostol, vaginal misoprostol and intracervical Foley's catheter for induction of labour at term. JK Science2009;11(2):75‐7. ">Sheikher 2009 (V25)</a>; <a href="./references#CD001338-bbs2-0066" title="SitthiwattanawongW . A comparison between oral and intravaginal administration of 50 microgram misoprostol for cervical ripening and induction of labor. Thai Journal of Obstetrics and Gynaecology2000;12(4):352. SitthiwattanawongW , PongsathaS . Oral misoprostol for cervical ripening and labour induction: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology1999;11(2):87‐92. ">Sitthiwattanawong 1999</a>; <a href="./references#CD001338-bbs2-0067" title="Rolland SouzaA . [Titrated oral suspension compared with vaginal misoprostol for labor induction: a randomized controlled trial] [Misoprostol em solução oral titulada escalonada versus via vaginal para indução do trabalho de parto: ensaio clínico randomizado]. Revista Brazileira de Ginecologia e Obstetricia2011;33(9):270. Rolland de SouzaA . Oral misoprostol titrated solution versus vaginal misoprostol for induction of labour: randomized controlled trial. http://clinicaltrials.gov/ct2/show/record/NCT00992524 (accessed 22 January 2013)2011. SouzaAS , FeitosaFE , CostaAA , PereiraAP , CarvalhoAS , PaixaoRM , et al. Titrated oral misoprostol solution versus vaginal misoprostol for labor induction. International Journal of Gynecology and Obstetrics2013;123(3):207‐12. ">Souza 2013(V25)(T)</a>; <a href="./references#CD001338-bbs2-0068" title="SultanaN , RoufS , RashidM . Oral versus vaginal misoprostol for induction of labour. Journal of Bangladesh College of Physicians and Surgeons2006;24(2):44‐9. ">Sultana 2006 (V100)</a>; <a href="./references#CD001338-bbs2-0071" title="ToppozadaMK , AnwarMYM , HassanHA , El‐GazaerlyWS . Oral or vaginal misoprostol for induction of labour. International Journal of Gynecology &amp; Obstetrics1997;56:135‐9. ">Toppozada 1997 (V100</a>). </p> </section> </section> <section id="CD001338-sec-0085"> <h4 class="title">Blinding</h4> <p>Of the studies we included, 14 were at low risk of bias for both performance and detection bias (<a href="./references#CD001338-bbs2-0002" title="AdairCD , WeeksJW , BarrilleauxPS , PhilibertL , EdwardsMS , LewisDF . Labor induction with oral versus vaginal misoprostol: a randomized, double‐blind trial. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S93. AdairCD , WeeksJW , BarrilleauxS , EdwardsM , BurlisonK , LewisDF . Oral or vaginal misoprostol administration for induction of labor: a randomised, double‐blind trial. Obstetrics &amp; Gynecology1998;92(5):810‐3. ">Adair 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0006" title="BeigiA , KabiriM , ZarrinkoubF . Cervical ripening with oral misoprostol at term. International Journal of Gynecology &amp; Obstetrics2003;83:251‐5. ">Beigi 2003</a>; <a href="./references#CD001338-bbs2-0007" title="BennettK , ButtK , CraneJ , HutchensD , YoungD . Misoprostol for labour induction at term. Society of Obstetricians and Gynaecologists of Canada 54th Annual Meeting; 1998 June; Victoria, Canada. 1998:11. BennettKA , ButtK , CraneJMG , HutchensD , YoungDC . A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction. Obstetrics &amp; Gynecology1998;92(4 Suppl 1):481‐6. ">Bennett 1998 (V50)</a>; <a href="./references#CD001338-bbs2-0011" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD001338-bbs2-0021" title="FisherS , DaviesG , MackenzieP . Oral versus vaginal misoprostol for induction of labour: a double‐blind, placebo‐controlled randomised trial. American Journal of Obstetrics and Gynecology2001;184(1):S117. FisherS , MackenzieV , DaviesG . Oral versus vaginal misoprostol for induction of labor: a double‐blind randomized controlled trial. American Journal of Obstetrics and Gynecology2001;185:906‐10. ">Fisher 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0025" title="HoffmanR , AnthonyJ , FawcusJ . Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2001;72:215‐21. HoffmanRAM , FawcusS , AnthonyJ . Oral misoprostol versus placebo in the management of prelabour rupture of membranes at term. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3‐6; Cape Town South Africa. 1999:65. ">Hoffman 2001</a>; <a href="./references#CD001338-bbs2-0027" title="HowH , LeaseburgeL , KhouryJ , SiddiqiT , SibaiB . Is there an ideal route of misoprostol administration for cervical ripening and labor induction [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S118. HowH , LeaseburgeL , KhouryJ , SiddiqiT , SpinnatoJ , SibaiB . A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. American Journal of Obstetrics and Gynecology2001;185:911‐5. ">How 2001 (V25)</a>; <a href="./references#CD001338-bbs2-0029" title="JindalP , AvasthiK , KaurM . A comparison of vaginal vs. oral misoprostol for induction of labor‐double blind randomized trial. Journal of Obstetrics and Gynecology of India2011;61(5):538‐42. ">Jindal 2011 (V50)</a>;<a href="./references#CD001338-bbs2-0031" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynecology &amp; Obstetrics2005;88:108‐11. ">Kipikasa 2005</a>; <a href="./references#CD001338-bbs2-0032" title="KwonJ , DaviesG , MacKenzieV . A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:23‐6. KwonJS , MackenzieVP , DaviesGAL . A comparison of oral and vaginal misoprostol for induction of labour. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S128. ">Kwon 2001 (V50)</a>;<a href="./references#CD001338-bbs2-0039" title="MehrotraS , SinghU , GuptaHP . A prospective double blind study using oral versus vaginal misoprostol for labour induction. Journal of Obstetrics &amp; Gynaecology2010;30(5):461‐4. ">Mehrotra 2010 (V50)</a>; <a href="./references#CD001338-bbs2-0067" title="Rolland SouzaA . [Titrated oral suspension compared with vaginal misoprostol for labor induction: a randomized controlled trial] [Misoprostol em solução oral titulada escalonada versus via vaginal para indução do trabalho de parto: ensaio clínico randomizado]. Revista Brazileira de Ginecologia e Obstetricia2011;33(9):270. Rolland de SouzaA . Oral misoprostol titrated solution versus vaginal misoprostol for induction of labour: randomized controlled trial. http://clinicaltrials.gov/ct2/show/record/NCT00992524 (accessed 22 January 2013)2011. SouzaAS , FeitosaFE , CostaAA , PereiraAP , CarvalhoAS , PaixaoRM , et al. Titrated oral misoprostol solution versus vaginal misoprostol for labor induction. International Journal of Gynecology and Obstetrics2013;123(3):207‐12. ">Souza 2013(V25)(T)</a>; <a href="./references#CD001338-bbs2-0069" title="* Tessier F , DanserauJ . Oral misoprostol versus vaginal dinoprostone for labor induction: a double‐blind randomized controlled trial. Personal communication1997. TessierF , DansereauJ . A double‐blind randomized controlled trial comparing oral misoprostol to vaginal prostaglandin E2 gel for the induction of labour at or near term. American Journal of Obstetrics and Gynecology1997;176(1):S111. ">Tessier 1997</a>; <a href="./references#CD001338-bbs2-0070" title="ThaisomboonA , RussameecharoenK , WanitpongpanP , PhattanachindakunB , ChangnoiA . Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. International Journal of Gynecology and Obstetrics2012;116(1):13‐6. ">Thaisomboon 2012 (T)</a>). Seven trials were at low risk performance bias but unclear risk of detection bias (<a href="./references#CD001338-bbs2-0017" title="DoddJ , CrowtherC , RonbinsonJ . Misoprostol for the induction of labour at term: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2005;45:347‐8. DoddJM , CrowtherCA , RobinsonJS . Factors associated with adverse maternal health outcomes following induction of labour at term: analyses from a randomised trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:86. DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol for induction of labour at term: randomised controlled trial. BMJ2006;332(7540):509‐13. DoddJM , CrowtherCA , RobinsonJS . Time of commencing induction of labour: a nested randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:85. ">Dodd 2006</a>; <a href="./references#CD001338-bbs2-0018" title="DoddJM , CrowtherCA , RobinsonJS . Oral misoprostol versus intravenous oxytocin for induction of labour following artificial or spontaneous rupture of membranes: a randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3‐6; Perth, Australia. 2006:258. ">Dodd 2006a (T)</a>; <a href="./references#CD001338-bbs2-0036" title="LoJ , AlexanderJ , McIntireD , LevenoK . Efficacy of oral misoprostol in nulliparous women with premature rupture of membranes. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. LoJ , AlexanderJ , McIntireD , LevenoK . Randomized trial of oral misoprostol in nulliparous women with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. LoJY , AlexanderJM , McIntireDD , LevenoKJ . Ruptured membranes at term: randomized, double‐blind trial of oral misoprostol for labor induction. Obstetrics &amp; Gynecology2003;101(4):685‐9. ">Lo 2003</a>; <a href="./references#CD001338-bbs2-0035" title="LevyR , VaisbuchE , FurmanB , BrownD , VolachV , HagayZJ . Induction of labor with oral misoprostol for premature rupture of membranes at term in women with unfavorable cervix: a randomized, double‐blind, placebo‐controlled trial. Journal of Perinatal Medicine2007;35:126‐9. LevyR , VaisbuchE , FurmanB , DoitchH , OronS , HagayZ . Prospective randomized clinical trial of immediate induction of labor with oral misoprostol for prelabor rupture of the membranes in women with unfavorable cervix at term. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S44. ">Levy 2007</a>; <a href="./references#CD001338-bbs2-0037" title="LyonsC , RumneyP , HuangW , MorrisonE , ThomasS , NageotteM , et al. Outpatient cervical ripening with oral misoprostol post‐term: induction rates decreased. American Journal of Obstetrics and Gynecology2001;184(1):S116. ">Lyons 2001</a>; <a href="./references#CD001338-bbs2-0043" title="NgaiCSW , ToWWK , LaoT , HoPC . Cervical priming with oral misoprostol in prelabour rupture of membranes at term. 27th British Congress of Obstetrics and Gynaecology;1995 July 4‐7, Dublin, Ireland. 1995:A479. NgaiSW , ToWK , LaoT , HoPC . Cervical priming with oral misoprostol in pre‐labor rupture of membranes at term. Obstetrics &amp; Gynecology1996;87:923‐6. ">Ngai 1996</a>; <a href="./references#CD001338-bbs2-0047" title="PaisarntantiwongR , GetganM . A comparison between single dose of 50 microg oral misoprostol and 25 microg vaginal misoprostol for labor induction. Journal of the Medical Association of Thailand2005;88(Suppl 2):S56‐S62. ">Pais'wong 2008 (V25)</a>). </p> <p>Fifteen trials were at a high risk of both performance and detection bias (<a href="./references#CD001338-bbs2-0001" title="Aalami‐HarandiR , KaramaliM , MoeiniA . Induction of labor with titrated oral misoprostol solution versus oxytocin in term pregnancy: randomized controlled trial. Revista Brasileira de Ginecologia e Obstetricia2013;35(2):60‐5. ">Aalami‐Harandi 2013 (T)</a>; <a href="./references#CD001338-bbs2-0008" title="ButtKD , BennettKA , CraneJM , HutchensD , YoungDC . Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstetrics &amp; Gynecology1999;94(6):994‐9. ">Butt 1999</a>; <a href="./references#CD001338-bbs2-0009" title="CarlanSJ , BouldinS , BlustD , O'BrienWF . Safety and efficacy of misoprostol orally and vaginally: a randomized trial. Obstetrics &amp; Gynecology2001;98:107‐12. ">Carlan 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0010" title="ChengSY , MingH , LeeJC . Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstetrics &amp; Gynecology2008;111(1):119‐25. ">Cheng 2008 (T) (V25)</a>; <a href="./references#CD001338-bbs2-0012" title="ColonI , ClawsonK , HunterK , DruzinML , TaslimiMM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. American Journal of Obstetrics and Gynecology2005;192:747‐52. ColonI , ClawsonK , TaslimiM , DruzinM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S15. ">Colon 2005 (V25)</a>; <a href="./references#CD001338-bbs2-0014" title="DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial. American Journal of Obstetrics and Gynecology2003;188(1):162‐7. DallenbachP , BoulvainM , ViardotC , IrionO . Oral misoprostol or vaginal dinoprostone for labor induction? A randomized controlled trial [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S108. ">Dallenbach 2003 (T)</a>; <a href="./references#CD001338-bbs2-0020" title="ElhassanEM , NasrAM , AdamI . Sublingual compared with oral and vaginal misoprostol for labor induction. International Journal of Gynecology &amp; Obstetrics2007;97(2):153‐4. ">Elhassan 2007 (V50)</a>; <a href="./references#CD001338-bbs2-0026" title="HofmyerGJ , AlfirevicZ , MatonhodzeB , BrocklehurstP , CampbellE , NikodemC . Titrated oral misoprostol solution for labour induction: a multi‐centre, randomised trial. BJOG: an international journal of obstetrics and gynaecology2001;108:952‐9. MatonhodzeB , AlfirevicZ , HofmeyrJ , BrocklehurstP . Titrated oral misoprostol for labour induction: a randomised trial [abstract]. Prenatal and Neonatal Medicine2000;5(Suppl 2):148. MatonhodzeB , AlfirevicZ , HofmeyrJ , CampbellL , BrocklehurstP . Titrated oral misoprostol for labour induction: a random allocation trial. Journal of Obstetrics and Gynaecology2000;20(Suppl 1):S19. MatonhodzeBB , HofmeyrGJ , LevinJ . Labour induction at term‐‐a randomised trial comparing Foley catheter plus titrated oral misoprostol solution, titrated oral misoprostol solution alone, and dinoprostone. South African Medical Journal2003;93(5):375‐9. ">Hofmeyr 2001(T)</a>; <a href="./references#CD001338-bbs2-0028" title="JavaidMK , HassanS , TahiraT . Management pre labour rupture of the membranes at term; induction of labor compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD001338-bbs2-0033" title="LangeneggerEJ , OdendaalHJ , GroveD . Oral misoprostol versus intracervical dinoprostone for induction of labour. International Journal of Gynecology &amp; Obstetrics2005;88:242‐8. ">Langenegger 2005</a>; <a href="./references#CD001338-bbs2-0042" title="NagpalMB , RaghunandanC , SailiA . Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2009;106(1):23‐6. ">Nagpal 2009</a>; <a href="./references#CD001338-bbs2-0054" title="RahmanH . Comparative evaluation of 50ug oral misoprostol and 25ug intra‐vaginal misoprostol for induction of labour at term. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5‐9; Hyderabad, Andhra Pradesh, India. 2011:316. RahmanH , PradhanA , KharkaL , RenjhenP , KarS , DuttaS . Comparative evaluation of 50 microgram oral misoprostol and 25 microgram intravaginal misoprostol for induction of labour at term: a randomized trial. Journal of Obstetrics and Gynaecology Canada : JOGC2013;35(5):408‐16. ">Rahman 2013 (V25)</a>; <a href="./references#CD001338-bbs2-0057" title="RouziAA . Randomized clinical trial between titrated oral dose of misoprostol and Propess for induction of labor. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000420943 (accessed 22 January 2013)2011. RouziAA , AlsibianiS , MansouriN , AlsinaniN , DarhouseK . Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor. American Journal of Obstetrics and Gynecology2014;210(1):56.e1‐6. ">Rouzi 2014</a>; <a href="./references#CD001338-bbs2-0066" title="SitthiwattanawongW . A comparison between oral and intravaginal administration of 50 microgram misoprostol for cervical ripening and induction of labor. Thai Journal of Obstetrics and Gynaecology2000;12(4):352. SitthiwattanawongW , PongsathaS . Oral misoprostol for cervical ripening and labour induction: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology1999;11(2):87‐92. ">Sitthiwattanawong 1999</a>; <a href="./references#CD001338-bbs2-0075" title="WingDA , FassettMJ , GubermanC , TranS , ParrishA , GuinnD . A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervix examinations. American Journal of Obstetrics and Gynecology2004;190:1689‐96. ">Wing 2004</a>). Two trials were at unclear risk of performance bias but high risk of detection bias (<a href="./references#CD001338-bbs2-0013" title="CraneJ , DelaneyT , HutchensD . Oral misoprostol labor induction in term prelabor membrane rupture. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. CraneJMG , DelaneyT , HutchensD . Oral misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:720‐4. ">Crane 2003</a>; <a href="./references#CD001338-bbs2-0015" title="DeA , BaggaR , GopalanS . The routine use of oxytocin after oral misoprostol for labour induction in women with an unfavourable cervix is not of benefit. Australian and New Zealand Journal of Obstetrics and Gynaecology2006;46(4):323‐9. ">De 2006</a>) and one trial was at high risk of performance bias and unclear risk of detection bias (<a href="./references#CD001338-bbs2-0075" title="WingDA , FassettMJ , GubermanC , TranS , ParrishA , GuinnD . A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervix examinations. American Journal of Obstetrics and Gynecology2004;190:1689‐96. ">Wing 2004</a>). Fifteen trials were at unclear risk of both performance and detection bias (<a href="./references#CD001338-bbs2-0003" title="AdamI , HassanOA , ElhassanEM . Oral misoprostol vs. vaginal misoprostol for cervical ripening and labour induction. International Journal of Gynecology &amp; Obstetrics2005;89:142‐3. ">Adam 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0004" title="Al‐HussainiTK , Abdel‐AalSA , YoussefMA . Oral misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2003;82(1):73‐5. ">Al‐Hussaini 2003</a>; <a href="./references#CD001338-bbs2-0005" title="BarthaJL , Comino‐DelgadoR , Garcia‐BenasachF , Martinez‐Del‐FresnoP , Moreno‐CorralLJ . Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: a randomized comparison. Obstetrics &amp; Gynecology2000;96:465‐9. ">Bartha 2000</a>; <a href="./references#CD001338-bbs2-0016" title="DeshmukhVL , YelikarKA , WasoV . Comparative study of efficacy and safety of oral versus vaginal misoprostol for induction or labour. Journal of Obstetrics and Gynaecology of India2013;63(5):321‐4. ">Deshmukh 2013 (V50)</a>; <a href="./references#CD001338-bbs2-0019" title="DyarTR , GreigP , CummingsR , NicholsK . The efficacy and safety of oral versus vaginal misoprostol for the induction of term labor. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S135. ">Dyar 2000 (V50)</a>; <a href="./references#CD001338-bbs2-0023" title="HallR , Duarte‐GardeaM , HarlassF . Oral versus vaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2002;99(6):1044‐8. ">Hall 2002 (V25)</a>; <a href="./references#CD001338-bbs2-0024" title="HenrichW , DudenhausenJW , HanelC , ChenFC . Oral misoprostol against vaginal dinoprostone for labor induction at term: a randomized comparison [Prospektiv randomisierte Studie zum Vergleich von Misoprostol oral mit Dinoproston vaginal bei der Geburtseinleitung am Termin]. Zeitschrift fur Geburtshilfe und Neonatologie2008;212(5):183‐8. ">Henrich 2008 (T)</a>; <a href="./references#CD001338-bbs2-0030" title="KhazardoostS , HakimiP , NoorzadehM , ShafaatM . Misoprostol for cervical ripening: a clinical trial in 60 pregnant women. Tehran University Medical Journal2011;68(10):595‐9. ">Khazardoost 2011 (V25)</a>; <a href="./references#CD001338-bbs2-0055" title="RathDM , ManasK . Induction of labor with oral misoprostol in women with prelabor rupture of membranes at term. Journal of Obstetrics and Gynecology of India2007;57(6):505‐8. ">Rath 2007</a>; <a href="./references#CD001338-bbs2-0056" title="RizviS , UmberF , YusufAW . Labour induction at term; oral versus intravaginal misoprostol. Annals of King Edward Medical College2007;13(1):119‐21. ">Rizvi 2007 (V25)</a>; <a href="./references#CD001338-bbs2-0060" title="SheikherC , SuriN , KholiU . Comparative evaluation of oral misoprostol, vaginal misoprostol and intracervical Foley's catheter for induction of labour at term. JK Science2009;11(2):75‐7. ">Sheikher 2009 (V25)</a>; <a href="./references#CD001338-bbs2-0068" title="SultanaN , RoufS , RashidM . Oral versus vaginal misoprostol for induction of labour. Journal of Bangladesh College of Physicians and Surgeons2006;24(2):44‐9. ">Sultana 2006 (V100)</a>; <a href="./references#CD001338-bbs2-0072" title="UludagS , SaricaliFS , MadazliR , CepniI . A comparison of oral and vaginal misoprostol for induction of labour. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2005;122:57‐60. ">Uludag 2005 (V50)</a>; <a href="./references#CD001338-bbs2-0073" title="WingD , HamD , PaulRH . A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(5):1155‐60. WingDA , HamD , PaulRH . A comparison of orally administered misoprostol to vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S127. ">Wing 1999 (V25)</a>; <a href="./references#CD001338-bbs2-0074" title="WingDA , ParkMR , PaulRH . A randomised comparison of oral and intravaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2000;95(6 Pt 1):905‐8. ">Wing 2000 (V25)</a>). </p> <p>Where the treatment was not blinded there is a real possibility of bias, both in clinical decision making and assessment of outcomes. A clinician with a prior belief that oral misoprostol is effective and safe might be less likely to perform a caesarean section in case of fetal distress or slow labour. On the other hand, a clinician who is anxious about possible risks of the new treatment may be more likely to intervene. </p> </section> <section id="CD001338-sec-0086"> <h4 class="title">Incomplete outcome data</h4> <p>There was wide variation in the outcomes reported in the studies, and some were not consistent with the outcomes in this review. So whilst 'vaginal birth within 24 hours' is an important summary primary outcome in this review, it is rarely used by trialists, many of whom prefer a continuous variable of time to birth (which is not one of the Cochrane outcomes). Similarly not all published papers use the strict Cochrane definition of hyperstimulation with or without fetal heart rate abnormalities despite these being important outcomes. In assessing these outcomes, the authors have had to use judgement in matching the reported outcomes (for example "hyperstimulation") with the predefined Cochrane outcomes. Increasingly, however, trialists are turning to the Cochrane reviews for their selection of outcomes, and so recent high‐quality studies are well matched to the Cochrane outcomes set. </p> </section> <section id="CD001338-sec-0087"> <h4 class="title">Selective reporting</h4> <p>There is a wide variation in reported outcomes, but no evidence of selective reporting was found. </p> </section> <section id="CD001338-sec-0088"> <h4 class="title">Other potential sources of bias</h4> <p>None.</p> </section> </section> <section id="CD001338-sec-0089"> <h3 class="title" id="CD001338-sec-0089">Effects of interventions</h3> <section id="CD001338-sec-0090"> <h4 class="title">(1) Comparison with placebo (analyses 1 to 4)</h4> <p>Nine trials with 1109 participating women in total compared oral misoprostol with placebo or no treatment. </p> <p><b>Primary outcomes:</b> women using oral misoprostol were more likely to give birth vaginally within 24 hours (although this was only assessed in one trial of 96 women (risk ratio (RR) 0.16, 95% confidence interval (CI) 0.05 to 0.49) in which women in both arms were given dinoprostone after 12 hours), <a href="./references#CD001338-fig-0003" title="">Analysis 1.1</a>. Oral misoprostol was associated with lower caesarean section (CS) rates (RR 0.72, 95% CI 0.54 to 0.95), <a href="./references#CD001338-fig-0005" title="">Analysis 1.3</a>. </p> <p><b>Secondary outcomes:</b> oral misoprostol was also associated with less oxytocin augmentation (RR 0.42, 95% CI 0.37 to 0.49), <a href="./references#CD001338-fig-0009" title="">Analysis 1.7</a>, fewer admissions to the neonatal intensive care unit (RR 0.42, 95% CI 0.32 to 0.56), <a href="./references#CD001338-fig-0014" title="">Analysis 1.14</a>, and lower rates of epidural use (RR 0.81, 95% CI 0.69‐0.96) <a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=256200030113425556%26versionPK1=z1704111151595379394774661554409%26versionPK2=z1708181634315558170947986693528#CMP-001.06" target="_blank">Analysis 1.6</a> There were no other clinically important differences in prespecified outcomes, including measures of uterine hyperstimulation. Most of the women studied had ruptured membranes, and analysis confined to this subgroup demonstrated similar findings to the overall analysis. </p> <p><b>Subgroups:</b> in the subgroup of all women with ruptured membranes, there was a significant increase in the number of women with a vaginal birth within 24 hours (one study of 96 women, RR 0.16, 95% CI 0.05 to 0.49), <a href="./references#CD001338-fig-0019" title="">Analysis 3.1</a>. In the subgroups of all women with intact membranes and primigravid women with ruptured membranes, there were no significant changes in the primary outcomes. </p> </section> <section id="CD001338-sec-0091"> <h4 class="title">(2) Comparison with vaginal dinoprostone (analyses 5 to 11)</h4> <p>A total of 3,240 women were randomised to oral misoprostol or vaginal dinoprostone in 10 trials. The most common dose of misoprostol used in these studies was 20 mcg oral solution given two‐hourly. </p> <p><b>Primary outcomes:</b> there was no effect on CS rate in those treated with oral misoprostol (RR 0.92, 95% CI 0.81 to 1.04), <a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=256200030113425556%26versionPK1=z1704111151595379394774661554409%26versionPK2=z1708181634315558170947986693528#CMP-005.03" target="_blank">Analysis 5.3</a> or in the number of women not achieving vaginal birth within 24 hours (RR 1.09, 95% CI 0.99 to 1.20), <a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=256200030113425556%26versionPK1=z1704111151595379394774661554409%26versionPK2=z1708181634315558170947986693528#CMP-005.01" target="_blank">Analysis 5.1</a>, </p> <p><b>Secondary outcomes: w</b>omen treated with misoprostol more frequently had an unchanged cervix after 12 to 24 hours (RR 1.41, 95% CI 1.01 to 1.96), <a href="./references#CD001338-fig-0032" title="">Analysis 5.6</a>. There were no other statistically significant differences between the groups in any of the outcomes, including hyperstimulation rates and frequency of meconium‐stained liquor. </p> <p><b>Subgroups:</b> six trials (n = 2,129) provided the data for a subgroup of women with intact membranes. The data show that women induced with misoprostol have fewer CSs (RR 0.85, 95% CI 0.73 to 0.99), <a href="./references#CD001338-fig-0053" title="">Analysis 6.3</a>. However, they had slower labours with increased rates of unchanged cervix after 12 to 24 hours (RR 1.51, 95% CI 1.03 to 2.20), <a href="./references#CD001338-fig-0056" title="">Analysis 6.6</a> and a lower rate of vaginal birth within 24 hours (RR 1.12, 95%CI 1.01‐1.25) <a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=256200030113425556%26versionPK1=z1704111151595379394774661554409%26versionPK2=z1708181634315558170947986693528#CMP-006.01" target="_blank">Analysis 6.1</a>. There were no other significant differences. </p> <p>Only two trials provided the data for women with ruptured membranes and there were only data for two outcomes. The number of women who did not achieve vaginal birth within 24 hours was reduced in the misoprostol group (RR 0.60, 95% CI 0.37 to 0.97), <a href="./references#CD001338-fig-0057" title="">Analysis 7.1</a>, i.e. induction with oral misoprostol achieved vaginal birth within the first 24 hours more frequently compared with vaginal dinoprostone. There were no other significant differences in primary outcomes between the subgroups. </p> <p>Only one study recruited women with previous CSs (n = 267) of which 23 had previous CS. No uterine ruptures were reported. </p> </section> <section id="CD001338-sec-0092"> <h4 class="title">(3) Comparison with intracervical prostaglandin E2 (analyses 12, 13 and 14)</h4> <p>This comparison was found in five trials, involving 681 women randomised to oral misoprostol or intracervical dinoprostone. Four trials included only women with intact membranes and one included only women with ruptured membranes. Three used misoprostol doses of 50 mcg (352 women) and two used 200 mcg (two trials, 390 women). </p> <p><b>Primary outcomes:</b> the rate of uterine hyperstimulation with fetal heart rate (FHR) changes was significantly higher in those treated with misoprostol (RR 3.57, 95% CI 1.11 to 11.54), <a href="./references#CD001338-fig-0068" title="">Analysis 12.2</a>. However, significantly more women in the oral misoprostol group achieved vaginal birth within 24 hours (39% versus 49%, RR 0.78, 95% CI 0.63 to 0.97), <a href="./references#CD001338-fig-0067" title="">Analysis 12.1</a>. </p> <p><b>Secondary outcomes:</b> the rate of uterine hyperstimulation without FHR changes was significantly higher in those treated with misoprostol (RR 6.25, 95% CI 1.14 to 34.31), <a href="./references#CD001338-fig-0074" title="">Analysis 12.8</a>. Only one study considered maternal dissatisfaction, and this was lower in those treated with oral misoprostol (RR 0.51, 95% CI 0.27 to 0.96), <a href="./references#CD001338-fig-0085" title="">Analysis 12.19</a>. There were no other differences between the groups. </p> <p><b>Subgroups:</b> the subgroups for those with intact membranes found the oral misoprostol group to have a significantly higher rate of uterine hyperstimulation with FHR changes (RR 4.60, 95% CI 1.19 to 17.80), <a href="./references#CD001338-fig-0087" title="">Analysis 13.2</a>. There was an increase in the number of women with a vaginal birth within 24 hours but this was not statistically significant (RR 0.81, 95% CI 0.65 to 1.00), <a href="./references#CD001338-fig-0086" title="">Analysis 13.1</a>. In the subgroup with ruptured membranes, there was only one study and this showed no significant difference in any of the primary outcomes. </p> <p>There was substantial heterogeneity for the 'need for oxytocin' outcome (I² = 80%), <a href="./references#CD001338-fig-0073" title="">Analysis 12.7</a>. Sensitivity and subgroup analysis indicated that this was not related to the poor quality study or dose. </p> </section> <section id="CD001338-sec-0093"> <h4 class="title">(4) Comparison with intravenous oxytocin (analyses 15, 16, 17, 18 and 19)</h4> <p>Nine trials including 1282 women have compared oral misoprostol with intravenous oxytocin. Five studies used 100 mcg (818 women), two studies used 50 mcg (178 women), one used 20 mcg solution (30 women) and one study used 25 mcg solution (256 women). </p> <p><b>Primary outcomes:</b> the CS rate was significantly lower in women who received oral misoprostol (RR 0.77, 95% CI 0.60 to 0.98), <a href="./references#CD001338-fig-0095" title="">Analysis 15.3</a>, but there were no significant differences seen in any of the other primary outcomes. However, the meta‐analysis of uterine hyperstimulation syndrome indicated substantial heterogeneity, <a href="./references#CD001338-fig-0094" title="">Analysis 15.2</a>. This may be explained by the trial by <a href="./references#CD001338-bbs2-0013" title="CraneJ , DelaneyT , HutchensD . Oral misoprostol labor induction in term prelabor membrane rupture. American Journal of Obstetrics and Gynecology2002;187(6 Pt 2):S168. CraneJMG , DelaneyT , HutchensD . Oral misoprostol for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology2003;189:720‐4. ">Crane 2003</a>. which used a dose of 75 mcg four‐hourly. That study found significantly less hyperstimulation with misoprostol, whilst the remainder found no difference. </p> <p><b>Secondary outcomes:</b> meconium staining of the liquor was seen more frequently in the misoprostol group (RR 1.65, 95% CI 1.04 to 2.60), <a href="./references#CD001338-fig-0103" title="">Analysis 15.11</a>, but this was not reflected in significant differences in any adverse fetal or neonatal outcomes.There were no other statistically significant differences between the oral misoprostol and intravenous oxytocin groups (except for oxytocin use, which was naturally higher in the oxytocin group). </p> <p><b>Subgroups:</b> in six of the trials (758 women) there were outcome data for women with ruptured membranes. In this subgroup, the percentage of women with meconium‐stained liquor (and the RR) was similar to that in the overall results (<a href="./references#CD001338-fig-0103" title="">Analysis 15.11</a>), but the reduced numbers meant that the difference was not statistically significant (RR 1.71, 95% CI 0.91 to 3.23), <a href="./references#CD001338-fig-0117" title="">Analysis 16.6</a>. </p> <p>There were no data reported for the subgroup of women with intact membranes.</p> </section> <section id="CD001338-sec-0094"> <h4 class="title">(5) Comparison with sublingual misoprostol (analysis 20)</h4> <p>There was just one study of poor methodological quality in this comparison which compared 50 mcg of oral, vaginal and sublingual misoprostol (50 in each group, <a href="./references#CD001338-bbs2-0020" title="ElhassanEM , NasrAM , AdamI . Sublingual compared with oral and vaginal misoprostol for labor induction. International Journal of Gynecology &amp; Obstetrics2007;97(2):153‐4. ">Elhassan 2007 (V50)</a>). There was no significant difference in CS rate, but the oral misoprostol group had significantly higher rates of meconium‐stained liquor than the sublingual misoprostol group (RR 10.50, 95% CI 4.07 to 27.09), <a href="./references#CD001338-fig-0124" title="">Analysis 20.2</a>, and significantly lower rates of instrumental vaginal birth (RR 0.47, 95% CI 0.22 to 0.99), <a href="./references#CD001338-fig-0125" title="">Analysis 20.3</a>. </p> </section> <section id="CD001338-sec-0095"> <h4 class="title">(6) Comparison with vaginal misoprostol (analyses 21 to 29)</h4> <p>This was the most commonly studied comparison, with 37 trials and 6417 randomised women. </p> <p><b>Primary outcomes:</b> the overall outcome for the rate of uterine hyperstimulation <i>with</i> FHR changes was highly heterogenous. The interaction test indicated that there was a significant difference between dosage subgroups (Test for subgroup differences: Chi² = 18.50, df = 3 (P = 0.0003), I² = 83.8%) with less hyperstimulation in the 25 mcg oral misoprostol dose (RR 0.30, 95% CI 0.07 to 1.19), rising to an increase in hyperstimulation with the 200 mcg oral misoprostol dose (RR 1.61, 95% CI 1.07 to 2.43), <a href="./references#CD001338-fig-0127" title="">Analysis 21.2</a>. Sensitivity analysis revealed that the overall result was not affected by the removal of low‐quality studies. </p> <p>The overall outcome for vaginal birth within 24 hours was also highly heterogenous, <a href="./references#CD001338-fig-0126" title="">Analysis 21.1</a>, but the interaction test did not indicate a subgroup difference in relation to oral misoprostol dosage. Sensitivity analysis with removal of the low‐quality studies did not explain the heterogeneity. </p> <p>The overall outcomes for the CS rate was also heterogenous (Heterogeneity: Tau² = 0.06; Chi² = 60.78, df = 34 (P = 0.003); I² = 44%), <a href="./references#CD001338-fig-0128" title="">Analysis 21.3</a>. The heterogeneity was not affected by the removal of low‐quality studies and the interaction test showed that there was no significant interaction between dosage subgroups. </p> <p>There were no other significant findings in the two remaining primary outcomes.</p> <p><b>Secondary outcomes:</b> when all the data are considered together, the only statistically significant differences without heterogeneity were a reduction in the Apgars of less than seven at five minutes in the oral misoprostol group (RR 0.60, 95% CI 0.44 to 0.82), <a href="./references#CD001338-fig-0138" title="">Analysis 21.13</a>, and a decrease in postpartum haemorrhage (RR 0.57, 95% CI 0.34 to 0.95), <a href="./references#CD001338-fig-0146" title="">Analysis 21.21</a>. However, the oral misoprostol group had an increase in meconium‐stained liquor (RR 1.22, 95% CI 1.03 to 1.44), <a href="./references#CD001338-fig-0137" title="">Analysis 21.12</a>. </p> <p>The overall outcome for the rate of uterine hyperstimulation <i>without</i> FHR changes was also highly heterogenous, <a href="./references#CD001338-fig-0133" title="">Analysis 21.8</a>. The heterogeneity was not affected by the removal of low‐quality studies and the interaction test showed that there was no significant interaction between dosage subgroups. </p> <p>The overall outcome for the use of oxytocin was also highly heterogenous, and the interaction test showed that there was a significant dosage subgroup interaction (Test for subgroup differences: Chi² = 9.10, df = 3 (P = 0.03), I² = 67.0%), <a href="./references#CD001338-fig-0132" title="">Analysis 21.7</a>. However, this was not in a dose‐dependent manner. The heterogeneity was not affected by the removal of low‐quality studies. </p> <p>No uterine ruptures were reported in the women who had previous CSs.</p> <p><b>Subgroups:</b> </p> <p>Intact membranes (analyses 22, 24, 27) </p> <p>Seventeen of the 34 trials gave data for women with intact membranes. As with the overall data, there was no difference in any of the primary outcomes. The outcomes for vaginal birth not achieved in 24 hours and uterine hyperstimulation with FHR changes showed significant heterogeneity. Only one study examined the effect on vaginal birth within 24 hours in women with intact membranes (<a href="./references#CD001338-bbs2-0073" title="WingD , HamD , PaulRH . A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(5):1155‐60. WingDA , HamD , PaulRH . A comparison of orally administered misoprostol to vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S127. ">Wing 1999 (V25)</a>) according to parity. That study showed a significant worsening in primigravid women given oral misoprostol (RR 1.25, 95% CI 1.01 to 1.55), <a href="./references#CD001338-fig-0160" title="">Analysis 24.1</a>, but not in multiparous women (RR 1.41, 95% CI 0.94 to 2.11), <a href="./references#CD001338-fig-0177" title="">Analysis 27.1</a>. </p> <p>Fifteen trials that reported uterine hyperstimulation with FHR changes showed no significant change in hyperstimulation in the oral misoprostol group (average RR 0.83, 95% CI 0.46 to 1.52; Heterogeneity: Tau² = 0.33; Chi² = 22.75, df = 11 (P = 0.02); I² = 52%), <a href="./references#CD001338-fig-0153" title="">Analysis 22.2</a>. However, there was significant heterogeneity in the results, with a significant association with dosage. The two 200 mcg studies had a significantly higher rate of uterine hyperstimulation with FHR changes and removing them from the analysis removed the overall heterogeneity and left the results as (RR 0.41, 95% CI 0.19 to 0.91). </p> <p>Ruptured membranes (analysis 25) </p> <p>Only two trials reported women with ruptured membranes as a subgroup (<a href="./references#CD001338-bbs2-0029" title="JindalP , AvasthiK , KaurM . A comparison of vaginal vs. oral misoprostol for induction of labor‐double blind randomized trial. Journal of Obstetrics and Gynecology of India2011;61(5):538‐42. ">Jindal 2011 (V50)</a>; <a href="./references#CD001338-bbs2-0053" title="PugaO , NienJ , GomezR , MedinaL , CarstensM , GonzalezR , et al. Premature rupture of membranes after 35 weeks: a randomized clinical trial of induction of labor with oral versus vaginal administration of misoprostol. American Journal of Obstetrics and Gynecology2001;184(1):S85. ">Puga 2001 (V50)</a>). The only two reported primary outcomes (CS and uterine hyperstimulation with FHR changes) showed no significant difference between oral and vaginal routes, <a href="./references#CD001338-fig-0171" title="">Analysis 25.1</a>; <a href="./references#CD001338-fig-0172" title="">Analysis 25.2</a>. </p> <p>Primiparae (analyses 24) </p> <p>Only three trials reported outcomes for this subgroup. An increase in the number of women who did not birth vaginally within 24 hours was seen in the trial by <a href="./references#CD001338-bbs2-0073" title="WingD , HamD , PaulRH . A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(5):1155‐60. WingDA , HamD , PaulRH . A comparison of orally administered misoprostol to vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics and Gynecology1999;180(1 Pt 2):S127. ">Wing 1999 (V25)</a>, in which a 50 mcg dose was used in primips with intact membranes and an unfavourable cervix (RR 1.25, 95% CI 1.01 to 1.55), <a href="./references#CD001338-fig-0160" title="">Analysis 24.1</a>. </p> <p>Multiparae (analyses 27) </p> <p>Only two trials analysed this subgroup of women separately (<a href="./references#CD001338-bbs2-0023" title="HallR , Duarte‐GardeaM , HarlassF . Oral versus vaginal misoprostol for labor induction. Obstetrics &amp; Gynecology2002;99(6):1044‐8. ">Hall 2002 (V25)</a>; <a href="./references#CD001338-bbs2-0071" title="ToppozadaMK , AnwarMYM , HassanHA , El‐GazaerlyWS . Oral or vaginal misoprostol for induction of labour. International Journal of Gynecology &amp; Obstetrics1997;56:135‐9. ">Toppozada 1997 (V100</a>)) and they found no difference in the four reported outcomes, <a href="./references#CD001338-fig-0177" title="">Analysis 27.1</a>; <a href="./references#CD001338-fig-0178" title="">Analysis 27.2</a>; <a href="./references#CD001338-fig-0179" title="">Analysis 27.3</a>; <a href="./references#CD001338-fig-0180" title="">Analysis 27.4</a>. </p> </section> <section id="CD001338-sec-0096"> <h4 class="title">(7) Hourly 20 mcg titrated oral misoprostol versus four‐hourly oral misoprostol 50 mcg (analysis 30) </h4> <p>One study of 64 women compared the effect of using hourly 20 mcg solution and four‐hourly 50 mcg solution (<a href="./references#CD001338-bbs2-0070" title="ThaisomboonA , RussameecharoenK , WanitpongpanP , PhattanachindakunB , ChangnoiA . Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. International Journal of Gynecology and Obstetrics2012;116(1):13‐6. ">Thaisomboon 2012 (T)</a>). There were no differences in any of the 12 outcomes, <a href="./references#CD001338-fig-0186" title="">Analysis 30.1</a>; <a href="./references#CD001338-fig-0187" title="">Analysis 30.2</a>; <a href="./references#CD001338-fig-0188" title="">Analysis 30.3</a>; <a href="./references#CD001338-fig-0189" title="">Analysis 30.4</a>; <a href="./references#CD001338-fig-0190" title="">Analysis 30.5</a>; <a href="./references#CD001338-fig-0191" title="">Analysis 30.6</a>; <a href="./references#CD001338-fig-0192" title="">Analysis 30.7</a>; <a href="./references#CD001338-fig-0193" title="">Analysis 30.8</a>; <a href="./references#CD001338-fig-0194" title="">Analysis 30.9</a>; <a href="./references#CD001338-fig-0195" title="">Analysis 30.10</a>; <a href="./references#CD001338-fig-0196" title="">Analysis 30.11</a>; <a href="./references#CD001338-fig-0197" title="">Analysis 30.12</a>. </p> </section> <section id="CD001338-sec-0097"> <h4 class="title">(8) Oral misoprostol 25 mcg three‐daily versus 50 mcg three‐daily (analysis 31)</h4> <p>In one study (<a href="./references#CD001338-bbs2-0031" title="KipikasaJH , AdairCD , WilliamsonJ , BreenJM , MedfordLK , Sanchez‐RamosL . Use of misoprostol on an outpatient basis for postdate pregnancy. International Journal of Gynecology &amp; Obstetrics2005;88:108‐11. ">Kipikasa 2005</a>), single oral doses of misoprostol were given every three days to women as outpatients. In this study there was no significant difference in any of the reported outcomes, <a href="./references#CD001338-fig-0198" title="">Analysis 31.1</a>; <a href="./references#CD001338-fig-0199" title="">Analysis 31.2</a>; <a href="./references#CD001338-fig-0200" title="">Analysis 31.3</a>; <a href="./references#CD001338-fig-0201" title="">Analysis 31.4</a>; <a href="./references#CD001338-fig-0202" title="">Analysis 31.5</a>; <a href="./references#CD001338-fig-0203" title="">Analysis 31.6</a>; <a href="./references#CD001338-fig-0204" title="">Analysis 31.7</a>; <a href="./references#CD001338-fig-0205" title="">Analysis 31.8</a>; <a href="./references#CD001338-fig-0206" title="">Analysis 31.9</a>; <a href="./references#CD001338-fig-0207" title="">Analysis 31.10</a>; <a href="./references#CD001338-fig-0208" title="">Analysis 31.11</a>; <a href="./references#CD001338-fig-0209" title="">Analysis 31.12</a>; <a href="./references#CD001338-fig-0210" title="">Analysis 31.13</a>; <a href="./references#CD001338-fig-0211" title="">Analysis 31.14</a>; <a href="./references#CD001338-fig-0212" title="">Analysis 31.15</a>. </p> </section> <section id="CD001338-sec-0098"> <h4 class="title">(9) Oral misoprostol 50 mcg versus 100 mcg (analyses 32, 33, 34)</h4> <p>Two studies containing 317 women addressed the relationship between the 50 and 100 mcg doses (<a href="./references#CD001338-bbs2-0011" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD001338-bbs2-0062" title="ShettyA , MartinR , DanielianP , TempletonA . A comparison of two dosage regimens of oral misoprostol for labor induction at term. Acta Obstetricia et Gynecologica Scandinavica2002;81:337‐42. ShettyA , MartinR , DanielianP , TempletonA . A comparison of two dose regimens of oral misoprostol in the induction of labour at term: a random allocation controlled trial [abstract]. Journal of Obstetrics &amp; Gynaecology2001;21(1):91. ">Shetty 2002</a>). There were no significant differences between the 50 mcg and 100 mcg oral doses in any of the 11 outcomes assessed. </p> </section> <section id="CD001338-sec-0099"> <h4 class="title">(10) Oral misoprostol 50 mcg, three‐ to four‐hourly versus six‐hourly (analyses 35, 36) </h4> <p>Two trials compared the outcomes when women were given oral tablets either three‐ to four‐hourly or six‐hourly. One study with 89 women (<a href="./references#CD001338-bbs2-0050" title="PongsathaS , TongsongT , SomsakT . A comparison between 50 mcg oral misoprostol every 4 hours and 6 hours for labor induction: a prospective randomized controlled trial. Journal of the Medical Association of Thailand2001;84(7):989‐94. SomsakT , PongsathaS . A comparison between oral misoprostol 50 micrograms every 4 hours and every 6 hours for labor induction. Thai Journal of Obstetrics and Gynaecology2000;12(4):334. ">Pongsatha 2001</a>) compared 50 mcg oral regimen four‐ or six‐hourly whilst the other, with 133 women (<a href="./references#CD001338-bbs2-0051" title="PongsathaS , SirisukkasemS , TongsongT . A comparison of 100ug oral misoprostol every 3 hours and 6 hours for labor induction: a randomized controlled trial. Journal of Obstetrics and Gynaecology Research2002;28(6):308‐12. ">Pongsatha 2002</a>), compared 100 mcg given orally three‐ or six‐hourly. There were no differences in any of the outcomes studied when the data were combined, although there was significant heterogeneity in results for the outcomes of uterine hyperstimulation with FHR changes and oxytocin augmentation. In the study using 100 mcg, there was significantly less need for oxytocin augmentation when the misoprostol was given three‐ to four‐hourly compared to when it was used six hourly (RR 0.72, 95% CI 0.54 to 0.96), <a href="./references#CD001338-fig-0232" title="">Analysis 35.3</a>.2. </p> </section> <section id="CD001338-sec-0100"> <h4 class="title">(11) Oral misoprostol three‐hourly versus oral misoprostol x two then routine oxytocin (analyses 37 and 38) </h4> <p>One study compared the use of oral misoprostol 25 mcg used three‐hourly until in labour with a policy of two oral misoprostol doses (25 mcg) followed by routine oxytocin (<a href="./references#CD001338-bbs2-0015" title="DeA , BaggaR , GopalanS . The routine use of oxytocin after oral misoprostol for labour induction in women with an unfavourable cervix is not of benefit. Australian and New Zealand Journal of Obstetrics and Gynaecology2006;46(4):323‐9. ">De 2006</a>). There were no statistically significant differences in any of the 10 outcomes. </p> </section> <section id="CD001338-sec-0101"> <h4 class="title">(12) Oral misoprostol versus delayed vaginal prostaglandins (analysis 39)</h4> <p>Another small study of 61 women compared two policies for dealing with ruptured membranes at term (<a href="./references#CD001338-bbs2-0063" title="ShettyA , StewartK , StewartG , RiceP , DanielianP , TempletonA . Active management of term prelabour rupture of membranes with oral misoprostol. BJOG: an international journal of obstetrics and gynaecology2002;109:1354‐8. ">Shetty 2002a</a>). One group had immediate oral misoprostol (50 mcg) whilst the other waited for 24 hours and then had vaginal prostaglandins (1 mg or 2 mg depending on Bishop Score). The only statistically significant outcome was in the 'vaginal birth not achieved in 24 hours' outcome, which was reduced in the immediate oral misoprostol group (RR 0.52, 95% CI 0.32 to 0.83), <a href="./references#CD001338-fig-0252" title="">Analysis 39.1</a>. </p> </section> <section id="CD001338-sec-0102"> <h4 class="title">(13) Oral misoprostol versus dinoprostone vaginal insert (analysis 40)</h4> <p>One study compared the use of hourly titrated oral misoprostol with 10 mcg dinoprostone vaginal insert placed for a maximum of 24 hours (<a href="./references#CD001338-bbs2-0057" title="RouziAA . Randomized clinical trial between titrated oral dose of misoprostol and Propess for induction of labor. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000420943 (accessed 22 January 2013)2011. RouziAA , AlsibianiS , MansouriN , AlsinaniN , DarhouseK . Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor. American Journal of Obstetrics and Gynecology2014;210(1):56.e1‐6. ">Rouzi 2014</a>). There were no statistically significant differences in any of the 10 outcomes. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001338-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001338-sec-0103"></div> <section id="CD001338-sec-0104"> <h3 class="title" id="CD001338-sec-0104">Efficacy compared to other induction agents</h3> <p>Oral misoprostol is more effective than placebo and equivalent to intravenous oxytocin, vaginal misoprostol and vaginal dinoprostone for the induction of labour in women. Oral misoprostol results in fewer caesarean sections than oxytocin alone. In the comparisons with oxytocin infusions, there seems to be a higher rate of meconium staining at all dosages, but this was not associated with any adverse effect on the fetus. It is possible that the meconium staining could be a direct effect of the misoprostol on the fetal gut. Gastrointestinal stimulation leading to diarrhoea is a well‐described side effect of oral misoprostol in adults, and small amounts of misoprostol in the fetus could lead to the expulsion of meconium and hence meconium‐stained liquor. This effect is also seen with vaginal misoprostol, but it appears to be smaller. This may be due to the lower peak serum concentrations that occur following vaginal administration. </p> <p>There have been concerns in the past about uterine hyperstimulation with oral misoprostol. In studies where most women were given low dose oral misoprostol (20‐25 mcg two‐hourly), the hyperstimulation rates were the same as for vaginal dinoprostone (i.e. around 5% overall and 2.9% with fetal heart rate (FHR) abnormalities). </p> <p>There were fewer studies comparing oral misoprostol and intracervical dinoprostone, but these found that the oral misoprostol (at doses of 50 and 200 mcg) resulted in stronger contractions than the dinoprostone. This led to higher rates of hyperstimulation and a more rapid labour, but with no effect on fetal outcomes. </p> <p>Whilst no increase in adverse fetal outcomes was seen in these studies, this meta‐analysis contains too few studies to exclude a difference in adverse outcomes which are rare (<i>see</i> additional <a href="#CD001338-tbl-0001">Table 1</a> for numbers needed). However, the comparable safety data on vaginal dinoprostone are also limited. There are nearly 14,000 women in the trials in this review, which compares favourably with the Cochrane review of the current standard treatment vaginal dinoprostone (PGE2) with 10,000 women (<a href="./references#CD001338-bbs2-0135" title="KellyAJ , MalikS , SmithL , KavanaghJ , ThomasJ . Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD003101.pub2] ">Kelly 2009</a>). </p> <div class="table" id="CD001338-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sample size calculation</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Baseline rate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>? Important change</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rel. Risk</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total sample size</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure to achieve vaginal birth within 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>778</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Caesarean section (CS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1294</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hyperstimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30,716</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Perinatal mortality and morbidity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61,686</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine rupture in women with previous CS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61,686</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maternal death or serious morbidity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>154,598</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD001338-sec-0105"> <h3 class="title" id="CD001338-sec-0105">Should misoprostol be used orally or vaginally?</h3> <p>The large variety of doses of both oral and vaginal misoprostol used in the direct comparisons make it very difficult to interpret these data. The only consistent findings were a reduction in low Apgar score at five minutes in those given oral misoprostol (but there is no corresponding reduction in special baby care unit admission), lower rates of postpartum haemorrhage, and an increase in meconium‐stained liquor. The cause of the improved Apgars in those given oral misoprostol is not clear, but it may relate to the hyperstimulation rates, which were generally lower in those given low‐dose oral misoprostol. The relative acceptability of the oral and vaginal routes also need to be considered alongside this clinical data. Satisfaction was only considered in one study of 200 women (<a href="./references#CD001338-bbs2-0012" title="ColonI , ClawsonK , HunterK , DruzinML , TaslimiMM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. American Journal of Obstetrics and Gynecology2005;192:747‐52. ColonI , ClawsonK , TaslimiM , DruzinM . Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S15. ">Colon 2005 (V25)</a>), and in this study only two women (one in each group) expressed dissatisfaction. However, other clinical studies comparing oral and vaginal misoprostol have found increased satisfaction with the oral route. </p> <p>In summary, there is some evidence that the oral route may result in improved clinical outcomes over the vaginal route. Given the likely greater acceptability for women using an oral route, it is the authors' opinion that the oral route should be preferred over the vaginal route. </p> </section> <section id="CD001338-sec-0106"> <h3 class="title" id="CD001338-sec-0106">What is the optimal dose of oral misoprostol?</h3> <p>The comparison with vaginal misoprostol is complicated by the wide variation in dosages used for both vaginal and oral misoprostol. Hence a comparison between 50 mcg oral misoprostol and 100 mcg vaginal misoprostol may give very different outcomes to a comparison between 200 mcg oral misoprostol and 25 mcg vaginal misoprostol. This is especially important given that both efficacy and side effects are a function of the ability of misoprostol to produce effective uterine contractions. The optimal dose will have to balance the desire for short induction to birth interval with impact of strong, effective uterine contractions on the fetal wellbeing and uterine muscle integrity. </p> <p>An attempt to assess the effect of dose on effectiveness and safety has been made with the subgroup analyses by various doses of oral misoprostol. This has resulted in multiple subgroup analyses with a high potential for spurious results (type I error). To protect against this, we have analysed further the subgroups with significant heterogeneity within the results. We have used the interaction test (a form of chi‐squared test) to assess the association with dosage. We chose uterine hyperstimulation without FHR changes as the outcome most closely representing a bioassay of misoprostol activity. The relative strength of various misoprostol dosages given vaginally and orally is best seen in the graph for outcome 21.8, where similar hyperstimulation rates are seen when the dose of oral misoprostol is about double that of the vaginal doses. Similarly, the use of the same doses orally and vaginally results in generally lower hyperstimulation rates in the oral group. This suggests that equivalent biological activity is seen when the dose of oral misoprostol is about double that of the vaginal dose. Given that the Cochrane review of vaginal misoprostol suggests a dosage of 25 mcg vaginal misoprostol, it might be expected that the optimal dose (i.e. that which is equivalent to vaginal dinoprostone) would be 50 mcg. In the comparison with vaginal dinoprostone, most trials used oral misoprostol dosages of 20 to 25 mcg and it is the trials using this dose in which the CS rate may be decreased (<a href="./references#CD001338-fig-0029" title="">Analysis 5.3</a>, <a href="./references#CD001338-fig-0053" title="">Analysis 6.3</a>). Overall, therefore, the results of this review suggest that the optimal dosage of oral misoprostol is 20 to 25 mcg given two‐hourly. </p> <p>Obtaining a misoprostol dosage of 25 mcg tablets by cutting a 200 mcg tablet into eighths is difficult and imprecise. To get around this, the studies that used 20 to 25 mcg have generally dissolved the 200 mcg tablet in 200 mL water and administered 20 mL. Bioassays suggest that misoprostol remains active for at least 24 hours in this form (<a href="./references#CD001338-bbs2-0141" title="MatonhodzeBB . Induction of labour in an under‐resourced environment. Johannesburg, South Africa: University of Witwatersrand, 2005. ">Matonhodze 2005</a>). Whilst this will undoubtedly produce a more precise dose, there are ongoing issues around the storage of the unused solution. In view of the lack of good information about the stability of misoprostol in solution and the risks involved in having unused solution sitting around in containers on a labour ward, the best advice would be to discard any unused solution after administering each dose. The recent availability of misoprostol 25 mcg tablets is welcome and should overcome many of these problems. </p> </section> <section id="CD001338-sec-0107"> <h3 class="title" id="CD001338-sec-0107">Risks of induction</h3> <p>Some observational studies have reported a high uterine rupture rate when vaginal misoprostol was given to women who have had previous CSs. There is less evidence for oral misoprostol, but there were rupture rates of 10% (one of 10) and 9.7% (four of 41) in two studies that used oral misoprostol for induction (<a href="./references#CD001338-bbs2-0109" title="AslanH , UnluE , AgarM , CeylanY . Uterine rupture associated with misoprostol labor induction in women with previous cesarean delivery. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2004;113:45‐8. ">Aslan 2004</a>; <a href="./references#CD001338-bbs2-0119" title="GhermanRB , HeathT . Trial of labor after cesarean delivery: a pilot study of oral misoprostol for preinduction cervical ripening. Obstetrics &amp; Gynecology2001;97(Suppl 1):S68. ">Gherman 2001a</a>). Whilst the lack of ruptures in the 158 women in this review's randomised trials who underwent induction is encouraging (<a href="./references#CD001338-bbs2-0009" title="CarlanSJ , BouldinS , BlustD , O'BrienWF . Safety and efficacy of misoprostol orally and vaginally: a randomized trial. Obstetrics &amp; Gynecology2001;98:107‐12. ">Carlan 2001 (V50)</a>; <a href="./references#CD001338-bbs2-0027" title="HowH , LeaseburgeL , KhouryJ , SiddiqiT , SibaiB . Is there an ideal route of misoprostol administration for cervical ripening and labor induction [abstract]. American Journal of Obstetrics and Gynecology2001;184(1):S118. HowH , LeaseburgeL , KhouryJ , SiddiqiT , SpinnatoJ , SibaiB . A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. American Journal of Obstetrics and Gynecology2001;185:911‐5. ">How 2001 (V25)</a>), it would take a trial of over 60,000 women to evaluate whether there was an increase in the 0.5% background scar rupture rate in women undergoing a trial of vaginal birth (<a href="#CD001338-tbl-0001">Table 1</a>). </p> <p>There is no consensus on what constitutes an acceptable risk of labour induction in the absence of life‐threatening conditions for mother and baby. It is likely that most parents and clinicians would not be prepared to accept a 0.5% to 1% increase in serious adverse outcomes. In fact, it is likely that women would be prepared to spend more time on delivery suite if this means a safer labour, but there is a noticeable lack of data on this. Indeed, most studies in this review did not assess women's views or satisfaction rates. </p> <p>Currently available data are nowhere near large enough to address the issue of safety of either the induction process (<a href="#CD001338-tbl-0001">Table 1</a>) ar the long‐term follow‐up of babies exposed to misoprostol. It is important to reiterate here that 'no evidence of difference' in this Cochrane review does not mean 'evidence of no difference'. In other words, when even more randomised data become available, small but important clinical differences between various regimens may become apparent, i.e. statistically significant. </p> <p>Trials or meta‐analyses that have adequate power to address the issue of rare adverse fetal outcomes will need to include an excess of 30,000 women. Until the logistics and financial resources are available to conduct such studies, alternative ways must be found of assessing the risk. Registries of women using oral misoprostol for induction may be a way of achieving this. </p> </section> <section id="CD001338-sec-0108"> <h3 class="title" id="CD001338-sec-0108">Summary of main results</h3> <p>In nine trials comparing oral misoprostol with placebo (1109 women, almost all with ruptured membranes), women using oral misoprostol were more likely to give birth vaginally within 24 hours (risk ratio (RR) 0.16, 95% confidence interval (CI) 0.05 to 0.49; one study in which all women received dinoprostone after 12 hours), needed less oxytocin (seven studies; 933 women) and had a lower CS rate (eight studies 1029 women). </p> <p>Ten trials compared oral misoprostol with vaginal prostaglandin (dinoprostone) (3,240 women). There was little difference in the frequency of: vaginal birth within 24 hours (5 trials; 2,128 women), uterine hyperstimulation with fetal heart rate changes (7 trials; 2,352 women), and caesarean birth (10 trials; 3240 women), but evidence of slower inductions (cervix unfavourable/unchanged after 12‐24 hours). </p> <p>Five trials compared administration of oral with intracervical misoprostol (681 women). Oral misoprostol was associated with fewer instances of failure to achieve vaginal birth within 24 hours (3 trials; 452 women) but more frequent uterine hyperstimulation with fetal heart rate changes (3 trials; 490 women). The available data for these comparisons was however limited and the differences in caesarean birth were small (5 trials; 742 women). </p> <p>Nine trials compared oral misoprostol with intravenous oxytocin (1282 women). There were no obvious differences in the frequency of: vaginal birth within 24 hours (6 trials; 789 women), or uterine hyperstimulation with fetal heart rate changes (7 trials; 947 women). There were, however, fewer caesarean births with oral misoprostol (RR 0.77, 95% CI 0.60 to 0.98; 9 trials; 1282 women). Oral misoprostol was associated with increased rates of meconium‐stained liquor (seven trials; 1172 women). </p> <p>Thirty‐seven trials compared oral misoprostol with vaginal misoprostol (6417 women). There was little difference in the frequency of: vaginal birth within 24 hours (14 trials; 2,448 women), uterine hyperstimulation with fetal heart rate changes (29 trials; 5,503 women), and caesarean birth (35 trials; 6,326 women). However, there were fewer babies born with a low Apgar score in the oral misoprostol group (19 studies, 4009 women) and fewer women with postpartum haemorrhage (10 trials, 1478 women), but increases in meconium‐stained liquor (24 studies, 3634 women). </p> </section> <section id="CD001338-sec-0109"> <h3 class="title" id="CD001338-sec-0109">Overall completeness and applicability of evidence</h3> <p>With 75 studies included in the review, there has been the opportunity to examine an extensive range of misoprostol regimens and comparisons with other induction methods. The studies have also been conducted in a wide range of settings, making the results applicable internationally. The studies have all however been conducted in settings where the participants can be closely monitored. This will reduce the risk to the baby of any uterine hyperstimulation, but means that the results may not be applicable to setting where fetal monitoring is not available. In those settings, priority should be given to induction methods with low rates of hyperstimulation and/or fetal risks. </p> </section> <section id="CD001338-sec-0110"> <h3 class="title" id="CD001338-sec-0110">Quality of the evidence</h3> <p>There is adequate high‐quality evidence within the 75 studies to make robust recommendations. There is however, a wide spread of oral misoprostol regimens examined in this review and a large variation in the quality of studies and reports. So whilst the quality of evidence for some comparisons is very robust (for example, oral misoprostol versus vaginal misoprostol), for other less common comparisons the strength of the recommendations must be lower (e.g. in those comparisons of different misoprostol regimens). With so many comparisons within the review, there is also a risk of statistical type 1 error, that is a false‐positive result. The results in which there are very few studies, or heterogeneity, or those in which the meta‐analysis result is of borderline statistical significance must therefore be treated with caution, and we have sought to do this. </p> </section> <section id="CD001338-sec-0111"> <h3 class="title" id="CD001338-sec-0111">Potential biases in the review process</h3> <p>Both review authors Z Alfirevic and AD Weeks have been involved in misoprostol research for many years, running some of the studies themselves and knowing many of the other people who have run other studies. There is therefore the potential to be biased in their assessment of the strength and importance of studies. The robustness of the methodology along with the peer review process will help to prevent any important effect on the results or recommendations of the review. </p> </section> <section id="CD001338-sec-0112"> <h3 class="title" id="CD001338-sec-0112">Agreements and disagreements with other studies or reviews</h3> <p>This review is one of several reviews within <i>The Cochrane Library</i> on induction techniques, but the only one that directly addresses the use of oral misoprostol. The World Health Organization, in preparation for their recommendations for the induction of labour, conducted an extensive review into all forms of induction of labour (<a href="./references#CD001338-bbs2-0151" title="WHO . WHO Recommendations for Induction of Labour. Geneva: World Health Organization, 2011. ">WHO 2011</a>). Their conclusion was that "oral misoprostol (25 mcg, two‐hourly) is recommended for induction of labour" along with other methods including dinoprostone, vaginal misoprostol (25 mcg) and cervical balloon catheter. A review focusing specifically on low‐dose oral misoprostol (20 to 25 mcg) was carried out using the Cochrane methodology by Kundodyiwa et al (<a href="./references#CD001338-bbs2-0139" title="KundodyiwaTW , AlfirevicZ , WeeksAD . Low‐dose oral misoprostol for induction of labor: a systematic review.. Obstet Gynecol2009;113 (2, Pt 1):374‐383. ">Kundodyiwa 2009</a>). The findings were similar to this review and the authors concluded that "low‐dose oral misoprostol solution (20 mcg) administered every two hours seems at least as effective as both vaginal dinoprostone and vaginal misoprostol, with lower rates of caesarean birth and uterine hyperstimulation, respectively". </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001338-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001338-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001338-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD001338-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 3 Caesarean section." data-id="CD001338-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 6 Epidural analgesia." data-id="CD001338-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 6 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 7 Oxytocin augmentation." data-id="CD001338-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 7 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 8 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 8 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 11 Instrumental vaginal delivery." data-id="CD001338-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 11 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 12 Meconium‐stained liquor." data-id="CD001338-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 12 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 13 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 13 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 14 Neonatal intensive care unit admission." data-id="CD001338-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 14 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 15 Perinatal death." data-id="CD001338-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 15 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 16 Nausea." data-id="CD001338-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 16 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 17 Vomiting." data-id="CD001338-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Oral misoprostol versus placebo/ no treatment (1): all women, Outcome 17 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Oral misoprostol versus placebo/ no treatment (1): all women with intact membranes, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Oral misoprostol versus placebo/ no treatment (1): all women with intact membranes, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD001338-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 3 Caesarean section." data-id="CD001338-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral misoprostol versus placebo/ no treatment (1): all primiparae with ruptured membranes, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Oral misoprostol versus placebo/ no treatment (1): all primiparae with ruptured membranes, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral misoprostol versus placebo/ no treatment (1): all primiparae with ruptured membranes, Outcome 2 Caesarean section." data-id="CD001338-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Oral misoprostol versus placebo/ no treatment (1): all primiparae with ruptured membranes, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral misoprostol versus placebo/ no treatment (1): all primiparae with ruptured membranes, Outcome 3 Serious maternal morbidity or death." data-id="CD001338-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Oral misoprostol versus placebo/ no treatment (1): all primiparae with ruptured membranes, Outcome 3 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 3 Caesarean section." data-id="CD001338-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD001338-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 7 Oxytocin augmentation." data-id="CD001338-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 7 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 8 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 8 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 9 Ruptured uterus." data-id="CD001338-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 9 Ruptured uterus. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 10 Epidural analgesia." data-id="CD001338-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 10 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 11 Instrumental vaginal delivery." data-id="CD001338-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 11 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 12 Meconium‐stained liquor." data-id="CD001338-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 12 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 13 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 13 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 14 Neonatal intensive care unit admission." data-id="CD001338-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.14</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 14 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 15 Neonatal encephalopathy." data-id="CD001338-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.15</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 15 Neonatal encephalopathy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 16 Perinatal death." data-id="CD001338-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.16</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 16 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 17 Maternal side effects (all)." data-id="CD001338-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.17</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 17 Maternal side effects (all). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 18 Nausea." data-id="CD001338-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.18</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 18 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 19 Vomiting." data-id="CD001338-fig-0045" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.19</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 19 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 20 Diarrhoea." data-id="CD001338-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.20</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 20 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 21 Shivering." data-id="CD001338-fig-0047" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.21</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 21 Shivering.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 22 Postpartum haemorrhage." data-id="CD001338-fig-0048" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.22</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 22 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 23 Serious maternal complications." data-id="CD001338-fig-0049" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.23</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 23 Serious maternal complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-005-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-005-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 24 Hyperpyrexia." data-id="CD001338-fig-0050" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.24</div> <div class="figure-caption"> <p>Comparison 5 Oral misoprostol versus vaginal PG (2): all women, Outcome 24 Hyperpyrexia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-005-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0051" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0052" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 3 Caesarean section." data-id="CD001338-fig-0053" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0054" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0055" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD001338-fig-0056" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Oral misoprostol versus vaginal PG (2): all women with intact membranes, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Oral misoprostol versus vaginal PG (2): all women with ruptured membranes, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0057" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Oral misoprostol versus vaginal PG (2): all women with ruptured membranes, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Oral misoprostol versus vaginal PG (2): all women with ruptured membranes, Outcome 2 Caesarean section." data-id="CD001338-fig-0058" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Oral misoprostol versus vaginal PG (2): all women with ruptured membranes, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Oral misoprostol versus vaginal PG (2): all women with unfavourable cervices, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0059" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Oral misoprostol versus vaginal PG (2): all women with unfavourable cervices, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Oral misoprostol versus vaginal PG (2): all women with favourable cervices, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0060" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Oral misoprostol versus vaginal PG (2): all women with favourable cervices, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Oral misoprostol versus vaginal PG (2): all multiparae, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0061" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Oral misoprostol versus vaginal PG (2): all multiparae, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Oral misoprostol versus vaginal PG (2): all multiparae, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0062" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Oral misoprostol versus vaginal PG (2): all multiparae, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Oral misoprostol versus vaginal PG (2): all multiparae, Outcome 3 Caesarean section." data-id="CD001338-fig-0063" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Oral misoprostol versus vaginal PG (2): all multiparae, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Oral misoprostol versus vaginal PG (2): all primiparae, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0064" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Oral misoprostol versus vaginal PG (2): all primiparae, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Oral misoprostol versus vaginal PG (2): all primiparae, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0065" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Oral misoprostol versus vaginal PG (2): all primiparae, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Oral misoprostol versus vaginal PG (2): all primiparae, Outcome 3 Caesarean section." data-id="CD001338-fig-0066" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Oral misoprostol versus vaginal PG (2): all primiparae, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0067" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0068" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 3 Caesarean section." data-id="CD001338-fig-0069" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0070" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0071" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.5</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours." data-id="CD001338-fig-0072" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.6</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 7 Oxytocin augmentation." data-id="CD001338-fig-0073" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.7</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 7 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 8 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0074" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.8</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 8 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 9 Uterine rupture." data-id="CD001338-fig-0075" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.9</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 9 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 10 Perinatal death." data-id="CD001338-fig-0076" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.10</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 10 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 11 Instrumental vaginal delivery." data-id="CD001338-fig-0077" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.11</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 11 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 12 Meconium‐stained liquor." data-id="CD001338-fig-0078" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.12</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 12 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 13 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0079" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.13</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 13 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 14 Neonatal intensive care unit admission." data-id="CD001338-fig-0080" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.14</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 14 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 15 Neonatal encephalopathy." data-id="CD001338-fig-0081" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.15</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 15 Neonatal encephalopathy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 16 Maternal death." data-id="CD001338-fig-0082" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.16</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 16 Maternal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 17 Maternal side effects (all)." data-id="CD001338-fig-0083" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.17</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 17 Maternal side effects (all). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 18 Postpartum haemorrhage." data-id="CD001338-fig-0084" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.18</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 18 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-012-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-012-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 19 Women not satisfied." data-id="CD001338-fig-0085" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.19</div> <div class="figure-caption"> <p>Comparison 12 Oral misoprostol versus intracervical PG (3): all women, Outcome 19 Women not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-012-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0086" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0087" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-013-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-013-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 3 Caesarean section." data-id="CD001338-fig-0088" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-013-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-013-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0089" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-013-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-013-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0090" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.5</div> <div class="figure-caption"> <p>Comparison 13 Oral misoprostol versus intracervical PG (3): all women with intact membranes, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-013-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Oral misoprostol versus intracervical PG (3): all women with ruptured membranes, Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD001338-fig-0091" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Oral misoprostol versus intracervical PG (3): all women with ruptured membranes, Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Oral misoprostol versus intracervical PG (3): all women with ruptured membranes, Outcome 2 Caesarean section." data-id="CD001338-fig-0092" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 Oral misoprostol versus intracervical PG (3): all women with ruptured membranes, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD001338-fig-0093" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0094" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 3 Caesarean section." data-id="CD001338-fig-0095" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0096" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.4</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0097" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.5</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 6 Oxytocin augmentation." data-id="CD001338-fig-0098" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.6</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 7 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0099" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.7</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 7 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 8 Uterine rupture." data-id="CD001338-fig-0100" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.8</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 8 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 9 Epidural analgesia." data-id="CD001338-fig-0101" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.9</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 9 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 10 Instrumental vaginal delivery." data-id="CD001338-fig-0102" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.10</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 10 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 11 Meconium‐stained liquor." data-id="CD001338-fig-0103" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.11</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 11 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 12 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0104" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.12</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 12 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 13 Neonatal intensive care unit admission." data-id="CD001338-fig-0105" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.13</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 13 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 14 Neonatal encephalopathy." data-id="CD001338-fig-0106" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.14</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 14 Neonatal encephalopathy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 15 Perinatal death." data-id="CD001338-fig-0107" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.15</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 15 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 16 Nausea." data-id="CD001338-fig-0108" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.16</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 16 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 17 Vomiting." data-id="CD001338-fig-0109" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.17</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 17 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 18 Diarrhoea." data-id="CD001338-fig-0110" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.18</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 18 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-015-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-015-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 19 Postpartum haemorrhage." data-id="CD001338-fig-0111" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.19</div> <div class="figure-caption"> <p>Comparison 15 Oral misoprostol versus oxytocin (4): all women, Outcome 19 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-015-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD001338-fig-0112" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0113" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-016-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-016-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 3 Caesarean section." data-id="CD001338-fig-0114" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-016-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-016-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0115" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.4</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-016-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-016-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0116" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.5</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-016-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-016-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 6 Meconium‐stained liquor." data-id="CD001338-fig-0117" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.6</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus oxytocin (4): all women with ruptured membranes, Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-016-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Oral misoprostol versus oxytocin (4): all primiparae, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0118" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Oral misoprostol versus oxytocin (4): all primiparae, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Oral misoprostol versus oxytocin (4): all primiparae, Outcome 2 Caesarean section." data-id="CD001338-fig-0119" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 Oral misoprostol versus oxytocin (4): all primiparae, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Oral misoprostol versus oxytocin (4): all primiparae with ruptured membranes, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0120" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 Oral misoprostol versus oxytocin (4): all primiparae with ruptured membranes, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-018-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-018-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Oral misoprostol versus oxytocin (4): all primiparae with ruptured membranes, Outcome 2 Caesarean section." data-id="CD001338-fig-0121" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-018-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18 Oral misoprostol versus oxytocin (4): all primiparae with ruptured membranes, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-018-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Oral misoprostol versus oxytocin (4): all multiparae, Outcome 1 Caesarean section." data-id="CD001338-fig-0122" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 Oral misoprostol versus oxytocin (4): all multiparae, Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Oral versus sublingual misoprostol (5): all women, Outcome 1 Caesarean section." data-id="CD001338-fig-0123" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 Oral versus sublingual misoprostol (5): all women, Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Oral versus sublingual misoprostol (5): all women, Outcome 2 Meconium‐stained liquor." data-id="CD001338-fig-0124" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 Oral versus sublingual misoprostol (5): all women, Outcome 2 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-020-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-020-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Oral versus sublingual misoprostol (5): all women, Outcome 3 Instrumental delivery." data-id="CD001338-fig-0125" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-020-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.3</div> <div class="figure-caption"> <p>Comparison 20 Oral versus sublingual misoprostol (5): all women, Outcome 3 Instrumental delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-020-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0126" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0127" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 3 Caesarean section." data-id="CD001338-fig-0128" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.3</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0129" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.4</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0130" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.5</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 6 Serious maternal complications." data-id="CD001338-fig-0131" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.6</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 6 Serious maternal complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 7 Oxytocin augmentation." data-id="CD001338-fig-0132" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.7</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 7 Oxytocin augmentation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 8 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0133" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.8</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 8 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 9 Uterine rupture." data-id="CD001338-fig-0134" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.9</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 9 Uterine rupture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 10 Epidural analgesia." data-id="CD001338-fig-0135" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.10</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 10 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 11 Instrumental vaginal delivery." data-id="CD001338-fig-0136" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.11</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 11 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 12 Meconium‐stained liquor." data-id="CD001338-fig-0137" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.12</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 12 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 13 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0138" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.13</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 13 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 14 Neonatal intensive care unit admission." data-id="CD001338-fig-0139" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.14</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 14 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 15 Neonatal encephalopathy." data-id="CD001338-fig-0140" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.15</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 15 Neonatal encephalopathy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 16 Perinatal death." data-id="CD001338-fig-0141" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.16</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 16 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 17 Maternal side effects (all)." data-id="CD001338-fig-0142" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.17</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 17 Maternal side effects (all). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 18 Nausea." data-id="CD001338-fig-0143" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.18</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 18 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 19 Vomiting." data-id="CD001338-fig-0144" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.19</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 19 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 20 Diarrhoea." data-id="CD001338-fig-0145" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.20</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 20 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 21 Postpartum haemorrhage." data-id="CD001338-fig-0146" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.21</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 21 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 22 Woman not satisfied." data-id="CD001338-fig-0147" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.22</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 22 Woman not satisfied. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 23 Vaginal delivery not achieved within 24 hours (subgroup by quality)." data-id="CD001338-fig-0148" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.23</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 23 Vaginal delivery not achieved within 24 hours (subgroup by quality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 24 Shivering." data-id="CD001338-fig-0149" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.24</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 24 Shivering.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 25 Uterine hyperstimulation with FHR changes (subgroup by quality)." data-id="CD001338-fig-0150" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.25</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 25 Uterine hyperstimulation with FHR changes (subgroup by quality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-021-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-021-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 26 Caesarean section (subgroup by quality)." data-id="CD001338-fig-0151" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.26</div> <div class="figure-caption"> <p>Comparison 21 Oral versus vaginal misoprostol (6): all women, Outcome 26 Caesarean section (subgroup by quality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-021-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-022-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0152" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0153"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-022-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-022-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0153" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.2</div> <div class="figure-caption"> <p>Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0153">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0154"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-022-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-022-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 3 Caesarean section." data-id="CD001338-fig-0154" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.3</div> <div class="figure-caption"> <p>Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0154">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0155"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-022-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-022-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0155" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.4</div> <div class="figure-caption"> <p>Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0155">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0156"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-022-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-022-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0156" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.5</div> <div class="figure-caption"> <p>Comparison 22 Oral versus vaginal misoprostol (6): all women with intact membranes, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0156">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-022-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0157"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-023-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-023-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Oral versus vaginal misoprostol (6): all primiparae with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0157" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-023-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.1</div> <div class="figure-caption"> <p>Comparison 23 Oral versus vaginal misoprostol (6): all primiparae with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0157">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-023-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0158"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-023-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-023-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Oral versus vaginal misoprostol (6): all primiparae with intact membranes, Outcome 2 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0158" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-023-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.2</div> <div class="figure-caption"> <p>Comparison 23 Oral versus vaginal misoprostol (6): all primiparae with intact membranes, Outcome 2 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0158">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-023-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0159"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-023-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-023-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Oral versus vaginal misoprostol (6): all primiparae with intact membranes, Outcome 3 Serious maternal morbidity or death." data-id="CD001338-fig-0159" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-023-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.3</div> <div class="figure-caption"> <p>Comparison 23 Oral versus vaginal misoprostol (6): all primiparae with intact membranes, Outcome 3 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0159">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-023-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0160"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0160" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.1</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0160">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0161"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0161" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.2</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0161">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0162"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 3 Caesarean section." data-id="CD001338-fig-0162" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.3</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0162">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0163"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 4 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0163" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.4</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 4 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0163">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0164"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 5 Serious maternal morbidity or death." data-id="CD001338-fig-0164" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.5</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 5 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0164">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0165"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 6 Oxytocin augmentation." data-id="CD001338-fig-0165" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.6</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 6 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0165">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0166"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 7 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0166" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.7</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 7 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0166">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0167"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 8 Instrumental vaginal delivery." data-id="CD001338-fig-0167" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.8</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 8 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0167">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0168"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 9 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0168" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.9</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 9 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0168">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0169"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 10 Nausea." data-id="CD001338-fig-0169" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.10</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 10 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0169">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0170"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-024-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-024-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 11 Vomiting." data-id="CD001338-fig-0170" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.11</div> <div class="figure-caption"> <p>Comparison 24 Oral versus vaginal misoprostol (6): all primiparae, Outcome 11 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0170">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-024-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0171"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-025-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-025-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 Oral versus vaginal misoprostol (6): all women with ruptured membranes, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0171" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-025-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.1</div> <div class="figure-caption"> <p>Comparison 25 Oral versus vaginal misoprostol (6): all women with ruptured membranes, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0171">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-025-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0172"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-025-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-025-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 Oral versus vaginal misoprostol (6): all women with ruptured membranes, Outcome 2 Caesarean section." data-id="CD001338-fig-0172" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-025-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.2</div> <div class="figure-caption"> <p>Comparison 25 Oral versus vaginal misoprostol (6): all women with ruptured membranes, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0172">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-025-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0173"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-026-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-026-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0173" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-026-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.1</div> <div class="figure-caption"> <p>Comparison 26 Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0173">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-026-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0174"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-026-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-026-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix, Outcome 2 Caesarean section." data-id="CD001338-fig-0174" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-026-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.2</div> <div class="figure-caption"> <p>Comparison 26 Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0174">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-026-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0175"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-026-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-026-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix, Outcome 3 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0175" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-026-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.3</div> <div class="figure-caption"> <p>Comparison 26 Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix, Outcome 3 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0175">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-026-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0176"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-026-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-026-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 26 Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix, Outcome 4 Serious maternal morbidity or death." data-id="CD001338-fig-0176" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-026-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.4</div> <div class="figure-caption"> <p>Comparison 26 Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix, Outcome 4 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0176">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-026-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0177"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-027-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-027-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 Oral versus vaginal misoprostol (6): all multiparae, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0177" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-027-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.1</div> <div class="figure-caption"> <p>Comparison 27 Oral versus vaginal misoprostol (6): all multiparae, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0177">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-027-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0178"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-027-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-027-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 Oral versus vaginal misoprostol (6): all multiparae, Outcome 2 Caesarean section." data-id="CD001338-fig-0178" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-027-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.2</div> <div class="figure-caption"> <p>Comparison 27 Oral versus vaginal misoprostol (6): all multiparae, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0178">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-027-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0179"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-027-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-027-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 Oral versus vaginal misoprostol (6): all multiparae, Outcome 3 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0179" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-027-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.3</div> <div class="figure-caption"> <p>Comparison 27 Oral versus vaginal misoprostol (6): all multiparae, Outcome 3 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0179">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-027-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0180"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-027-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-027-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 27 Oral versus vaginal misoprostol (6): all multiparae, Outcome 4 Serious maternal morbidity or death." data-id="CD001338-fig-0180" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-027-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.4</div> <div class="figure-caption"> <p>Comparison 27 Oral versus vaginal misoprostol (6): all multiparae, Outcome 4 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0180">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-027-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0181"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-028-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-028-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 28 Oral versus vaginal misoprostol (6): all multiparae with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0181" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-028-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 28.1</div> <div class="figure-caption"> <p>Comparison 28 Oral versus vaginal misoprostol (6): all multiparae with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0181">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-028-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0182"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-029-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-029-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0182" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-029-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.1</div> <div class="figure-caption"> <p>Comparison 29 Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0182">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-029-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0183"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-029-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-029-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix, Outcome 2 Caesarean section." data-id="CD001338-fig-0183" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-029-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.2</div> <div class="figure-caption"> <p>Comparison 29 Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0183">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-029-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0184"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-029-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-029-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix, Outcome 3 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0184" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-029-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.3</div> <div class="figure-caption"> <p>Comparison 29 Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix, Outcome 3 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0184">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-029-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0185"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-029-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-029-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 29 Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix, Outcome 4 Serious maternal morbidity or death." data-id="CD001338-fig-0185" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-029-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 29.4</div> <div class="figure-caption"> <p>Comparison 29 Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix, Outcome 4 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0185">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-029-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0186"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0186" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.1</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0186">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0187"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 2 Caesarean section." data-id="CD001338-fig-0187" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.2</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0187">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0188"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 3 Serious neonatal morbidity or perinatal death." data-id="CD001338-fig-0188" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.3</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 3 Serious neonatal morbidity or perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0188">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0189"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 4 Oxytocin augmentation." data-id="CD001338-fig-0189" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.4</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 4 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0189">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0190"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 5 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0190" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.5</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 5 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0190">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0191"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 6 Uterine rupture." data-id="CD001338-fig-0191" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.6</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 6 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0191">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0192"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0192" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.7</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0192">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0193"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 8 Neonatal intensive care unit admission." data-id="CD001338-fig-0193" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.8</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0193">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0194"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 9 Nausea." data-id="CD001338-fig-0194" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.9</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 9 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0194">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0195"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 10 Vomiting." data-id="CD001338-fig-0195" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.10</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 10 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0195">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0196"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 11 Diarrhoea." data-id="CD001338-fig-0196" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.11</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 11 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0196">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0197"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-030-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-030-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 12 Postpartum haemorrhage." data-id="CD001338-fig-0197" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 30.12</div> <div class="figure-caption"> <p>Comparison 30 Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women, Outcome 12 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0197">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-030-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0198"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0198" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.1</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0198">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0199"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 2 Caesaraean section." data-id="CD001338-fig-0199" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.2</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 2 Caesaraean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0199">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0200"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 3 Serious maternal morbidity or death." data-id="CD001338-fig-0200" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.3</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 3 Serious maternal morbidity or death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0200">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 4 Oxytocin augmentation." data-id="CD001338-fig-0201" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.4</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 4 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 5 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0202" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.5</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 5 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 6 Uterine rupture." data-id="CD001338-fig-0203" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.6</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 6 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 7 Meconium‐stained liquor." data-id="CD001338-fig-0204" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.7</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 7 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0205"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 8 Neonatal intensive care unit admission." data-id="CD001338-fig-0205" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.8</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0205">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0206"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 9 Perinatal death." data-id="CD001338-fig-0206" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.9</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 9 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0206">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0207"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 10 Nausea." data-id="CD001338-fig-0207" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.10</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 10 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0207">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0208"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 11 Maternal side effects(all)." data-id="CD001338-fig-0208" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.11</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 11 Maternal side effects(all). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0208">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0209"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 12 Nausea." data-id="CD001338-fig-0209" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.12</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 12 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0209">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0210"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 13 Vomiting." data-id="CD001338-fig-0210" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.13</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 13 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0210">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0211"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 14 Diarrhoea." data-id="CD001338-fig-0211" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.14</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 14 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0211">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0212"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-031-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-031-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 15 Shivering." data-id="CD001338-fig-0212" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 31.15</div> <div class="figure-caption"> <p>Comparison 31 Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women, Outcome 15 Shivering. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0212">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-031-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0213"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0213" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.1</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0213">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0214"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0214" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.2</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0214">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0215"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 3 Caesarean section." data-id="CD001338-fig-0215" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.3</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0215">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0216"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 4 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0216" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.4</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 4 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0216">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0217"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 5 Oxytocin augmentation." data-id="CD001338-fig-0217" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.5</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 5 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0217">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0218"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 6 Epidural analgesia." data-id="CD001338-fig-0218" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.6</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 6 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0218">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0219"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 7 Instrumental vaginal delivery." data-id="CD001338-fig-0219" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.7</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 7 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0219">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0220"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 8 Meconium‐stained liquor." data-id="CD001338-fig-0220" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.8</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 8 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0220">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0221"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 9 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0221" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.9</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 9 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0221">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0222"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 10 Neonatal intensive care unit admission." data-id="CD001338-fig-0222" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.10</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 10 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0222">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0223"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 11 Nausea." data-id="CD001338-fig-0223" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.11</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 11 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0223">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0224"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-032-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-032-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 12 Diarrhoea." data-id="CD001338-fig-0224" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 32.12</div> <div class="figure-caption"> <p>Comparison 32 Oral misoprostol 50 mcg versus 100 mcg (9): all women, Outcome 12 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0224">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-032-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0225"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-033-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-033-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 33 Oral misoprostol 50 mcg versus 100 mcg (9): all women with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours." data-id="CD001338-fig-0225" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-033-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 33.1</div> <div class="figure-caption"> <p>Comparison 33 Oral misoprostol 50 mcg versus 100 mcg (9): all women with intact membranes, Outcome 1 Vaginal delivery not achieved within 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0225">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-033-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0226"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-033-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-033-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 33 Oral misoprostol 50 mcg versus 100 mcg (9): all women with intact membranes, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0226" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-033-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 33.2</div> <div class="figure-caption"> <p>Comparison 33 Oral misoprostol 50 mcg versus 100 mcg (9): all women with intact membranes, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0226">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-033-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0227"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-033-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-033-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 33 Oral misoprostol 50 mcg versus 100 mcg (9): all women with intact membranes, Outcome 3 Caesarean section." data-id="CD001338-fig-0227" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-033-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 33.3</div> <div class="figure-caption"> <p>Comparison 33 Oral misoprostol 50 mcg versus 100 mcg (9): all women with intact membranes, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0227">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-033-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0228"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-034-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-034-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 34 Oral misoprostol 50 mcg versus 100 mcg (9): all women with ruptured membranes, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0228" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-034-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 34.1</div> <div class="figure-caption"> <p>Comparison 34 Oral misoprostol 50 mcg versus 100 mcg (9): all women with ruptured membranes, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0228">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-034-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0229"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-034-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-034-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 34 Oral misoprostol 50 mcg versus 100 mcg (9): all women with ruptured membranes, Outcome 2 Caesarean section." data-id="CD001338-fig-0229" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-034-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 34.2</div> <div class="figure-caption"> <p>Comparison 34 Oral misoprostol 50 mcg versus 100 mcg (9): all women with ruptured membranes, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0229">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-034-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0230"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-035-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-035-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0230" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.1</div> <div class="figure-caption"> <p>Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0230">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0231"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-035-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-035-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 2 Caesarean section." data-id="CD001338-fig-0231" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.2</div> <div class="figure-caption"> <p>Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0231">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0232"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-035-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-035-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 3 Oxytocin augmentation." data-id="CD001338-fig-0232" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.3</div> <div class="figure-caption"> <p>Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 3 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0232">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0233"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-035-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-035-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 4 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0233" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.4</div> <div class="figure-caption"> <p>Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 4 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0233">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0234"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-035-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-035-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 5 Instrumental vaginal delivery." data-id="CD001338-fig-0234" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.5</div> <div class="figure-caption"> <p>Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0234">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0235"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-035-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-035-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 6 Meconium‐stained liquor." data-id="CD001338-fig-0235" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.6</div> <div class="figure-caption"> <p>Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0235">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0236"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-035-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-035-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 7 Nausea." data-id="CD001338-fig-0236" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.7</div> <div class="figure-caption"> <p>Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 7 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0236">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0237"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-035-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-035-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 8 Diarrhoea." data-id="CD001338-fig-0237" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 35.8</div> <div class="figure-caption"> <p>Comparison 35 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women, Outcome 8 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0237">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-035-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0238"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-036-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-036-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 36 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women with intact membranes, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0238" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-036-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 36.1</div> <div class="figure-caption"> <p>Comparison 36 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women with intact membranes, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0238">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-036-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0239"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-036-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-036-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 36 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women with intact membranes, Outcome 2 Caesarean section." data-id="CD001338-fig-0239" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-036-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 36.2</div> <div class="figure-caption"> <p>Comparison 36 Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women with intact membranes, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0239">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-036-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0240"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD001338-fig-0240" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.1</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0240">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0241"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0241" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.2</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0241">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0242"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 3 Caesarean section." data-id="CD001338-fig-0242" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.3</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0242">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0243"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 4 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0243" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.4</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 4 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0243">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0244"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 5 Instrumental vaginal delivery." data-id="CD001338-fig-0244" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.5</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 5 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0244">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0245"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 6 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0245" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.6</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 6 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0245">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0246"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 7 Neonatal intensive care unit admission." data-id="CD001338-fig-0246" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.7</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 7 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0246">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0247"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 8 Postpartum haemorrhage." data-id="CD001338-fig-0247" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.8</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 8 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0247">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0248"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 9 Diarrhoea." data-id="CD001338-fig-0248" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.9</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 9 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0248">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0249"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-037-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-037-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 10 Vomiting." data-id="CD001338-fig-0249" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 37.10</div> <div class="figure-caption"> <p>Comparison 37 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women, Outcome 10 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0249">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-037-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0250"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-038-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-038-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 38 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all primiparae, Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD001338-fig-0250" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-038-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 38.1</div> <div class="figure-caption"> <p>Comparison 38 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all primiparae, Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0250">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-038-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0251"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-038-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-038-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 38 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all primiparae, Outcome 2 Caesarean section." data-id="CD001338-fig-0251" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-038-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 38.2</div> <div class="figure-caption"> <p>Comparison 38 Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all primiparae, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0251">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-038-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0252"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 1 Vaginal delivery not achieved in 24 hours." data-id="CD001338-fig-0252" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.1</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 1 Vaginal delivery not achieved in 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0252">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0253"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 2 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0253" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.2</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 2 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0253">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0254"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 3 Caesarean section." data-id="CD001338-fig-0254" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.3</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0254">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0255"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 4 Oxytocin augmentation." data-id="CD001338-fig-0255" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.4</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 4 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0255">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0256"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 5 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0256" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.5</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 5 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0256">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0257"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 6 Instrumental vaginal delivery." data-id="CD001338-fig-0257" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.6</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 6 Instrumental vaginal delivery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0257">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0258"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0258" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.7</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0258">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0259"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 8 Neonatal intensive care unit admission." data-id="CD001338-fig-0259" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.8</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 8 Neonatal intensive care unit admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0259">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0260"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-039-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-039-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 9 Nausea." data-id="CD001338-fig-0260" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 39.9</div> <div class="figure-caption"> <p>Comparison 39 Oral misoprostol versus delayed vaginal postaglandins (12): all women, Outcome 9 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0260">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-039-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0261"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 1 Uterine hyperstimulation with FHR changes." data-id="CD001338-fig-0261" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.1</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 1 Uterine hyperstimulation with FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0261">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0262"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 2 Caesarean section." data-id="CD001338-fig-0262" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.2</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0262">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0263"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 3 Serious neonatal morbidity/perinatal death." data-id="CD001338-fig-0263" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.3</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 3 Serious neonatal morbidity/perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0263">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0264"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 4 Oxytocin augmentation." data-id="CD001338-fig-0264" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.4</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 4 Oxytocin augmentation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0264">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0265"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 5 Uterine hyperstimulation without FHR changes." data-id="CD001338-fig-0265" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.5</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 5 Uterine hyperstimulation without FHR changes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0265">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0266"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 6 Meconium‐stained liquor." data-id="CD001338-fig-0266" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.6</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 6 Meconium‐stained liquor. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0266">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0267"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 7 Apgar score &lt; 7 at 5 minutes." data-id="CD001338-fig-0267" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.7</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 7 Apgar score &lt; 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0267">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0268"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 8 Perinatal death." data-id="CD001338-fig-0268" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.8</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 8 Perinatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0268">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0269"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 9 Nausea." data-id="CD001338-fig-0269" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.9</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 9 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0269">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001338-fig-0270"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/urn:x-wiley:14651858:media:CD001338:CD001338-CMP-040-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_t/tCD001338-CMP-040-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 10 Vomiting." data-id="CD001338-fig-0270" src="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 40.10</div> <div class="figure-caption"> <p>Comparison 40 Oral misoprostol versus dinoprostone vaginal insert, Outcome 10 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-fig-0270">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/media/CDSR/CD001338/image_n/nCD001338-CMP-040-10.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD001338-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sample size calculation</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Baseline rate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>? Important change</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rel. Risk</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total sample size</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Failure to achieve vaginal birth within 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>778</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Caesarean section (CS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1294</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hyperstimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30,716</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Perinatal mortality and morbidity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61,686</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Uterine rupture in women with previous CS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61,686</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maternal death or serious morbidity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>154,598</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sample size calculation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/full#CD001338-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oral misoprostol versus placebo/ no treatment (1): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.05, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.05, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>669</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [0.84, 8.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.15 [0.25, 105.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [0.54, 8.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.15 [0.13, 75.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1029</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.54, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Dose not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.38, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.54, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.40, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.28, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.69, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.77, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.44, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>933</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.37, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Dose not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.43, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.38, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.29, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.16, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.78 [0.73, 31.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.39, 10.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.0 [1.77, 95.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9 Postpartum haemorrhage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.37, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.30, 3.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.13, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.31, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>561</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.66, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.65, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.31, 3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.27, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.24, 2.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.04, 3.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.26, 3.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>734</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.32, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.27, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.36, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.15, 2.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Dose not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.24, 102.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.24, 102.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.42, 6.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.42, 6.93]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oral misoprostol versus placebo/ no treatment (1): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Oral misoprostol versus placebo/ no treatment (1): all women with intact membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.06, 6.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Oral misoprostol versus placebo/ no treatment (1): all women with intact membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.05, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.62 [1.01, 21.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>875</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.58, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Oral misoprostol versus placebo/ no treatment (1): all women with ruptured membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Oral misoprostol versus placebo/ no treatment (1): all primiparae with ruptured membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.0 [0.37, 132.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.39, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Oral misoprostol versus placebo/ no treatment (1): all primiparae with ruptured membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.99, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1928</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.99, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.83, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.59, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1827</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.51, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.26, 9.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.24, 102.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.81, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.75, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>685</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.83, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.58, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>930</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.01, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>930</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.01, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.73, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>685</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.97, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.98, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.32, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.29, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.0 [0.37, 133.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Ruptured uterus <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2757</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>799</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.98, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.98, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.76, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2524</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.88, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1857</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.83, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.73, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.71, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.86, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1463</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.89, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.67, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.41, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.32, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1856</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.35, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.03, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.59, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.57, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.19, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.47, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Neonatal encephalopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1899</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.06, 15.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.06, 15.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Maternal side effects (all) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.77, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.77, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1023</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.44, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>965</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.41, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.14 [0.21, 22.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.79, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.71, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.68, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>965</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.27, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>965</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.27, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Shivering <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>891</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.81, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>891</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.81, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1633</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1633</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Serious maternal complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>692</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>692</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Hyperpyrexia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>965</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>965</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women with intact membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [1.01, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.51, 3.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.73, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>741</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [1.03, 2.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women with intact membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women with ruptured membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.37, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [0.81, 5.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women with ruptured membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women with unfavourable cervices</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.70, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women with unfavourable cervices</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women with favourable cervices</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.71, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all women with favourable cervices</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all multiparae</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.86, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.22, 12.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.56, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all multiparae</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all primiparae</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.61, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.7 [0.29, 25.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.62, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Oral misoprostol versus vaginal PG (2): all primiparae</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Oral misoprostol versus intracervical PG (3): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.63, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.63, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.52, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.57 [1.11, 11.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.6 [1.19, 17.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>742</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.63, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.59, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.52, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cervix unfavourable/unchanged after 12‐24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.43, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.43, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.20, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.61, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.25 [1.14, 34.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.06, 14.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.0 [1.00, 290.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>642</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.62, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 5.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.63, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.96, 2.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [0.84, 3.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.77, 2.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>552</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.48, 2.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 5.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.51, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Neonatal encephalopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Maternal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Maternal side effects (all) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 5.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Women not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.27, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Oral misoprostol versus intracervical PG (3): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Oral misoprostol versus intracervical PG (3): all women with intact membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.65, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.67, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.52, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.6 [1.19, 17.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.6 [1.19, 17.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.62, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.59, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.52, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Oral misoprostol versus intracervical PG (3): all women with intact membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Oral misoprostol versus intracervical PG (3): all women with ruptured membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.16, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.16, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.21, 4.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.21, 4.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Oral misoprostol versus intracervical PG (3): all women with ruptured membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.59, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.38, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.81, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>947</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.43, 3.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.25, 3.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>809</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.35, 6.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.60, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.37, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.51, 2.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>818</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.66, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.02, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.02, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.39, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.39, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.59, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.59, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.41 [0.10, 58.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.41 [0.10, 58.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>518</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.89, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.53, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.91, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>854</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.66, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.48, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.62, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.04, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.60, 7.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [1.01, 2.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>716</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.42, 4.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.82 [0.24, 98.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>608</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.24, 3.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>866</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.85, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.51, 2.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.82, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Neonatal encephalopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>493</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [0.11, 67.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [0.11, 67.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.37, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.37, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.43, 3.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.43, 3.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.25, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.35, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.06, 13.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all women with ruptured membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.56, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>749</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.33, 3.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.66, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>648</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [0.91, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all women with ruptured membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all primiparae</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.82, 3.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.67, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all primiparae</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all primiparae with ruptured membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.82, 3.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.65, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all primiparae with ruptured membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all multiparae</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.15, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Oral misoprostol versus oxytocin (4): all multiparae</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Oral versus sublingual misoprostol (5): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.74, 3.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.74, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.5 [4.07, 27.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.5 [4.07, 27.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Instrumental delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.22, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 50mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.22, 0.99]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Oral versus sublingual misoprostol (5): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.86, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.27, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.93, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.63, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.64, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.47, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.07, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2507</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.23, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.66, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.07, 2.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.81, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.11, 2.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.79, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.66, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [1.00, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1772</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.60, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.60, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 20.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>971</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 20.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Serious maternal complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 25mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5756</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [1.08, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.27, 2.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2930</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [1.15, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.90, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.93, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.46, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.19, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.44, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.33, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1859</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.96, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 72.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>655</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.95, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.91, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.86, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1767</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.82, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.92, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.61, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3634</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [1.03, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.74, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.02, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.82, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.44, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.15, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1701</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.33, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.17, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.51, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.86, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>427</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.27, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1648</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.80, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>913</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.65, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.85, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Neonatal encephalopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>797</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.4 200 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Maternal side effects (all) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.53, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.49, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.29, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1563</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.94, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [1.03, 2.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>777</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.70, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.04 [0.49, 18.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1635</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.90, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [0.90, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>797</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.62, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.04 [0.63, 14.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.78, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.63, 3.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.58, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.42, 5.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1478</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.34, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.17, 2.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>698</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.35, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.3 100 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.12, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Woman not satisfied <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.08, 18.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.08, 18.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Vaginal delivery not achieved within 24 hours (subgroup by quality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 High quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.81, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Unknown/poor quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.50, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Shivering <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.43, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 25 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.07, 16.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.41, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Uterine hyperstimulation with FHR changes (subgroup by quality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.1 High quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3911</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.39, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.2 Unknown/poor quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.28, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Caesarean section (subgroup by quality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5948</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.79, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 High quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.71, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 Unknown/poor quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1938</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.78, 1.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all women with intact membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.98, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3068</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.46, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.89, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>732</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all women with intact membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all primiparae with intact membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [1.01, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all primiparae with intact membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all primiparae</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [1.01, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [1.01, 2.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.67, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.87, 3.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.67 [0.73, 9.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.23, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.23, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.26, 8.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all primiparae</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all women with ruptured membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.71, 2.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.81, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all women with ruptured membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 26.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [1.01, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.89 [0.76, 4.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 26.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all primiparae with unfavourable cervix</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 27.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all multiparae</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.94, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.11, 1.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 27.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all multiparae</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0029"> <div class="table-heading"><span class="table-label">Comparison 28.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all multiparae with intact membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.94, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 28.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all multiparae with intact membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0030"> <div class="table-heading"><span class="table-label">Comparison 29.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.94, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.06, 12.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 29.</span> <span class="table-title">Oral versus vaginal misoprostol (6): all multiparae with unfavourable cervix</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0030">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0031"> <div class="table-heading"><span class="table-label">Comparison 30.</span> <span class="table-title">Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.92, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.77, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity or perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.59, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [0.92, 17.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 71.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 30.</span> <span class="table-title">Hourly 20mcg titrated oral misoprostol versus 4‐hrly oral misoprostol 50mcg (7): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0031">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0032"> <div class="table-heading"><span class="table-label">Comparison 31.</span> <span class="table-title">Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesaraean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.33, 2.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious maternal morbidity or death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.26 [0.22, 23.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.28, 2.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.05, 5.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Maternal side effects(all) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Shivering <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 31.</span> <span class="table-title">Oral misoprostol 25 mcg 3‐daily versus 50 mcg 3‐daily (8): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0032">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0033"> <div class="table-heading"><span class="table-label">Comparison 32.</span> <span class="table-title">Oral misoprostol 50 mcg versus 100 mcg (9): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.95, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.73, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.90, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.66, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.59, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.71, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.06, 15.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.39, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.71, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 32.</span> <span class="table-title">Oral misoprostol 50 mcg versus 100 mcg (9): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0033">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0034"> <div class="table-heading"><span class="table-label">Comparison 33.</span> <span class="table-title">Oral misoprostol 50 mcg versus 100 mcg (9): all women with intact membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved within 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.95, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.75, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 33.</span> <span class="table-title">Oral misoprostol 50 mcg versus 100 mcg (9): all women with intact membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0034">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0035"> <div class="table-heading"><span class="table-label">Comparison 34.</span> <span class="table-title">Oral misoprostol 50 mcg versus 100 mcg (9): all women with ruptured membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.18, 3.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 34.</span> <span class="table-title">Oral misoprostol 50 mcg versus 100 mcg (9): all women with ruptured membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0035">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0036"> <div class="table-heading"><span class="table-label">Comparison 35.</span> <span class="table-title">Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.07, 4.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 50mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.02, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 100mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.25, 8.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.71, 2.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.49, 5.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 100mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.56, 3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.63, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 50mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.63, 2.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 100mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.54, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.25, 8.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 100mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.25, 8.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.23, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 50mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.16, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 100mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.14, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.20 [0.13, 76.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 50mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.20 [0.13, 76.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.04, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 50mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.01, 8.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 100mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.02, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.01, 8.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 50mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.01, 8.51]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 35.</span> <span class="table-title">Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0036">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0037"> <div class="table-heading"><span class="table-label">Comparison 36.</span> <span class="table-title">Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women with intact membranes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.07, 4.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.71, 2.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 36.</span> <span class="table-title">Oral misoprostol 3/4‐hourly versus 6‐hourly (10): all women with intact membranes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0037">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0038"> <div class="table-heading"><span class="table-label">Comparison 37.</span> <span class="table-title">Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.56, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.44, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.31, 5.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.31, 5.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 37.</span> <span class="table-title">Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0038">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0039"> <div class="table-heading"><span class="table-label">Comparison 38.</span> <span class="table-title">Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all primiparae</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.59, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.48, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 38.</span> <span class="table-title">Oral miso 3‐hourly vs oral miso x2 then routine oxytocin (11): all primiparae</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0039">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0040"> <div class="table-heading"><span class="table-label">Comparison 39.</span> <span class="table-title">Oral misoprostol versus delayed vaginal postaglandins (12): all women</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Vaginal delivery not achieved in 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.32, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.32, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.33, 3.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.33, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.44, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.44, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.16, 6.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.16, 6.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Instrumental vaginal delivery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.61, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.61, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal intensive care unit admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [0.13, 73.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [0.13, 73.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.22, 2.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 50 mcg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.22, 2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10 Oxytocin augmentation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 39.</span> <span class="table-title">Oral misoprostol versus delayed vaginal postaglandins (12): all women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0040">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001338-tbl-0041"> <div class="table-heading"><span class="table-label">Comparison 40.</span> <span class="table-title">Oral misoprostol versus dinoprostone vaginal insert</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Uterine hyperstimulation with FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.4 [0.46, 4.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.24, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serious neonatal morbidity/perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.0 [0.88, 55.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Oxytocin augmentation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.58, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Uterine hyperstimulation without FHR changes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.50, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Meconium‐stained liquor <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Apgar score &lt; 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Perinatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.32, 28.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 40.</span> <span class="table-title">Oral misoprostol versus dinoprostone vaginal insert</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001338.pub3/references#CD001338-tbl-0041">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001338.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001338-note-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001338-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001338-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD001338-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD001338-note-0009">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD001338-note-0001">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001338\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001338\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001338\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001338\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001338\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7a2tKMcJ&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001338.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001338.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001338.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001338.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001338.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715683881"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001338.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715683885"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001338.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d8d14c91e9371',t:'MTc0MDcxNTY4NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 